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Identification of in vivo Protein Targets of Nitric Oxide in Drosophila melanogaster 
A thesis submitted to the University of Sussex for the degree of Master of Philosophy  
By Shreya Saha 
School of Life Sciences 
 May 2010 
Nitric Oxide (NO) is known to alter cell proliferation and growth. This project investigated 
the molecular targets of NO, using the salivary glands of Drosophila melanogaster third 
instar larvae. 
A screen of 75 transgenic Drosophila lines expressing Yellow Fluorescent Protein tagged 
proteins, for those that showed a rapid alteration in sub-cellular localization after organ 
culture with an NO donor was undertaken. This screen revealed Mi-2 as a target of NO action. 
This was confirmed in vivo as localization of Mi-2-YFP was altered in whole salivary glands 
expressing Nitric Oxide Synthase (NOS2). The localization of the endogenous Mi-2 protein 
was similarly altered in NOS2 expressing single cells. A quantitative analysis using the image 
analysis software “Velocity” demonstrated an increase in the nuclear concentration of Mi-2 
protein in these cells. Targeted expression of RNAi-Mi-2 as well as analysis of Mi-2 
transheterozygous mutant larvae revealed that NO can impart its reduced growth phenotype 
independently of Mi-2.   
Dref can associate with Mi-2 and can control cell proliferation and growth. Localisation of 
Dref did not show any noticeable change in single cells expressing NOS. However when 
these cells were double labelled both with anti-Dref and anti-Mi-2 antibodies, the anti-Dref 
staining was altered. This indicates that NO can alter the availability of the Dref antigen by 
reorganising the Mi-2/Dref complex.  
Mi-2 is a component of the NuRD complex. The effect of NO in altering the Mi-2/Dref 
complex was exploited to investigate the effect of simj (a regulatory component of NuRD), on 
either of the proteins after potential disassociation of the complex. The data demonstrated an 
independent effect of simj on the localization of each protein.  
NO and FOXO regulate the expression of a common set of genes and FOXO is required for 
the anti growth properties of NO. Thus the effect of FOXO expression on Mi-2 and Dref 
protein distribution was determined. Although no consistent alteration of Mi-2 localization 
was observed, a quantitative analysis showed a large increase of Dref protein concentration in 
FOXO expressing cells. Double antibody staining of these cells with both anti-Dref and anti-
Mi-2 antibodies showed a novel nuclear localization of the proteins imparted by FOXO. Thus 
this study has identified the regulation of the Mi-2/Dref protein complex as a possible growth 
control mechanism by NO and FOXO.       (x) 
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CHAPTER 1: General Introduction 
 
1.1. Brief introduction to cell signalling: NO as signalling molecule 
 
Cell signalling is essential for the physiological functions, growth and biochemistry of 
cells. Cell signalling can be achieved by molecules which are expressed on the surface 
or secreted from one cell and interact with the receptors on or in other cells. These 
signalling molecules mediate a series of intracellular reactions which can regulate cell 
proliferation, differentiation, survival and metabolism (Alberts et al., 2002). There are 
two different types of cell signalling, one is contact dependent signalling, which is also 
referred as direct cell to cell signalling and occurs by the direct interaction with the 
neighbouring cells. The other is through the action of secreted signalling molecules 
(Alberts et al., 2002). Signalling, mediated by secreted signalling molecules can be of 
three different types, endocrine signalling, paracrine signalling and autocrine signalling 
(Hancock, 1997). In case of endocrine signalling, cells secrete signalling molecules into 
the circulatory system, which can carry the signal to target cells, distributed throughout 
the body. The main class of molecules in endocrine signalling are hormones, which, 
after release, diffuse and travel a long distance to impart their effect on a distantly 
placed second cell. In the case of paracrine signalling, the signalling molecules act as 
local mediators and affect the neighbouring cells present in the immediate environment. 
Neurotransmitters released from neurons, imparting their effect on neighbouring 
neurons, are good examples of paracrine signalling molecules. Cells involved in 
autocrine signalling release molecules which can bind back to their own receptors. 
Production of growth hormones by tumour cells, stimulating their own growth, is an 
example of autocrine signalling (Hancock, 1997). Signalling molecules range from cell 
surface receptor proteins, intracellular signalling proteins to simple gases. Hydrogen 
peroxide and carbon monoxide are simple gases acting as signalling molecules. Nitric 
Oxide (NO) is a vital and highly studied example of a gas acting as a signalling 
molecule (Hancock, 1997). By acting as a paracrine signalling molecule NO can 
regulate guanylyl cyclase activity, control neurotransmitter release and itself acts as a 
neurotransmitter. NO performs several physiological roles on the nervous and 
cardiovascular systems. Moreover, it plays a major role in the variety of physiological 
processes such as immune defence, regulation of cell death (apoptosis), cell motility and 
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as a physiological modulator of cell proliferation (Villalobo, 2006). Due to all these 
vital roles NO was declared to be the molecule of the year (Culotta and Jr., 1992).  
 
1.2. Synthesis and Mode of action of NO 
 
Acetylcholine, which is released from axons, when activated neurons send an electrical 
impulses along their axon, plays an important role in cell signalling as a 
neurotransmitter (Hancock, 1997). It has been observed that acetylcholine acts on the 
muscarinic receptors of the cells of rabbit thorasic aorta and other blood vessels in the 
presence of endothelial cells, to trigger the synthesis of a substance which causes 
relaxation of vascular smooth muscles (Furchgott and Zawadzki, 1980). By using 
―sandwich mount method‖ it has been shown that, when the endothelial cells of rabbit 
aortic strips are stimulated by acetylecholine, a relaxing factor is released, termed 
Endothelium Derived Relaxing Factor or EDRF (Furchgott, 1983). A detailed 
comparative study between the biological and chemical properties of EDRF and NO 
revealed that the EDRF is NO (Ignarro LJ et al., 1987). The preliminary step of Nitric 
Oxide synthesis is triggered by the release of neurotransmitters like acetylcholine from 
the activated nerve terminus to the walls of blood vessels during several physiological 
processes such as dilation of the blood vessels, regulation of the contraction of smooth 
muscles. Acetylecholine acts on the endothelial cells and activates NOS (Nitric Oxide 
Synthase), catalysing the formation of NO from L-arginine. The guanidine group of L-
arginine is oxidized by using five electrons resulting in the synthesis of citruline and 
NO along with two molecules of water passing through an  intermediary step in which 
hydroxyarginine (N
ω
~-hydroxy-L-arginine) is formed. Formation of the intermediate, 
N
ω
~-hydroxy-L-arginine (NOH-ARG) from L-Arginine, catalysed by NOS requires 1 
equivalent of NADPH. The primary role of NADPH in the reaction is to contribute two 
electrons required for the oxidation of guanidino nitrogen of L-arginine. NOH-ARG 
undergoes three-electron-oxidation, with the electrons contributed by 0.5 equivalents of 
NADPH leading to the formation of NO and citruline (Griffith OW and DJ., 1995). 
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Figure 1.1. NO biosynthesis from L-arginine. The intermediate in the formation of NO, the 
enzyme bound N-hydroxy-L-arginine is shown. The dotted line shows recycling of L-citrulline 
back to L-arginine. Figure adapted from (Bruckdorfer, 2005).  
 
After synthesis, NO diffuses rapidly across the plasma membrane and can enter 
neighbouring cells. Within neighbouring cells NO can react with iron bound to the 
active site of the enzyme guanylyl cyclase resulting in the increase of its enzymatic 
activity and in the production of the second messenger molecule cyclic GMP. cGMP 
induces muscle cell relaxation and dilation of blood vessels. It has been reported that the 
accumulation of cGMP is elicited by nitric oxide (CA Gruetter et al., 1981). A study of 
the biochemical interaction between guanylyl cyclase and NO demonstrated that 1 mol 
of NO-heme complex is bound to 1 mol of holoenzyme (heme containing guanylate 
cyclase) followed by a 50 fold increases in the specific activity of the heme bound 
guanylate cyclase (Ignarro et al., 1986).  
However, there are many other effector molecules that NO has been shown to activate 
and much of the signalling from NO has been shown to be guanylate cyclase 
independent. NO is reported to activate delayed rectifier potassium channel (Iks) 
independent of soluble guanylate cyclase (Asada et al., 2009). A Study of NOS2 
(Section 1.3) knockout macrophages of mammalian cells revealed that NOS2 mediates 
regulation of several genes by interferon gamma and the process is cGMP independent 
as reviewed in (Stamler et al., 2001).  
NO is a free radical denoted as NO
.
, which means that it contains an unpaired electron. 
Because of the presence of the unpaired electron, NO is always in an unfavoured 
 
 
 
 
 
 
L-arginosuccinate 
Fumarate ATP Aspartate 
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electronic state which makes it highly reactive. Being a highly reactive molecule NO is 
extremely unstable and thus has a very short half life of 3-6 seconds in tissue and 1-2 
seconds in blood (Malinski) and thus its mode of action is restricted within local regions.   
 
1.3. Nitric Oxide Synthases  
 
The enzyme which catalyses the synthesis of NO is NOS (Nitric Oxide Synthase), is a 
family of protein isoforms in vertebrates. A soluble, native, monomeric enzyme was 
purified from rat cerebellum by utilizing 2’, 5’ – ADP affinity column eluted with 
NADPH and showed a single 150-kDa band on SDS/PAGE (Bredt and Snyder, 1990). 
Three different isoforms of NOS have been purified from mammalian system: bNOS 
(brain NOS, now known as NOS1)  (Schmidt et al., 1991), eNOS (epithelial NOS, now 
known as NOS3) (Pollock et al., 1991) and macNOS (macrophage NOS now known as 
NOS2) (Yui et al., 1991). Unlike the Drosophila NOS (dNOS) gene, the NOS2 gene 
used in this study, is not regulated by calcium (Regulski and Tully, 1995). As this 
mouse NOS2 gene is not regulated by Ca
2+
, it was decided to use this in the present 
study instead of using the dNOS gene. This mouse NOS2 cDNA has been previously 
expressed in Drosophila under the control of a heat shock promoter (Kuzin et al., 1996). 
The same NOS2 cDNA was cloned into pUAST (Brand and Perrimon, 1993)  and four 
transformants were generated. These transformants were mapped to the X chromosome, 
two on the second chromosome and one on the third chromosome (Kimber, 2005). The 
transformant which was used for this particular study was UAS-NOS2, located on the X 
chromosome, as it showed the highest levels of expression. 
Although NOS isoforms differ from each other in their sensitivity to react with various 
agrinine analogue, (Bredt DS and SH., 1994) in size, in expression levels and in 
regulation, they show a 30-40% amino acid homology at their C-terminal end and 
function as homodimers (Griffith OW and DJ., 1995). A structural study of cytokine-
inducible mouse NOS isoform (NOS2) revealed that, two N-terminal catalytic 
oxygenase domains of each subunit interact with each other and form a dimmer in a 
head to head manner whereas the C-terminal reductase domains are extended from the 
end of each subunit. The oxygenase domain contains heme (iron protoporphyrin IX) and 
(6R)-5,6,7,8-tetrahydro-lbiopterin (H4bioprotein) whereas the  reductase domain 
contains two flavin molecules (one FMN and one FAD) all of which function as bound 
prosthetic groups or cofactors (Stuehr and Ikeda-Saito, 1992). 
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Figure 1.2. Biochemical structure of NOS2: Figure showing the head to head 
alignment of 56kDa of NOS oxygenase subunits and the 74kDa reductase subunits as 
extensions (Stuehr, 1997).  
 
In addition to the prosthetic groups, the oxygenase domain has a binding site for L-
arginine and the reductase domain has a binding site for NADPH (Essam A. Sheta et al., 
1994). The transfer of reducing equivalents from NADPH to the heme group by the 
FAD and FMN molecules facilitates the binding of oxygen with the oxygenase domain 
resulting in the step-wise oxidation of L-arginine (Stuehr, 1997). By performing steady 
state and stopped flow kinetic studies on a nNOS, Miller et al reported that resembling 
the cytochrome P450 reductase (CPR) the oxygenase domain of NOS receives the 
electrons required for the L-arginine oxidation from the reductase domain (R. Timothy 
Miller et al., 1999).  
There are several inhibitors of NOS present in blood which prevent the synthesis of NO 
by NOS. Arginine methyl-transferases are the enzymes which catalyse the formation of 
several arginine analogues such as L-monomethylarginine (L-NMMA), asymmetric 
dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) by methylating the 
guanidino nitrogen group of arginine residues within proteins leading to their post 
translational modification (Leiper et al., 1999). Proteolysis of proteins containing these 
arginine analogues causes the release of the methylarginines. These methylarginines [L-
NMMA and ADMA but not SDMA] (Leiper et al., 1999) compete with L-arginine 
binding with NOS and result in the loss of the catalytic activity of NOS and hence 
synthesis of NO is prevented (Bruckdorfer, 2005). 
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1.4. Physiological Roles of NO 
 
1.4.1. Nitric Oxide signalling in smooth muscle 
 
NO plays a vital role in the lowering of blood pressure by allowing relaxation and 
dilation of smooth muscle. NO opposes the effect of vasoconstrictors and increases the 
smooth flow of blood, limiting the chances of hypertension (Naseem, 2005). In case of 
several diseases such as atherosclerosis, the process of endothelium regulated 
vasorelaxation is prevented indicating the loss of NO activity (Naseem, 2005). It has 
been reported that coronary arteries, obtained from the hearts of cardiac transplantation 
patients having atherosclerosis, show impairment of cardiac muscle relaxation mediated 
by EDRF/NO (Forstermann et al., 1988) (Louis J. IGNARRO et al., 1987).  
 
1.4.2. Nitric Oxide signalling in platelets 
       
A simultaneous study of platelet aggregation and NO production by activated platelets 
was performed by using NO-selective microelectrode in a standard platelet 
aggregometer which revealed that a NOS inhibitor, N-nitro-L-arginine methyl ester 
(L-NAME), reduced NO production (92%) and cyclic GMP production (33%) along 
with an increase of platelet aggregation (35%) (Freedman et al., 1997). Another study 
reported that aggregating platelets from patients suffering from acute coronary 
syndrome produces less NO as compared to controls (Freedman et al., 1998). 
 
   1.4.3. Nitric Oxide signalling in nervous system 
 
NO displays many of the properties of a neurotransmitter. Neurons, whose transmission 
function is brought about with the release of NO are termed as Nitrergic Nerves 
(Salvador Moncada et al., 1997). In the central nervous system, NO plays a vital role as 
a principal non-adrenergic, non-cholinergic (NANC) neurotransmitter by regulating 
relaxation of smooth muscles in the cerebral circulations and also regulates aspects of 
learning and memory (Bredt, 1999). It has been reported that the deletion of both 
endothelial and the neuronal NOS isoforms, expressed in neurons, reduced the rate of 
induction of long term potentiation (LTP) which is a form of synaptic plasticity 
associated with learning and memory (Duncan and Heales, 2005). A detailed study has 
shown that the inhibitors of NOS can cause the destruction of spatial learning (Holscher, 
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1997). Smith et al reported the involvement of the powerful oxidant, peroxynitrile, in 
Alzeimer’s disease, by measuring the immunoreactivity index of nitrotyrosine produced 
during the nitration of tyrosine residue by peroxynitrile, which is formed as a result of 
the reactions between NO and superoxides (Mark A. Smith et al., 1997).   
 
1.4.4. Nitric Oxide and cell proliferation   
 
Endogenous NO synthesized by NOS acts as an antiproliferative agent to down-regulate 
the proliferation of a variety of cells (Villalobo, 2006). The inhibition of proliferation of 
lymphocytes is mediated by the presence of exogenous L-Arginine and increasing the 
number of macrophages and is suppressed by the presence of N
G
-monomethyl-L-
arginine (NMMA), a specific inhibitor of nitric oxide synthesis (Denham and Rowland, 
1992). The soluble cytokine, interferon-gamma, shows anti-proliferative activity on rat 
vascular smooth muscle cells with an increase in the level of cyclic GMP (cGMP) 
concentration by Nitric Oxide generation and this anti-proliferative activity of NO is 
repressed by N
G
-nitro-L-arginine, a Nitric Oxide (NO) synthase inhibitor (Nunokawa 
and Tanaka, 1992). NO induces the cytostatic effect of nerve growth factor (NGF) 
followed by growth arrest and changes the program of cell proliferation towards cell 
differentiation. Inhibition of NOS causes interruption in the cytostatic effect of NGF 
thus preventing cell differentiation (Natalia and Grigori, 1995). Another study reveals 
that vascular endothelial growth factor (VEGF) induced proliferation of BeWo cells is 
up regulated by the NOS inhibitor, L-NAME, but is repressed by the NO donor, sodium 
nitroprusside (Cha et al., 2001). An important role of NO is in growth arrest and cell 
cycle regulation of cancer and tumour cells as there is a negative relationship between 
proliferation of tumour cells and NOS activity in them. A study reported that in the 
neuroblastoma cell line (SK-N-BE) and in primary cerebellar granule cells, NO 
represses cell proliferation leading to cell differentiation along with a simultaneous 
decrease in the expression level of the proto-oncogene, N-Myc (Ciani et al., 2004). 
Measurements of cell growth, as determined by the rates of protein and DNA synthesis, 
has revealed that a concentration of 1-30 µM of NOHA (the principle intermediate 
formed during NO production) and NO (in the form of DETA/NO) inhibit proliferation 
of human Caco-2 tumor cells by 30-85% (Buga et al., 1998). Partially purified 
ribonucleotide reductase (RR) from L1210 mouse lymphoma cells, which is a rate 
limiting enzyme of DNA synthesis, has been inhibited leading to the inhibition of DNA 
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synthesis by NO produced by activated macrophages (Kwon et al., 1991). Therefore NO 
can impart its antiproliferative action by negatively regulating DNA synthesis.  
 
1.5. NO donor molecules 
 
NO is poorly soluble in water (only 2-3mM) and being a free radical gas, having a lone 
unpaired electron, NO is unstable in the existence of numerous oxidants (Tingwei Bill 
Cai). This chemical nature makes the introduction of NO to a biological system complex. 
Consequently several chemical agents, which can act as NO donors and can release NO 
in biological systems have been utilised to study the biochemical effects of NO. Hence 
the practical aspect of study of the antiproliferative effect of NO on normal cells requires 
extensive use of chemical NO donors. With the advancement of chemistry, numerous 
NO donors have been developed which have made possible the spontaneous discharge of 
NO and thus the controlled donation of NO in biological systems. Diverse NO donors 
differ in their chemical reactivity and also in NO release mechanisms as they have 
variation in their chemical structures. There are three different types of mechanisms of 
release NO by NO donors. The first way is to liberate NO spontaneously through 
thermal or photochemical self-decomposition which is performed by S-nitrosothiols, 
diazeniumdiolates, oximes. The second way is liberating NO by reacting with acid, 
alkali, metal and thiols which is accomplished by several NO donors such as organic 
nitrates, nitrites and syndnonimines and the third mode is oxidation, catalyzed by some 
enzymes such as NO synthases or oxidases which metabolically activate NO release 
from N-hydroxyguanidines. Being capable to release NO under specific conditions, 
numerous NO donors are found to be of great importance to treat diseases like 
hypertension and atherosclerosis which are caused by scarcity of NO production in 
biological systems. The NO donor Glyceryl trinitrate has been used as a vasodialator 
drug since 1879 and is also used to relieve acute attacks of angina pectoris (Tingwei Bill 
Cai). Besides being used as medicines, several chemical NO donors have already proved 
to be efficient tools for research into the treatment of diseases resulting from extreme 
proliferation and uncontrolled cell growth. By incorporating [
3
H] thymidine, performing 
flow cytometry and calculating cell numbers it has been established that Sodium 
nitroprusside (SNP) represses epidermal growth factor regulated development of 
vascular smooth muscle cells (VSMC) at G1/S phase of cell cycle, and also restrains 
EGF induced DNA synthesis along with an up-regulation of the level of cGMP. The 
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mechanism of antiproliferative activity of SNP mimics that of endothelium released NO 
which also participates in the regulation of vascular smooth muscle cells (VSMC) 
proliferation via a cGMP regulated mechanism (Yu et al., 1997). Another investigation 
reported evidence of cell cycle arrest during G0/G1 phase when p53 deficient SW620 
colon cancer cells were exposed to the NO donor S-nitrosoglutathione (GSNO) (Jeon et 
al., 2005). A study examining the antiproliferative effect of another NO donor, Glyco-2 
SNAP, on the development and proliferation of MDA-MB-231 breast cancer cell lines 
discovered that 100µM concentration of this NO donor inhibited DNA synthesis of these 
cells. (Laudanski et al., 2001). The antiproliferative action of NO in fibroblasts requires 
p53 signaling as it has been shown that p53 lacking cell lines do not exhibit growth 
arrest when given a 30mins exposure to the NO donor SNAP (Nakaya N et al., 2000).  
 
1.6. Study of NO by using Drosophila melanogaster as a model organism 
 
The role of NO in halting cell growth and directing the cell cycle towards cell 
differentiation has been extensively studied by in Drosophila. The Drosophila NOS 
gene (dNOS) synthesises a 152kDa protein which shows 43% amino acid sequence 
similarity with the NOS isolated from rat neuronal cells (Regulski and Tully, 1995). NO 
acts as an antiproliferative agent allowing cell differentiation to occur at late larval 
stages, in transgenic Drosophila carrying the mouse NOS2 cDNA gene under the 
control of heat shock promoter (Kuzin et al., 1996). The action of NO on the 
suppression of DNA Synthesis was shown by analysing BrdU (5-bromo-deoxyuridine)  
incorporation during S phase of imaginal disc growth of third instar larvae (Kuzin et al., 
1996). Kuzin et al reported that imaginal tissues from larvae of transgenic flies carrying 
nitric oxide synthase gene (dNOS1) induced by the heat shock promoter showed fewer 
BrdU-labeled cells as compared to flies in which NOS expression is inhibited (Kuzin et 
al., 2000).  
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1.7. Technologies For Gene Manipulation In Drosophila melanogaster 
Drosophila has long been a favourite organism for genetics and developmental research, 
but it was primarily through the use of several ingenious gene transformation 
technologies that the powerful tools of molecular biology were fully exploited.  
1.7.1. Transposon associated gene manipulation 
Among the foremost genetic tools for introducing transgenic DNA into flies are 
transposons such as P elements (Spradling and Rubin, 1982). The P element is 2.9 kb 
long transposon and contains 31 bp terminal inverted repeat sequences. It generates 
direct repeats of target DNA of 8 bp at the site of insertion upon integration. The P 
element has 4 open reading frames and encodes a protein called transposase, an enzyme 
required for transposition of the P element. Because of the expressional specificity of 
transposase in germ line cells transposition, mobilization of P element occurs only in the 
germ line. P elements can be engineered to carry a marker gene to identify transformants. 
Both selectable and visible markers can be used but the transformation efficiency is 
often higher if a visible marker (eye colour gene) is used instead of a selectable marker 
(neomycin resistance gene) (Spradling and Rubin, 1982). P elements can carry an insert 
up to 40kb (Haenlin et al., 1985). The most important use of P element is generation of 
transgenic flies. The drawback of using P element is their insertional specificity (Venken 
and Bellen, 2005).  P element insertion often occurs within 400bp of the transcriptional 
start site of genes. Approximately two thirds of all P-element insertions occur in 
disproportionately few genomic locations termed hot or medium hot spots. To overcome 
this problem, use of the Piggy Bac vector has been employed which has no obvious 
insertional preference as reviewed in (Venken and Bellen, 2005). Unlike the P-element, 
Piggy Bac inserts do not frequently produce mutant alleles of the tagged gene. As a 
result, Piggy Bac insertions are not useful in generating new mutant alleles of genes. As 
remedy of this drawback a hybrid transposable element has been constructed by carrying 
a Piggy Bac backbone with P element inserted inside. Use of this hybrid vector, has 
increased the probability of random insertion (due to the presence of Piggy Bac 
backbone) along with mutagenesis (through imprecise excisions of the P-element) 
(Venken and Bellen, 2005).  
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1.7.2. Enhancer Trapping 
In this technique a reporter LacZ is fused to a weak promoter and is controlled by the 
activity of a nearby enhancer. The reporter gene used in this enhancer trap constructs 
was originally the LacZ gene from Escherichia coli, which codes for β-galactosidase 
(O'Kane and Gehring, 1987). The LacZ promoter fusion is mobilised within a P element 
and inserted in Drosophila (O'Kane and Gehring, 1987). LacZ fusions act as an efficient 
cell marker, which facilitate genetic and developmental studies. This strategy of gene 
manipulation made possible the visualization of tissue and cell specific expression of 
Lac-Z (O'Kane and Gehring, 1987). Enhancer trap strategies allow a thorough study of 
expression patterns of trapped genes, but are not informative at the protein level, 
particularly the subcellular localisations of proteins (Xavier Morin et al., 2001). A 
technique which establishes a correspondence between gene and protein and also 
facilitates the study of the gene product was necessary (Jarvik et al., 1996). A more 
recent strategy of ―Protein Trapping‖ has been developed (Discussed in Section 3.1.1). 
1.8. Previous research in laboratory 
As the present investigation is a continuation of the previous research which was on 
going in our laboratory, a brief description of the previous findings will be given. 
Microarray analysis of tissue culture cells treated with 200M of the NO donor S-
nitroso-N-acetyl-penicillamine (SNAP), identified Thor as one of seven transcripts up-
regulated after 4hrs of NO treatment which was also up-regulated at 8 and 12hrs post 
NO exposure (Kimber, 2005). Further analysis, and comparison to other data sets, 
showed that expression of a common set of genes are regulated both by NO and the 
transcription factor FOXO (Kimber, 2005). Subsequently Drosophila FOXO was 
confirmed to be a target of NO (Scott, 2009).  
Previous work attempted to identify other targets of NO. For this purpose YFP tagged 
CPTI (transgenic Drosophila) lines were used. Previously, salivary glands from more 
than 35 YFP tagged CPTI lines were examined after exposure to the NO donor S-
Nitroso-N-acetylpenicillamine (SNAP). Among these, the Mi-2 tagged line CPTI-
000232, showed consistent changes after SNAP exposure for 24hrs, 20hrs, 16hrs, 12hrs, 
8hrs and 4 hrs respectively (Lasala, 2007). It was observed that the expression of the 
YFP tagged Mi-2 protein was higher after NO treatment compared to untreated control 
salivary glands. Up regulation of the expression of YFP tagged Mi-2 in CPTI-000232 
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established Mi-2 as another probable target of NO. It is possible that the up-regulation of 
the expression of Mi-2 after SNAP treatment may be controlled by FOXO. 
1.9. Why use the salivary gland? 
The growth of larval salivary glands is achieved by endoreplication where there no 
cytokinesis after DNA replication resulting in an increase in cell size instead of cell 
number (Demerec, 1950) (Andrew et al., 2000). After determination of the salivary 
gland primordia (8hrs AEL) there is an increase in polytenization until the end of the 
third larval instar (Demerec, 1950). Hence, the individual cells of the mature third 
instar larval salivary glands are large (Demerec, 1950). This large cell and nuclear size 
makes the study of subcellular localization of proteins easier.  Previous work has 
demonstrated that the salivary glands cells respond to NO expressed from within those 
cells with reduced growth and increased expression of NO dependent genes (Scott, 
2009, Kimber, 2005). Exogenously provided NO has also been demonstrated to alter 
the localisation of some tagged proteins in a small scale pilot study (Lasala, 2007). I 
therefore decided to use larval salivary glands to study the subcellular accumulation of 
proteins in response to NO. 
1.10. A Brief introduction about Mi-2 and associated proteins 
 
1.10.1. Mi-2 - A brief description  
Immunofluorescence study with anti-Mi-2 positive sera of dermatomyositis patients 
recognized the 218 kDa nuclear human Mi-2 protein, encoded on chromosome 12 (Hans 
Peter Seelig  et al., 1995). Drosophila Mi-2 is reported to contain a HMG box, two PHD 
fingers, two chromodomains and a ATPase domain (Bouazoune et al., 2002).   
 
1.10.2. Mi-2 is a component of NuRD complex 
Immunoprecipitation experiments performed with human Hela cells have demonstrated 
that Mi-2 is a component of multiprotein Nucleosome Remodelling Deacetylating 
(NuRD) complex (Ahringer, 2000) (Tong et al., 1998). The 2MDa NuRD complex 
(Ahringer, 2000) consists of eight polypeptides: MTA1/2, HDAC1, HDAC2, RbAp46, 
RbAp48, MBD3, p66  and Mi-2 (Ng and Bird, 2000) (Ahringer, 2000). The nucleosome 
remodelling activity of NuRD is provided by its Mi-2/CHD protein complex which 
contains helicase/ATPase domains (Ahringer, 2000). The histone deacetylases (HDAC 
1/2) present in NuRD provides the histone deacetylation activity (Yi Zhang et al., 1998). 
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Therefore, NuRD contributes to both ATP dependent nucleosome disruption and also 
histone deacetylase activity (Yi Zhang et al., 1998) (Xue et al., 1998, Tong JK et al., 
1998).  
 
1.10.3. Functional roles of Mi-2/NuRD 
Transcriptional activators are commonly associated with histone acetyltransferases 
(HATs), whereas transcriptional repressors have a functional connection with histone 
deacetylases (HDACs) (Ng and Bird, 2000, Struhl, 1998). The functional link between 
histone deacetylation and transcriptional suppression became evident when a 
mammalian histone deacetylase, HDAC1, purified via its affinity for the histone 
deacetylase inhibitor trapoxin, was shown to be related to the yeast transcriptional 
repressor, RPD3 (Taunton et al., 1996). The exact mechanism through which the SIN3-
RPD3 associated transcriptional repressor Ume6 decaetylates histone H4, leading to a 
transcriptional suppression of Ume6 binding site containing genes, has been 
demonstrated in Saccharomyces cerevisiae (Stephen E. Rundlett et al., 1998). Therefore, 
this evidence suggests that HDACs in NuRD play a vital role in transcriptional 
repression. The structural similarity of NuRD with the Sin3 complex suggests that, like 
Sin3, NuRD also takes part in transcriptional repression (Ayer, 1999). Further data 
linking NuRD with transcriptional repression is that one subunit of NuRD is the 
metastasis associated protein MTA1 (Toh et al., 1994). MTA1 has a high degree of 
similarity with the nuclear receptor corepressor, N-CoR (Xue et al., 1998). N-CoR, is an 
associated factor of the transcriptional repressor complex Sin3 and facilitates Mxi1/Sin3 
regulated transcription of Myc family transcriptional repressors leading to overall 
growth arrest and tumour suppression. (Alland et al., 1997) 
 Mi-2, a core component of the NuRD complex, facilitates chromatin and nucleosome 
remodelling through ATP hydrolysis leading to a transcriptional activation (Wade et al., 
1998). Mi-2 is a member of SWI2/SNF2 family proteins which show a DNA stimulated 
ATPase activity required to destabilise histone-DNA interactions in nucleosomes 
leading to binding of transcription factors to histone associated DNA (Pazin and 
Kadonaga, 1997). The two chromodomains present in Mi-2 are essential for the binding 
of nucleosomes to Mi-2 through protein-DNA binding during the preliminary stage of 
nucleosome remodelling (Bouazoune et al., 2002). It has been revealed that, the 
nucleosome structure is destabilized to permit the binding to DNA of sequence specific 
transcription factors and other transcriptional machinery (Tsukiyama and Wu, 1997). In 
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Drosophila, Mi-2 mutant germ cells do not develop to produce embryos and this can be 
rescued by expressing a Mi-2 transgene. This indicates that the Mi-2 protein is essential 
for germline development in Drosophila. (Kehle et al., 1998).  
A sequence specific DNA binding protein Hunchback (Hb) initiates Hox gene 
repression whereas Polycomb group, PcG, proteins, maintain the suppression activity in 
Drosophila (Pirrotta, 1997). Drosophila Mi-2 has been assumed to take part in HoX 
gene repression. Hb requires NuRD in this repression activity via interactions with Mi-2 
which in turn modifies the chromatin structure, facilitating the binding of PcG and DNA 
resulting in HoX gene repression (Kehle et al., 1998). The methylation of DNA at the 
dinucletide CpG is performed by the methyl CpG binding protein MeCp2, which in turn 
brings about transcriptional regulation. It has been reported that MeCp2 protein recruits 
the transcriptional repressor and decaetylase complex Mi-2/NuRD for gene regulation 
by DNA methylation in mouse (Nan et al., 1998) . Therefore, the process of gene 
regulation by transcriptional silencing is achieved by a relationship between DNA 
methylation and histone decaetylation established by MeCp2 and Mi-2/NuRD. This 
regulation  has also been shown in Xenopus laevis (Wade et al., 1999).  
In addition, the Mi-2α associated proteins, Ikaros and Aiolos, are associated with the 
NuRD complex (Kim et al., 1999) These proteins act as sequence specific DNA binding 
factors required for the development of the mouse haemopoietic system (Cortes et al., 
1999). Ikaros is reported to be necessary in the regulation of mouse B and T cell 
differentiation (Georgopoulos et al., 1997).   
In summary ATP hydrolysis dependent changes in chromatin structure such as 
acetylation, deacetylation and methylation of core histones, which regulate the contact 
of several transcription factors with DNA, are achieved by three core components of 
NuRD: Mi-2, HDAC1/2, and MBD3, resulting in the regulation of gene expression.  
 
1.10.4. P66 the regulatory component of NuRD    
In Drosophila, the p66 component of NuRD is localised in the nucleus and represses 
wingless target genes and performs vital roles in development through the regulation of 
ecdysone-responsive genes (Kon et al., 2005). Purified MeCP1 contains methyl-CpG-
binding protein, MBD2 along with all the components of Mi-2/NuRD complex 
including p66 (Feng and Zhang, 2001). A confocal microscopic study revealed the 
direct association between p66 protein family members and the MBD2/3 proteins, 
which are the components of MeCP1 protein complex in DNA methylation mediated 
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transcriptional repression (Brackertz et al., 2002). Analysis and characterization of the 
MeCP1 complex revealed two p66 homologues p66 and p68. These homologues, 
isolated from different organisms showed two highly conserved regions, CR1 and CR2. 
CR1 is involved in the attachment of p66 with the other MeCP1 components whereas 
CR2 functions in localisation of p66 and MBD2/3 to specific loci during DNA 
methylation mediated transcriptional repression (Feng et al., 2002). Another report 
suggests that the DNA demethylase, MBD2, which is a component of MeCP1 complex, 
interacts with Mi-2/NuRD and directs it to methylated DNA (Zhang et al., 1999). p66 is 
reported to interact with MBD2 and MBD3 (Kon et al., 2005) and over expression of 
p66 alters the localisation of  MBD3 (Feng and Zhang, 2001). All these reports support 
the hypothesis that p66 involves NuRD in methylation mediated gene silencing through 
MBD2, and hence functions as a regulatory component of Mi-2/NuRD (Kon et al., 
2005).  
Some parts of this study will focus to determine the effect of NO on p66 in Drosophila. 
According to the gene naming in Flybase, p66 will be referred to as Simj in the rest of 
this thesis.  
 
1.10.5. Dref - An associated protein of Mi-2 
Antibodies raised against Dref (DNA replication related element factor) can co-
immunoprecipitate Mi-2 in Drosophila which confirms the in vivo presence of Dref/Mi-
2 complex (Hirose et al., 2002). Mi-2 genetically interacts with Dref. Mi-2 and Dref are 
found to negatively regulate each other’s function. Binding of Mi-2 and Dref to 
polytene chromosome is mutually exclusive (Hirose et al., 2002). Active Dref is a 
86kDa homodimeric polypeptide.  BLAST searches revealed that the human homologue 
of Dref has 22% sequence homology with Drosophila Dref (Ohshima et al., 2003). 
DNAase I foot-printing analysis indicates that Drosophila Dref  binds with the DRE 
(DNA replication related element) (Fumiko Hirose et al., 1993). DRE is the 
transcription regulatory region which contains an 8 bp palindromic sequences (5’-
TATCGATA) and stimulates the promoter activity of DNA replication related genes 
(Fumiko Hirose et al., 1993). Dref contains 701 amino acids (Hirose et al., 1996). 
Proliferating cell nuclear antigen (PCNA) interacts with DNA polymerase during DNA 
synthesis. The DNA binding region of PCNA probably functions to increase the 
processivity of DNA polymerase (Yamaguchi et al., 1990). The presence of the 8 base 
pair DRE sequence was identified in both the DNA polymerase α and PCNA genes 
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(Hirose et al., 1991). The DRE sequence can effect within 1.4 kb from the transcription 
initiation site and its presence in the DNA polymerase α and PCNA gene promoters 
suggests that expression of both the genes is regulated by Dref (Fumiko Hirose et al., 
1993). More than 150 genes which are involved in several physiological reactions 
related to cell proliferation carry DRE sequences. This indicates that expression of these 
genes is likely to be controlled by Dref (Matsukage et al., 2008). A gradual decrease in 
the expression of Dref is mediated by several differentiation related transcription factors 
and suggests differentiation-coupled suppression of cell proliferation by DRE/Dref 
(Matsukage et al., 2008).  Parts of this study will concentrate on the effect of NO on the 
Mi-2 associated protein Dref. 
 
1.11. Aims of the project 
The primary aim of this study was to identify the in vivo protein targets of Nitric Oxide 
signalling in Drosophila melanogaster particularly from the perspective of cell 
proliferation, growth and development. As previous work in the laboratory had 
identified Mi-2 as a target of NO, the present study was focused on the confirmation 
and extension of these previous results. This study extended the understanding of the 
effects of NO on Mi-2 and its associated proteins.  
Previous data in the laboratory also identified FOXO as a probable target of NO (Scott, 
2009) and revealed that a common set of genes are regulated by both NO and FOXO 
signalling (Kimber, 2005).  
Therefore, this research also focused on the analysis of whether the effect of NO on Mi-
2 is regulated by FOXO. Moreover, the dependency of NO on Mi-2 for growth 
regulation was also determined.  
Although the core area of the present research is focused on the study of the effect of 
NO on Mi-2 and associated proteins, another aspect of the project covers the annotation 
and analysis of several YFP tagged transgenic Drosophila lines generated by 
Cambridge Protein Trap Insertion project (CPTI).  Records of this can be obtained from 
CPTI created Drosophila database ―The Flannotator‖. In addition, a screen for other 
targets of NO was also performed by exploiting YFP tagged CPTI transgenic 
Drosophila lines.  
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                        Chapter 2:  Material and Methods 
2.1. General 
2.1.1. Fly Husbandry 
Drosophila stocks and crosses were grown on D+ food, in 8cm x 2.5cm plastic vials, 
sealed with either cotton wool or rayon balls. Flies were raised at either 25
o
C or 18
o
C on 
a 12 hour light-dark cycle. Adult flies were observed using CO2. Dissection of third 
instar larvae was performed using microscope with a Microtec MFO-90 light source.  
 
D+ Glucose Food Media   
Agar 40g 
D+ Glucose anhydrous 551g (Fisher Scientific) 
Yeast 143g 
Sucrose 185g 
Maize meal 236g 
Propionic acid 25mls 
Nipagen 10%w/v 82mls 
Water 5500mls 
 
Method 
Yeast and anhydrous D+ Glucose were mixed to prepare a paste by using a small 
amount of water. The agar and maize were mixed with the rest of the water and were 
boiled together to dissolve. The paste was then added and the mixture was brought to 
the boil again. Lastly the mixture was allowed to cool before pouring into plastic vials 
or glass bottles.  
2.1.2. Over expression using the Gal4-UAS system 
The Gal4-UAS system as described in (Greenspan, 1997) and in (Ornitz et al., 1991) 
was utilized for over expression of specific genes. The gene to be over expressed was 
linked to an element containing multiple UAS (upstream activator sequence) sequences 
(Brand and Perrimon, 1993, Tuan Rocky. S and Lo W Cecillia, 2000). The transcription 
factor GAL4 binds to UAS and drives the transcription of the desired gene subcloned 
downstream of UAS. Flies carrying the gene to be expressed linked to UAS sequence, 
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were crossed to flies that carrying the Gal4 coding sequence fused to a tissue specific 
promoter or enhancer. Offspring carrying both the UAS and Gal4 inserts were observed. 
  
2.1.3. Generating single cell clones 
Single cell clones were generated by using a combination of UAS-GAL4 and FLP/FRT 
technique (Tuan Rocky. S and Lo W Cecillia, 2000). FLP is a site-specific recombinase 
encoded by the S. cerevisiae 2m plasmid. The expression of FLP is regulated by a heat 
shock promoter, so the recombinase is also referred as hsFLP. FLP efficiently catalyzes 
recombination between two copies of its specific 34 bp recognition site (called the Flp 
recognition target (FRT). A heat shock FLP construct was used to remove a segment of 
DNA flanked by FRT sites, which lies in between the Actin5C promoter and the Gal4 
driver, preventing the expression of the later. After the excision of the FRT cassette 
ubiquitous expression of the GAL4 driver occurs under the control of Actin 5C 
promoter followed by expression of the UAS tagged gene of interest (Duffy, 2002) 
(Tuan Rocky. S and Lo W Cecillia, 2000). Recombination was induced at a low level, 
24-48 hours after egg laying (AEL), (Demerec, 1950) by heat shocking the larvae for 
between 4 to 5 and half minutes. This system produced single cells expressing UAS-
GFP/UAS-mRFP as a marker or simultaneously expressing the marker and UAS-NOS 
(or any other gene of interest). The single cells expressing NOS2 produced by this 
experimental design could then be used to study the molecular and cellular 
consequences of high levels of NO production as compared to surrounding wild type 
cells which are not affected by Flp mediated recombination thus do not over express the 
gene of interest.   
 
2.1.4. Visualisation of protein expression in YFP tagged CPTI transgenic 
Drosophila lines 
Materials: 
1xPBS (10xPBS: 1.37M NaCl, 0.1M Na2HPO4, 0.01M NaH2PO4; pH7.4). 
Method: 
The coordinating team of Department of Genetics, University of Cambridge, have 
generated CPTI-YFP transgenic Drosophila lines. In each transgenic Drosophila 
melanogaster line a particular gene is tagged by utilizing a fluorescent tagging method, 
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where YFP is used as a reporter gene to study the expression of the tagged gene 
(Section 3.1.2). 150 CPTI transgenic Drosophila lines were examined to study the 
expression of YFP tagged genes in different tissues. Third instar larvae were used as 
sources of three sample tissues (the brain, the imaginal discs, and the salivary gland) to 
study the expression of the genes tagged with. Larvae were dissected in 1X PBS and 
sample tissues were mounted on clean glass slides. Images of the tissues were collected 
using a Zeiss LSM 510 Meta Laser scanning Confocal microscope at 488nm, and 
modifying the excitation to avoid fluorescence saturation. 
2.1.5. Ex vivo culture and NO donor treatment 
Materials  
1xPBS (10xPBS: 1.37M NaCl, 0.1M Na2HPO4, 0.01M NaH2PO4; pH7.4). 
SNAP (S-Nitroso-N-acetylpenicillamine) (Sigma Aldrich,  N 3398, original stock 
20mM dissolved in DMSO) 
DMSO (Sigma Aldrich). 
Schneider’s tissue culture medium (Gibco-BRL, USA).  
Method 
Salivary glands from CPTI lines were treated with SNAP. 1µl 20mM SNAP was added 
into 95ul of Schneider’s tissue culture medium to achieve an ultimate SNAP 
concentration of 200µM, which is optimum to stop cell proliferation and growth but not 
affect viability (Kimber, 2005). Salivary glands were incubated in this mixture for 16-
17 hours or 4 hours. In all incubations one of a pair of salivary gland from a larva was 
treated with SNAP, whereas, the other of the same pair of gland, from the same larva 
was treated with DMSO (1µl DMSO in 95µl of Schneider’s tissue culture medium) as 
control. Images of both the SNAP treated and DMSO treated) glands were collected by 
using a Zeiss LSM 510 Meta Laser scanning Confocal microscope at 488nm, modifying 
the excitation levels to avoid fluorescence saturation. 
The CPTI lines which consistently showed changes in expression after SNAP exposure 
were chosen for shorter treatment with SNAP. Two pairs of salivary glands were taken 
from two different larvae of a particular CPTI line. One of a pair of salivary gland was 
incubated in a mixture of 1µl SNAP + 95ul of Schneider’s tissue culture medium for 
 20 
0.5hrs minutes and subsequently for 3.5 hours in 1µl DMSO + 95ul of Schneider’s 
tissue culture medium. The other of the same pair of salivary gland was incubated in the 
similar mixture of SNAP (1µl SNAP + 95ul of Schneider’s tissue culture medium) for 4 
hrs. One of the another pair of salivary gland from the same CPTI line was incubated in 
1µl SNAP+ 95ul of Schneider’s tissue culture medium for 0.5hrs  and subsequently for 
3.5 hours in 1µl DMSO + 95ul of Schneider’s tissue culture medium. The other of the 
same pair was incubated in 1µl DMSO + 95ul of Schneider’s tissue culture medium for 
4hrs. After incubation images of the four different salivary glands given different 
treatments images were collected as above. 
2.2. Immunohistochemistry 
2.2.1. Antibody staining 
Materials 
1xPBS (10xPBS: 1.37M NaCl, 0.1M Na2HPO4, 0.01M NaH2PO4; pH7.4). 
4% Paraformaldehyde in 1xPBS. 
100% Methanol. 
PBT (1xPBS, 0.1% Triton X-100, 0.2% BSA). 
Appropriate primary and secondary antibodies (Section 2.2.2.). 
Normal Goat and Horse sera (Sigma) (Section 2.2.2.) 
DAPI  1:20,000 in 1x PBS with 0.1% Triton X-100. 
Aquamount (Polyscience). 
 
Method 
Wandering third instar larvae were dissected by inversion and fixed in 4% 
paraformaldehyde for 20 minutes at room temperature. Tissue was then washed 2x 5min 
in 1xPBS. If the tissue was to be stored it was washed twice in Methanol and stored at –
20
o
C in Methanol. The tissue was then washed in 1xPBS before making it permeable in 
PBT for 2 x 30 minutes. The tissue was then incubated in primary antibody overnight at 
4
o
C. Primary antibody was removed and stored, and the tissue was washed 4 x 20 
minutes in PBT at room temperature. The tissue was rinsed x 2 in PBT containing 2% 
animal sera compatible for the respective secondary antibody (Section 2.2.2) then 
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incubated with secondary antibody in PBT with 2% animal sera (suitable with the 
secondary antibody being used) at room temperature for 2 hours. The tissue was then 
washed 4 x 15 minutes in PBT at room tem 
perature.  DAPI staining of tissue was performed for 15 min. Tissue was then washed 
2x 5minutes in 1xPBS before dissection. The required tissues were mounted on a glass 
slide in Aquamount and examined on a LSM Zeiss inverted-LSM 510 META COMBI 
Confocal Microscope with Coherent Enterprise UV laser using 40x water lens. 
 
 2.2.2. Primary and Secondary antibodies with their respective animal sera 
Mi-2 antibody: 
Both N-terminus and C-terminus rabbit anti-dMi-2 (Brehm et al., 2000) were gifts from 
Alexander Brehm, used at 1:1000. 
Secondary antibody: goat anti-rabbit Cy5 IgG (Jackson ImmunoResearch Laboratories, 
Inc.) used at 1:100 in 2% goat sera. 
 
Dref antibody: 
Mouse anti-Dref (Hirose et al., 2002) was a gift from Fumiko Hirose, was used at 1:100.   
Secondary antibody: horse anti-mouse Cy5 IgG (Jackson ImmunoResearch Laboratories, 
Inc.) used at 1:100 in 2% horse sera.  
Goat anti-mouse Alexa fluor 555 IgG (Invitrogen, Molecular Probe) used at 1: 200 in 2% 
goat sera. 
 
2.3. Nuclei Staining and Measurement 
 
Materials 
1xPBS (10xPBS: 1.37M NaCl, 0.1M Na2HPO4, 0.01M NaH2PO4; pH7.4) 
4% Paraformaldehyde in 1xPBS 
DAPI: 1:20,000 in  1x PBS with 0.1% Triton X-100 
Aquamount (Polysciences) 
 
Method 
Wandering third instar larvae were dissected by inversion and fixed in 4% 
paraformaldehyde for 20 minutes.  Tissue was then washed 2x 5min in 1xPBS. The 
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tissue was then incubated in diluted DAPI solution of for 15 min. Tissue was then 
washed 2x 5 minutes in 1xPBS before dissection. Tissues were mounted on a slide in 
Aquamount and examined on a Zeiss AxioPhot Microscope at 40x.  
 
2.4. Image Analysis on Velocity 
Confocal images were analysed using quantitative software package from velocity 
(Improvision / Perkin Elmer) (http://www.cellularimaging.com/products/Volocity). 
which generates 3D image of the acquired stacks. 
 
Method 
 
2.4.1. Quantitative analysis of YFP tagged protein localization in the nuclei 
 
Nuclei from 5 pairs of salivary gland images (5 experimental and 5 control genotypes) 
were captured on velocity through the Z axis to cover the YFP fluorescence in whole 
section thickness. YFP fluorescence of those nuclei which were available up to 10 μm 
depth of image Z stack were measured. Sensitivity settings of confocal microscope were 
kept constant between a control and experimental pair but not necessarily between 
different pair of comparators. Hence, the threshold point in velocity was kept constant 
for all the nuclei of a particular pair of control and experimental comparators. 
Additional analysis and data presentations were performed by exporting velocity 
acquired datasets into Microsoft Excel. 
 
2.4.2. Quantitative analysis of the volume of nuclei  
DAPI staining was performed following the same method mentioned in section 2.3. 
Using velocity, xy, xz and yz dimensions of nuclei were constructed from Z section 
series of stacks from salivary gland images of different genotypes to cover the entire 
volume of nuclei. The threshold point was kept constant for all the nuclei of a particular 
salivary gland image. Additional analysis and data presentations were performed by 
exporting velocity acquired datasets into Microsoft Excel. 
 
2.4.3 Estimation of protein accumulation in the nuclei of clone images 
Using velocity, xy, xz and yz dimensions of nuclei were constructed from Z stacked 
image planes of both the clone cell and the non adjacent wild type cells of a particular 
image to encompass the protein accumulation in the whole section. In this case, 
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intensity of protein localization in the nuclei of clone cell was compared with that of the 
non adjacent wild type cells of that particular salivary gland. Hence, sensitivity settings 
of confocal images differed for every image. Therefore, the threshold point in velocity 
was kept constant for all the nuclei of a particular salivary gland image. Additional 
analysis and data presentations were performed by exporting velocity acquired datasets 
into Microsoft Excel. 
 
2.5. Statistical Analysis on ANOVA 
Method 
Statistical comparison of nuclear size between genotypes was made using one way 
ANOVA on MINI tab statistical software package. During the analysis p < 0.05 was 
taken for indicating statistically significant difference across the comparative genotypes. 
A post hoc Tukey analysis was undertaken on MINI tab for further accurate analysis of 
nuclear size among the experimental and control genotypes. 
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Chapter 3: Annotation and Screening of CPTI lines 
3.1. Introduction 
3.1.1. Brief introduction about protein trapping in Drosophila 
Protein traps were first used as ―CD tagging‖ in Chlamydomonas and later in 
mammalian cells (Jarvik et al., 1996). In CD tagging the gene is tagged by sequence 
specific nucleotides and the protein is tagged by sequence specific peptide. As these tags 
are unique, use of sequence specific nucleotide or antibody probes facilitates the 
identification and analysis of the functional properties of the gene at the protein level 
(Jarvik et al., 1996).  
CD tagging has been applied to develop a protein trap system which makes use of the P 
element transposon to carry green fluorescent protein (GFP) as a mobile exon. These 
GFP fusions facilitate the study of sub-cellular and cellular distribution of the fusion 
proteins in live tissues (Xavier Morin et al., 2001). GFP was originally cloned from the 
jellyfish  Aequorea Victoria (Tsien, 1998). The biggest advantage of using GFP as a 
reporter is, it has made possible the study of subcellular localisation of proteins in living 
cells. Hence the investigation of the movement of proteins and their interaction with 
cellular components are possible by live cell imaging (Lippincott-Schwartz et al., 2001).  
3.1.2. Use of yellow fluorescent protein as a reporter in protein trap strategy 
Yellow fluorescent protein (YFP) is a variant of GFP and has found to be more useful in 
biological systems because of its intense fluorescence, brightness and reduced 
sensitivity to environmental factors such as pH and ionic strength (Rekas et al., 2002). 
Moreover, the use of YFP as a reporter has overcome the problem of the slow 
maturation shown by GFP (Nagai et al., 2002). Therefore, a protein trap strategy using 
YFP as a reporter gene was developed. A network of Drosophila researchers in the UK 
of thirty different universities, co-ordinated by the Department of Genetics, University 
of Cambridge, has established the Cambridge Protein Trap insertion (CPTI) Project. 
The scientists of CPTI project make use of hybrid vectors combining Piggy Bac and P-
elements.  
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These vectors contain the following features: 
 
 The mini white gene to track the element in stocks. 
 Affinity purification tags: StrepII and FLAG. 
 YFP exon. 
 Splice accepter and splice donor site. 
 
 
 
Figure 3.1. PiggyBac construct  
Figure adapted from (E. Ryder et al.) 
PB = Piggybac ends 
P = P element ends 
 
 
 
 
Figure 3.2. Diagrammatic representation of mRNA and protein production from 
an endogenous gene.  
After transcription of mRNA the introns are spliced out. The spliced mRNA product is 
translated to protein.  
Figure adapted from (E. Ryder et al.) 
 
 Exon 1 Exon 2 Exon 3  
Exon 1 Exon 2 Exon 2 protein 
Normal 
gene 
Spliced mRNA 
product 
5PB 5P    mini w SA Strp FLAG YFP   SD 3P 3PB 
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Figure 3.3. Diagrammatic representation of transcription and translation of a 
fluorescent tagged protein in YFP protein trap 
The YFP construct contains splice acceptor (SA) and splice donor (SD) sites. Transcription 
results in incorporation of SA and SD sites into the YFP fused spliced mRNA. If the PiggyBac 
element transposes into the intron of a gene in the correct orientation and frame, a functional 
YFP fusion protein will be expressed (E. Ryder et al.). 
5    
mini w 
SA Strp FLA
G 
YFP   
 
SD 3 
 Exon 1 Strp FLA
G 
YFP   
 
Exon 2 Exon 2 
Insertion line 
YFP fusion mRNA 
product 
Protein with YFP 
expression 
Exon 1  Exon 2 Exon 3  
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In the Piggy Bac and P-element hybrid vector, YFP reporter, devoid of initiation and 
stop codons, flanked by SA (splice accepter) and SD (splice donor), is used as a mobile 
artificial exon. If the PiggyBac transposes into the intron in a correct orientation, then 
the splicing will take place at the SA and SD sites and the remaining YFP exon is 
inserted into the spliced mRNA product. If the YFP exon is inserted in the correct frame, 
the protein will be translated from the YFP fused mRNA resulting in a YFP expressing 
fusion protein (E. Ryder et al.). The researchers of CPTI project have created a new 
Drosophila database termed ―The Flannotator‖ which allows annotation and 
characterization of the expression patterns of YFP tagged protein trap lines at all stages 
of development and all tissue types. ―The Flannotaor‖ acts as a software package for the 
storage of annotated gene expression patterns in Drosophila melanogaster (E. Ryder et 
al., 2009). 
Experiments of this chapter were designed for annotation of several YFP tagged protein 
trap transgenic Drosophila lines created and supplied by the coordinating team of 
Cambridge Protein Trap Insertion Project (CPTI). Another aspect of this chapter was to 
undertake a genetic screen to search for molecular targets of NO action by examining the 
effect of NO on YFP tagged proteins of the CPTI lines.  
3.1.3. A brief introduction about NO donors 
NO is poorly soluble in water (only 2-3mM) and being a free radical gas, having a lone 
pair of electron NO is unstable in the existence of numerous oxidants Hence, the 
practical aspect of study of the antiproliferative effect of NO on normal cells of different 
tissue origin requires the use of chemical NO donors (Tingwei Bill Cai, 2005). A 
comparative study of the antiproliferative effect between five different NO donors (DEA 
⁄ NO•, PAPA ⁄ NO•, SPER ⁄ NO•, DPTA ⁄ NO•, DETA ⁄ NO•) was performed after 
exposing rat aortic smooth muscle cells (RA-SMC) to the NO donors for different time 
periods. The most antiproliferative effect was shown by 500 µm concentration of 
DETA/NO as cell growth was completely inhibited on 1
st
, 3
rd
, and 5
th
 days as confirmed 
by a 7 days measurement study of the cell numbers (Daniel L. Mooradian et al., 1995). 
A concentration of 10
-4
 M to 10
-3 
M, of a chemical NO donor PAPA NONOate (pNO) 
was reported to impart cytostatic effects by inhibiting ribonucleotide reductase, within 
24-48hrs, which is similar to the cytostatic effect of NO (Jarry et al., 2004).  
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3.1.4. SNAP (S-Nitroso-N-acetylpenicillamine) 
An advantage of SNAP (S-Nitroso-N-acetylpenicillamine) is, it can release NO within 
30 minutes which is much shorter time period compared to that of the other NO donors. 
The antiproliferative action of NO in fibroblasts acts through the p53 signaling pathway. 
Cell lines lacking p53 are unable to accomplish growth arrest when given a 30mins 
exposure to SNAP. It has been shown that, a 30mins exposure of NIH3T3 cell lines to 
SNAP induces the phosphorylation of Ser18 and Ser373 residues in the active sites of 
p53, leading to increased cellular level of p53 (Nakaya et al., 2000).  
Chemical structure of SNAP (S-Nitroso-N-acetylpenicillamine) (Butler and Rhodes, 
1997) 
CH3 S NO 
 
CH3 
CH3COHN             CO2H 
SNAP and other S- nitrosothiol compounds are generated by a reaction between thiols 
and NO
+ 
generating nitrous acid, N2O3 or an alkyl nitrite (Butler and Rhodes, 1997).   
RSH + NO
+
               RSNO + H
+ 
RS
-
 + RONO                RSNO + RO
- 
S- nitrosothiol compounds decompose to produce corresponding disulphide and NO 
(Butler and Rhodes, 1997).  
 
RSNO                     NO + ½ RSSR  
 
Three structurally and chemically dissimilar vasodilator drugs: sodium nitroprusside, S-
nitroso-N-acetylpenicillamine (SNAP) and isosorbide dinitrate along with 8-bromo-
cGMP dose dependently inhibit the mitogenesis and proliferation of rat vascular smooth 
muscle cells. This inhibitory effect is repressed by the NO scavenger haemoglobin but 
is strengthened by superoxide dismutase, which implies that NO has been formed by 
theses drugs and acts as the eventual effector (Garg and Hassid, 1989).  
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The experiments of this chapter principally focus on the annotations of CPTI lines and 
on the screening of CPTI lines which respond to ex vivo application of NO. 
 
3.2. Results 
 
3.2.1. Visualization of protein expression 
The coordinating team of Department of Genetics, University of Cambridge, have 
generated CPTI-YFP transgenic Drosophila lines. As discussed above (Section 3.1.2), 
in each transgenic Drosophila line a particular gene is tagged with YFP to study the 
expression of the YFP tagged protein. 100 CPTI lines (listed in Appendix C.1) were 
examined to study the expression of YFP tagged proteins in different tissues. The 
expression patterns of the CPTI lines were annotated by using standard Drosophila 
anatomy ontology and corresponding controlled vocabulary (CV) terms mentioned in 
Flybase (http://flybase.org/). 
Third instar larvae of the CPTI lines were used as sources of three sample tissues (brain, 
imaginal discs, and salivary glands) to examine the expression of the tagged gene. 
Images of the tissues were collected using a Zeiss LSM 510 Meta Laser scanning 
Confocal microscope at 488nm, by modifying the excitation levels to avoid 
fluorescence saturation (Fig 3.4, 3.5, 3.6 and 3.7). Images of the tissues of 75 CPTI 
lines were uploaded to the Flannotator database (http://www.flyprot.org).  
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YFP 
Figure 3.4 Examples of protein trap insertions showing expression of YFP in 
cerebral hemisphere, ventral ganglion, leg discs and eye antennal discs of 
third instar larvae of CPTI-000944 transgenic Drosophila. 
 CPTI-000944 image undertaken at 6% laser excitation (Zoom 1)  
Black arrow - Ventral ganglion. 
Red arrows - Cerebral hemisphere. 
Blue arrow - Antenna disc. 
Purple arrows - Leg discs.   
Scale bar = 100 µm. 
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YFP 
Figure 3.5 Protein trap insertion showing the expression of YFP tagged 
genes in wing discs, haltere discs, and in leg discs of third instar larvae 
of  CPTI-000239 line. 
Image undertaken at 3% laser excitation (zoom 1.4)  
Black arrow - Wing disc. 
Red arrow - Haltere disc. 
Purple arrow - III Leg disc. 
Blue arrow - Trachea. 
Scale bar = 100 µm. 
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Figure 3.6 Examples of YFP expression in salivary glands of third instar 
larvae from 9 different CPTI lines. 
A) Subcellular localisation of YFP was observed in the nucleus, but no expression 
was seen in the nucleolus of mature larval salivary gland cells of CPTI-000239.  
B) Uniform expression of the YFP tagged protein was seen throughout the nucleus of 
salivary gland cells of CPTI-001488. 
C) The nuclear expression of YFP in CPTI-002035 was not found to be uniform. The 
nucleolus was not expressing the YFP tagged protein.  
D) Localisation of the YFP tagged protein was observed to be distinctly nuclear 
membrane associated in the larval salivary gland cells of CPTI-001735.  
E) In CPTI-001403 the expression of YFP in salivary gland cells was predominantly 
cell membrane-associated and not nuclear. 
F) Salivary gland of CPTI-100038 showed a cytoplasmic, cell membrane bound and 
perinuclear distribution of the YFP tagged protein.  
G) Although some traces of cytoplasmic expression was found, the YFP tagged 
protein was predominantly cell membrane and nuclear membrane associated in CPTI-
002264. 
H) & I) subcellular localisation of the YFP tagged protein was exclusively cell 
membrane associated in case of the salivary gland cells of  CPTI-001589 and CPTI-
001718. 
CPT I-001718 
 
I 
CPTI-001589 
 
H 
LOW POWER (10X) HIGH POWER (63X) 
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3.2.2. Ex vivo NO treatment  
YFP
YFP 
YFP 
Figure 3.7 Examples of expression of YFP in the proventriculus of third 
instar larvae of 3 different CPTI lines.  
i) Subcellular localisation of YFP tagged protein was observed in the nucleus, of 
mature proventricular cells of CPTI-000239. 
ii) Uniform expression of YFP tagged protein was observed throughout the 
proventriculus, mid-intestine, esophagus and gastric caecum of CPTI-001137. 
iii) Expression of YFP tagged protein was observed in the nucleus of mature 
proventricular cells of CPTI-001569. 
Red arrows - Proventriculus. 
Yellow arrow - Mid-intestine. 
Blue arrow - Oesophagus. 
Purple arrow - Gastric caeca. 
Scale bars = 50µm 
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Ex vivo culture was employed to determine the effect of NO on the expression of a 
randomly selected subset of 75 YFP tagged proteins of the CPTI lines. Salivary glands 
from CPTI lines (listed in Appendix C.2) were treated with the NO donor, S-Nitroso-N-
acetylpenicillamine (SNAP).One of the pair of salivary glands was added into a mixture 
of SNAP (dissolved in DMSO) and Schneider’s tissue culture media. The other salivary 
gland of the pair was treated with the same quantity of DMSO and tissue culture media. 
After incubation images of both the SNAP treated (experimental) and DMSO treated 
(control) glands were collected on meta laser Confocal microscope.75 CPTI-YFP lines 
were treated with SNAP. All images were taken under 63X objective (high power) of 
the Confocal microscope for detailed visualization of any change in protein localisation 
or expression level as a result of SNAP treatment. The majority (71) of CPTI lines 
showed no alteration in the level or localisation of the tagged proteins after exposure to 
SNAP (data not shown). However, four lines exhibited differences in the sub cellular 
localisation of the YFP tagged protein following SNAP treatment. A decrease in the 
YFP tagged protein expression was observed in the salivary glands of CPTI-000106 
after 16 hrs exposures in SNAP compared with the controls (Fig 3.8 A). A different 
localisation pattern of YFP tagged protein was observed in the salivary gland of CPTI-
000847 after 16 hrs exposure in SNAP. Both the control and experimental salivary 
gland showed traces of membrane associated YFP tagged protein. The localisation of 
the protein was cytoplasmic and cell membrane associated but was non nuclear in the 
control salivary gland whereas, after treatment with SNAP the protein was mostly 
found uniformly distributed in the cytoplasm and in the nucleus as well (Fig 3.8 B). An 
increase in the nuclear and cytoplasmic localisation of the YFP tagged protein was 
observed in CPTI-000239 after 16 hrs exposure in SNAP (Fig 3.8 C).  The nuclear 
accumulation of YFP tagged protein was found to be enhanced in CPTI-000232 after 
treating the salivary gland in SNAP for 16 hrs (Fig 3.8 D).  Unfortunately the changes 
shown by CPTI-000106, CPTI-000847 and CPTI-000239 after giving SNAP exposure 
were not consistent. Only CPTI-000232 showed a consistent increase in YFP tagged 
protein localisation with SNAP exposure. It was therefore decided to use this particular 
CPTI stock for shorter SNAP exposure and further experiments.   
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  Figure 3.8 CPTI lines which showed modification in YFP tagged protein 
localisation after 16 hrs of SNAP treatment. 
 
A) Salivary glands of CPTI-000106 showed weaker YFP expression compared to 
the control after 16hrs treatment of SNAP. 
 
B) Traces of membrane associated YFP tagged protein was observed in both DMSO 
treated and SNAP treated salivary glands of CPTI-000847 line. However the DMSO 
treated salivary gland showed a cytoplasmic but non nuclear distribution of the YFP 
tagged protein whereas uniformly distributed YFP tagged protein was found  
throughout the cytoplasm and in the nucleus of the SNAP treated salivary gland.  
  
C) The salivary gland cells of CPTI-000239 showed higher YFP tagged protein 
expression both in the nucleus and cytoplasm after 16hrs treatment with SNAP. 
 
D) The nuclear expression of YFP tagged protein in the salivary gland cells of 
CPTI-000232 was observed to be raised after 16 hrs incubation in SNAP. 
 
Scale Bar = 50μm  
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Figure 3.8 CPTI lines which showed modification in YFP tagged protein 
localisation after 16 hrs of SNAP treatment. 
 
A) Salivary glands of CPTI-000106 showed weaker YFP expression compared to 
the control after 16hrs treatment of SNAP. 
 
B) Traces of membrane associated YFP tagged protein was observed in both DMSO 
treated and SNAP treated salivary glands of CPTI-000847 line. However the DMSO 
treated salivary gland showed a cytoplasmic but non nuclear distribution of the YFP 
tagged protein whereas uniformly distributed YFP tagged protein was found  
throughout the cytoplasm and in the nucleus of the SNAP treated salivary gland.  
  
C) The salivary gland cells of CPTI-000239 showed higher YFP tagged protein 
expression both in the nucleus and cytoplasm after 16hrs treatment with SNAP. 
 
D) The nuclear expression of YFP tagged protein in the salivary gland cells of 
CPTI-000232 was observed to be raised after 16 hrs incubation in SNAP. 
 
Scale Bar = 50μm  
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3.2.3. Shorter SNAP exposure of CPTI-000232 larvae 
DMSO CONTROL SNAP 
EXPERIMENTAL 
CPTI-000106 A 
CPTI-000847 B 
CPTI-000239 C 
CPTI-000232 D 
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Salivary glands of wandering third instar CPTI-000232 larvae were given a shorter 
SNAP exposure of 0.5 hours followed by a 3.5 hour incubation in tissue culture media, 
to determine whether a short exposure to SNAP caused any changes in the YFP tagged 
protein localisation. Two pairs of salivary glands were taken from two different larvae 
of CPTI-000232 line. One of a pair of salivary gland was incubated in a mixture of 
SNAP and tissue culture media for 0.5 hours. The other of the same pair of salivary 
gland was also incubated in the similar mixture of SNAP and tissue culture media but 
for 4 hrs. After 0.5 hours the first gland of this pair was taken from SNAP and was 
incubated in a mixture containing DMSO and tissue culture media for further 3.5hrs. 
Therefore, the first gland of the pair was incubated in two different mixtures: initially 
for 0.5 hours in SNAP and then for 3.5 hrs in DMSO (total 0.5 hours + 3.5hours = 
4hours) whereas the other gland of the same pair was incubated in SNAP only 
continuously for 4hours. After 4 hrs of incubation confocal images were acquired and 
compared.  
One of the second pair of salivary glands from another animal of the same line (CPTI-
000232) was incubated in SNAP and tissue culture media for 0.5 hours and other of the 
same pair was incubated in a mixture of DMSO and tissue culture media for 4hours. 
After 0.5 hours the first gland of this pair was taken out from the SNAP mixture and 
was further incubated in DMSO and tissue culture media for another 3.5hrs. Therefore, 
in this case also the first gland of this pair was incubated two times in two different 
mixtures: 0.5 hours in SNAP and 3.5hrs in DMSO, thus total incubation of 4hrs was 
achieved. After 4 hours incubation, confocal images were acquired and compared. This 
experiment was designed to compare and analyse the effect of 0.5 hours exposure to 
SNAP with no exposure to SNAP (DMSO control) on the expression of the tagged 
protein in salivary glands. 
The salivary gland which was given 0.5 hours exposure to SNAP and then further 
cultured in DMSO and tissue culture media for 3.5 hrs showed highest increase in YFP 
tagged protein expression (Fig 3.9, Ci and Cii). The expression of YFP in the salivary 
gland which was incubated in SNAP for 4hrs (Fig 3.9, Bi and Bii) was lower than one 
treated in SNAP for 0.5 hours (Fig 3.9, Ci and Cii).  The control salivary gland which 
was incubated in DMSO for 4 hrs showed the weakest expression (Fig 3.9, Ai and Aii).    
  
 41 
 
Ai) Aii) 
                                              
 
 
Bi)                                                       Bii)                                    
 
 
 
 
Ci) Cii) 
 
 
 
YFP YFP 
YFP YFP 
YFP 
YFP 
Figure 3.9.  Shorter exposure to SNAP 
Ai) Salivary gland of CPTI-000232 third instar larva incubated in a mixture of 
DMSO and tissue culture media for 4 hrs.  
Aii) High magnification image of a nucleus shown in Fig (Ai). 
Bi) Salivary gland of CPTI-000232 third instar larva incubated with a mixture of 
SNAP and tissue culture media for 4 hrs showed an increase in YFP tagged protein 
expression compared to Fig Ai.  
Bii) High magnification image of a nucleus shown in Fig (Bi). 
Ci) Salivary gland of CPTI-000232 third instar larva incubated with SNAP for 0.5 
hours showed maximum accumulation of YFP tagged protein in the nucleus 
compared to Fig (Ai) and Fig (Bi).  
Cii) High magnification image of a nucleus shown in Fig (Ci). 
Images acquired and processed using identical settings. 
Scale bar = 20 µm. 
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3.3. Discussion 
3.3.1. Visualization of YFP tagged protein expression in CPTI lines 
The localisation pattern of YFP tagged proteins was different in all CPTI lines (listed in 
appendix C.1). Images of the tissues of 75 CPTI lines were uploaded to the Drosophila 
genome database Flannotator (http://www.flyprot.org).  
 
3.3.2. The protein trapped in CPTI-000232 is a probable target of NO action 
The changes in the YFP tagged protein expression shown by CPTI-000106, CPTI-
000847 and CPTI-000239 after 16 hrs of SNAP treatment (Fig 3.8 A, B, C) were not 
consistently repeated in subsequent SNAP exposures. This variation may be caused by 
small differences in developmental stages of the larvae or by other environmental 
factors. CPTI-000232 showed a consistent increase in the YFP fluorescence after 16hrs 
(Fig 3.8 D) and 0.5 hours exposure to SNAP (Fig 3.9 Ci and Cii). This shows even 0.5 
hours exposure to SNAP is sufficient to cause changes in protein accumulation.  
The CPTI-000232 line traps the gene Mi-2, which spans from 19875145 to 19903309 
on chromosome 3L. This YFP tagged allele of Mi-2 will be referred to as Mi-2
CPTI-000232
.  
The localisation of Mi-2
CPTI-000232
 protein was exclusively nuclear.  
A previous researcher in our laboratory had independently shown an increase in the 
expression of YFP tagged Mi-2
CPTI-000232
 in a time course exposure to SNAP (Lasala, 
2007). Therefore the results of this chapter confirmed Mi-2
CPTI-000232
 as a probable target 
of NO action. Experiments in the following chapters were designed on the basis of the 
data found in this chapter.  
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Chapter 4: NO action on Mi-2/NuRD and associated proteins    
 
4.1. Introduction 
 
4.1.1. Mi-2 - A Probable Target of NO 
 
Mi-2 is a component of the nucleosome remodelling and deacetylating (NuRD) 
complex (Tong et al., 1998). A link between cell proliferation and Mi-2 has also been 
demonstrated. Dermatomyositis patients producing antibodies against Mi-2 (Seelig HP 
et al., 1996 ) are susceptible to malignancy resulting from excessive cell proliferation 
(Airio et al., 1995).  
Nitric Oxide has been reported to act as an antiproliferative agent to down regulate the 
proliferation of several diverse cell lines (Villalobo, 2006) such as neuronal precursor 
cells (Contestabile and Ciani, 2004), vascular smooth muscle cells (Nunokawa and 
Tanaka, 1992) human Caco-2 tumor cells (Buga et al., 1998) leading to cell 
differentiation.  
All these data suggest that cell proliferation can be controlled by both Nitric Oxide and 
Mi-2. The biochemical pathway of NO action may intersect with that of Mi-2 at a 
specific point in the process of growth and proliferation arrest. A previous study in the 
laboratory involving SNAP exposure identified Mi-2 as a possible target of NO (Lasala, 
2007). Results of the present study confirmed Mi-2 as a target of NO action (Sections 
3.2.2 and 3.2.3). This chapter investigated and extended the ex vivo observations 
(Sections 3.2.2 and 3.2.3) through in vivo experiments. 
 It was hypothesised that the action of NO may be accomplished via Mi-2/NuRD 
complex. Hence, another important aspect of this chapter was to examine whether the 
impact of NO on growth regulation is dependent on Mi-2.  
 
4.1.2. NO action on Simj 
Simj is reported to function in recruiting the NuRD complex in the induction of 
methylation mediated gene silencing and hence acts as a regulatory component of 
NuRD. Simj plays developmental roles through the regulation of ecdysone-responsive 
genes in Drosophila (Kon et al., 2005). Interestingly NO also activates the ecdysone 
induced protein 75 (E75) and failure in NO production and inactivation of E75 in the 
ring glands (glands which produce metamorphosis inducing hormone, ecdysone) results 
into the failure of proper metamorphosis (Aleksandar S. Necakov and (unpublished)). It 
was therefore hypothesised that some functional links may exist between NO and Simj. 
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The experiments of this chapter were designed to analyse a functional connection 
between NO and Simj.   
 
4.1.3. NO action on Dref 
Mi-2 genetically and physically interacts with Dref (Hirose et al., 2002). Dref binds 
with the 8 bp palindromic sequence called the DNA replication related element (DRE) 
(Fumiko Hirose et al., 1993). This element is present in the promoter region of several 
cell proliferation related genes and is assumed to be required for their transcription 
(Matsukage et al., 2008). A gradual decrease in human Dref (hDref ) expression was 
observed in differentiating PC12 cells (Matsukage et al., 2008). In the presence of nerve 
growth factor (NGF), high levels of three NOS isoforms were identified in PC12 cells 
during the onset of growth arrest and differentiation (Natalia and Grigori, 1995). The 
switch of the cell cycle from proliferation to differentiation mediated by differentiation 
related transcription factors, is probably under the direct control of Dref (Matsukage et 
al., 2008). Interestingly NO is known to prevent proliferation of rat brown adipocytes 
during the onset of differentiation (Enzo Nisoli and Carruba, 1998). NO is also reported 
to mediate the cell cycle switch from proliferation to differentiation during neurogenesis 
of several nervous system related cells (Gibbs, 2003). As Dref and NO can both 
influence the switch from proliferation to differentiation, it was hypothesized that the 
effect of Dref on cell proliferation may be controlled by NO. Hence, the response of the 
Dref protein to NO expression was also analysed in this chapter.   
 
4.1.4. Study of NO action on Mi-2, Simj and Dref  
In order to examine the effect of NO on Mi-2, Simj and Dref, two genetic approaches 
were used: 
In the first approach, the GAL4/UAS binary system (Section 2.1.2) was used to induce 
NOS2 expression in the whole salivary glands of YFP tagged Mi-2 
CPTI000232
 larvae, as 
the salivary glands of these larvae showed increased YFP tagged Mi-2 expression when 
cultured briefly with SNAP (Section 3.3.2).  
However, when NOS2 (Section 1.3) was driven in the whole salivary glands by c147-
GAL4 of Mi-2
CPTI-000232
 animals, the cells showed reduction in size, as high levels of 
NO slow down the progression of cell cycle during development (Kuzin et al., 1996). 
Hence, the approach of expressing NOS in the whole salivary glands did not take into 
account any physiological affects that the reduced growth of salivary gland may have. It 
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was not possible to infer if the change in YFP tagged Mi-2
CPTI-000232
 expression was due 
to the effect of NO signalling or a consequence of the reduced size of the salivary gland 
resulting from NO expression. Therefore, it was important to monitor whether the 
expression of Mi-2
 
was altered when the growth of whole salivary gland was minimally 
effected in response of NO.   
In a second approach, NOS2 was expressed in single cells of the salivary glands to 
avoid any physiological changes resulting from reduced growth of the whole salivary 
gland. To achieve this, expression of NO was induced in single cells by using FLP/FRT 
technique or Flip out system. In this system random clones are generated via Flp 
recombinase catalysed recombination between two of it’s target sites, FRTs. Flp is a 
site-specific recombinase encoded by the S. cerevisiae 2m plasmid and efficiently 
catalyses the recombination between two copies of its 34 bp recognition site termed as 
Flp recognition target (FRT). A construct containing the Actin5C promoter separated 
from the Gal4 coding sequence by DNA flanked with FRT sites is used. Hence, there is 
no expression of Gal4 from this construct in the non clone cells. However in some cells, 
Flp, under the control of a heat shock promoter (hs-FLP) catalyses the excision of the 
FRT cassette allowing the expression of Gal4 (Duffy, 2002) (Tuan Rocky. S and Lo W 
Cecillia, 2000). This system produced single cell clones expressing UAS-GFP/UAS-
mRFP as a marker or simultaneously expressing the marker and UAS-NOS (or any 
other gene of interest) (Fig 4.1).  
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The single cells expressing NOS2 produced by this experimental design, could then be 
used to study the molecular and cellular consequences of high levels of NO production 
in comparison to the wild type cells which are not affected by Flp mediated 
recombination. 
 
 
 
Figure 4.1. The Flip-out system for clonal Gal4 expression: 
Flip recombinase (FLP) target sites (FRTs) are arranged as direct repeats flanking the 
y+ FRT cassette. Flp under the control of a heat shock promoter induces the 
recombination between the FRT sites resulting into the excision of the y+ FRT cassette. 
Gal4 is thus juxtaposed next to the Actin5C promoter element leading to the expression 
of Gal4.   
Figure adapted from (Tuan Rocky. S and Lo W Cecillia, 2000).  
 
Act5C promoter 
y+ FRT cassette Gal4 
+ FLP recombinase 
Act 5C promoter Gal4  
+ 
y+ FRT cassette 
 
FRT 
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4.1.5. Does NO signaling and its antiproliferative action require Mi-2? 
Although the previous results of the present study have identified Mi-2 as a probable 
target of NO signaling, it was not known whether the antiproliferative action of NO is 
dependent on Mi-2. NOS2 was expressed in Mi-2 down regulated animals to determine 
whether Mi-2 regulates NO dependent proliferation arrest. 
4.1.5.1. RNAi Approach 
An efficient way of reducing the expression of proteins is the use of RNA interference 
(RNAi) which allows a targeted knockdown of proteins. RNAi is a process of genetic 
interference using dsRNA for physiological gene silencing in an organism (Fire et al., 
1998). This particular technique of gene silencing was first exploited in the nematode 
Caenorhabditis elegans (Fire et al., 1991) and proved to be more efficient compared to 
single stranded RNAs (Fire et al., 1998). A RNase III-type enzyme, Dicer, initiates the 
process of RNA interference by converting linear, long double stranded RNA or hairpin 
RNA substrates in to 21-23nt base pair long siRNAs containing 2-nt overhangs at their 
3′ ends and phosphate groups at their 5′ ends. The antisense strand of siRNAs, referred 
as guide strand, is then assembled with the RNA-induced silencing complex (RISC) 
leading to the formation of a RNA-protein complex known as siRISC. The guide strand 
containing RISC then cleaves the target mRNA between 10 and 11 nt upstream of the 5′ 
ends exactly where the perfect complementary region exists resulting in the degradation 
of mRNA and thus achieving post transcriptional gene silencing (Fig 4.2) (Rana, 2007). 
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Figure 4.2. An overview of RNAi interference: Long double-stranded (ds)RNA or 
hairpin RNA substrates are cut by Dicer into smaller (21-nucleotide (nt)) small 
interfering (si)RNAs with 2-nt overhangs at the 3' ends and phosphate groups at the 5' 
ends. Alternatively, siRNA duplexes (19–23 nt) can be introduced into cells, where they 
are phosphorylated at the 5' ends by cellular kinases. These small dsRNAs assemble 
into the RNA-induced silencing complex (RISC), which contains AGO2, Dicer, and 
other cellular factors. siRNA then forms activated RISC (siRISC) that contains an 
antisense (guide) strand. Activated RISC finds its target mRNA and uses the antisense 
strand to guide the cleavage of the target mRNA. RISC is recycled and could carry out 
several cleavage events (Rana, 2007). 
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The first report using RNA interference in Drosophila demonstrated the functions of 
genes acting in the wingless pathway (Kennerdell and Carthew, 1998). The Vienna 
Drosophila RNAi Centre (VDRC) stock centre has generated 22,270 transgenic lines, 
capable of expressing RNAi corresponding to 88% of the predicted protein-coding 
genes in the Drosophila genome (Dietzl et al., 2007). These lines can be expressed by 
using tissue specific GAL4 drivers.  
To examine whether NO dependent growth regulation requires Mi-2, the size of the 
salivary gland nuclei of UAS-RNAi-Mi-2 and UAS-NOS2 co-expressed animals would 
be compared with that of larvae only expressing NOS2. 
4.1.5.2. Mi-2 transheterozygous mutants 
Another approach to reduce levels of Mi-2 was the use of Mi-2 alleles that showed 
reduced levels of Mi-2 expression. The effect of NOS on the salivary gland size of Mi-2 
down regulated third instar larvae was determined. Thus Mi-2 allelic combinations that 
were viable until the third larval stage were required. The two Mi-2 alleles used in this 
study were supplied by Bloomington Stock Centre. One of the mutant lines, Mi-2[j3D4], 
(Flybase id FB2009_10, Genotype: y[1]w[*];PMi-
2[j3D4]Su(Tpl)[j3D4]/TM3;Sb[1]Ser[1]) carries an insertion of P{lacW} at 19900352 
location of chromosome 3L situated in the first intron of Mi-2. Mi-2[j3D4] 
homozygotes are reported to be post embryonic lethal (Kehle et al., 1998) and were 
found to survive till the 2
nd
 larval stage (Khattak et al., 2002).  
The other mutant allele used (Flybase id FB2009_10, Genotype y[1] 
w[67c23];P{w[+mC]y[+mDint2]=EPgy2}Mi-
2[EY08138]Su(Tpl)[EY08138]/TM3;Sb[1]Ser[1]) carries an insertion of  P{EPgy2} 
transposable element at 19888742 location of chromosome 3L situated in the first intron 
of Mi-2 (Bellen et al., 2004).  
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4.2. Results 
4.2.1. Analysis of YFP tagged Mi-2
CPTI-000232  
expression in whole salivary glands 
expressing NOS2 
In order to monitor the effects of long term NOS expression, NOS2 was over expressed 
in the whole salivary glands of YFP tagged Mi-2
CPTI-000232
 larvae, under the control of 
the salivary gland specific c147-GAL4 driver. The localisation of Mi-2
CPTI-000232
 in 
NOS2 expressing larvae was compared with that of the control animals to monitor any 
change in YFP tagged Mi-2
CPTI-000232 
expression. The nuclei of the salivary glands from 
the third instar larvae expressing UAS-NOS2 were smaller in size as compared to the 
controls (Fig 4.3). 
Images of salivary glands from five wandering third instar larvae expressing NOS2 were 
acquired on the confocal microscope and were compared with five salivary glands from 
the control animals (Fig 4.3). All salivary glands of the experimental third instar larvae 
expressing NOS2 showed an increase in the nuclear expression of the YFP tagged Mi-
2
CPTI-000232
 as compared with that of the control larvae. The data from these larvae were 
analysed using imaging analysis software Velocity 
(http://www.cellularimaging.com/products/Volocity). The data showed that the mean 
intensity of brightness of YFP-tagged Mi-2
CPTI-000232
 per volume of the nucleus is higher 
in the salivary glands of NOS2 expressing experimental larvae compared to that of the 
control larvae. Quantification analysis of YFP fluorescent intensities of individual 
nuclei of each genotype (40 nuclei from five control larvae and 59 nuclei from five 
UAS-NOS2 expressing larvae) demonstrated a 1.7 fold average increase of YFP tagged 
Mi-2
CPTI-000232
 expression in UAS-NOS2 expressing animals. 
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                       A)                                                         B) 
 
   
  
     
 
 
 
 
 
 
 
 
 
  
DAPI 
Figure 4.3. Expression of YFP tagged Mi-2 in third instar salivary glands. 
A: salivary gland of control larva of genotype c147-GAL4 / +; YFP-Mi-2
CPTI-000232
 / 
+ 
B: salivary gland of experimental larva of genotype UAS-NOS2 / +; c147-    
GAL4 / +; YFP-Mi-2
CPTI-000232
 / + showing a higher expression of YFP tagged Mi-2  
 
(Scale bar = 20 µm)      
Images acquired and processed using identical settings. 
Raw data is available in Appendix B.1 
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4.2.2. Analysis of the expression of YFP tagged Mi-2
CPTI-000232 
  in NOS2 expressing 
single cell clones 
The result of previous experiment showed an increase in the nuclear localisation of YFP 
tagged Mi-2
CPTI-000232 
when NOS2 was expressed in the whole salivary gland. The 
increase in the Mi-2
CPTI-000232 
expression could have been a consequence of reduction of 
salivary gland size caused by NOS2 expression. Therefore a genetic system where 
growth of the salivary gland is minimally effected by NOS expression was used. This 
was achieved by generating Flp/FRT induced, UAS-NOS2 expressing single cell clones 
in the salivary glands of YFP tagged Mi-2
CPTI-000232 
larvae by 4min heat shock at 38
o
C 
between 24- 48hr after egg laying..  
NO is known to diffuse between cells (Haley, 1998). Hence, the expression of YFP 
tagged Mi-2
CPTI-000232 
may be influenced by NO in the cells immediately adjacent to a 
NOS2 expressing clone. Thus, the expression of Mi-2
CPTI-000232 
in cells of the immediate 
neighbours to those expressing NOS2, was not considered for the comparison. The 
intensity of YFP tagged Mi-2
CPTI-000232 
expression in NOS2 expressing clone cell was 
compared to that of the wild type cells not adjacent to the clone cell. 
NOS2 expressing clone cells showed an increase in the nuclear expression of YFP 
tagged Mi-2
CPTI-000232 
compared to the non adjacent wild type cells (Fig 4.4).
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Figure 4.4. Nuclear localisation of YFP tagged Mi-2
CPTI-000232
 in NOS2 
expressing clones.  
Clones were generated using a 4min heat shock at 38
o
C between 24- 48hr AEL, of 
animals with genotype: UAS-NOS2 / hsFLP; UAS-mRFP / CyO; YFP-Mi-2
CPTI-000232
 
/ Act5c>y
+
>Gal4.   
Clone is marked with RFP expression.  
NOS2 clone shows an increase of YFP tagged Mi-2 expression (red arrow).  
An increase in YFP tagged Mi-2 expression was also observed in cells immediately 
adjacent to the NOS2 expressing clone (blue arrow).  
Blue: DAPI, Green: YFP + Mi-2, Red: RFP.   
DAPI YFP + Mi-2 
CPTI-000232
 
RFP MERGE 
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4.2.3. Visualization of Mi-2 protein in single cell clones expressing NOS 
To confirm that the endogenous Mi-2 protein responded in a similar fashion to the YFP 
tagged protein when NOS was expressed, the localisation of endogenous Mi-2 protein 
was determined using an anti-Mi-2 antibody. GFP marked clones expressing NOS2 
were generated in a similar way to section 4.2.2.  
Rabbit anti-Mi-2 antibody (Brehm et al., 2000) was used in combination with goat anti-
rabbit Cy5 secondary antibody to visualize the localisation of Mi-2 protein.  
            The intensity of nuclear localisation of Mi-2 protein in each NOS2 expressing 
clone was compared with that of 10 non adjacent wild type cells of that salivary gland. 
The NOS2 expressing clones showed increased nuclear expression of Mi-2 protein when 
compared with the surrounding wild type cells (Fig 4.5.i. A and B).  High magnification 
of the anti-Mi-2 antibody stained wild type nuclei showed non-nucleolar distribution of 
Mi-2 protein. Although minor traces of anti-Mi-2 staining was found in the nucleolus of 
these wild type salivary glands (Fig 4.5.ii. A). In contrast, high magnification of NOS2 
expressing clone cells showed a uniform distribution of Mi-2 protein throughout the 
nucleus (including the nucleolus) (Fig 4.5.ii. B). However nuclei of both wild type and 
NOS2 expressing clone cells also showed a perinuclear localisation of Mi-2 protein (Fig 
4.5.ii. A and B). An accurate quantitative analysis of the intensity of Mi-2 localisation 
in NOS2 expressing clone cells was performed using the image analysis software 
velocity. This demonstrated increased Mi-2 levels in the NOS2 expressing clone cells 
compared to that of non-adjacent surrounding cells. A 2.074 : 1 (+ 1.199 /- 1.199) ratio 
of Mi-2 expression in NOS2 expressing clones versus surrounding wild type cells was 
recorded (Fig 4.6). In contrast, control GFP marked clones showed no difference in Mi-
2 expression compared to surrounding wild type cells; a 0.97:1 (+ 0.371 /- 0.371) ratio 
of Mi-2 expression in control GFP clones versus surrounding wild type cells was 
observed (Fig 4.6).  
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                              A)                                                             B)
Figure 4.5 (i). Antibody staining of Mi-2 protein expression in wild type and 
NOS2 expressing clones of salivary gland cells.  
 
Clones were generated using a 4min heat shock at 38
o
C between 24- 48hr AEL.  
 
A) GFP marked control clone (white arrow) showing no noticeable change in the    
intensity or localisation of  Mi-2. 
Genotype: hsFLP/+; Act5c>y
+
>Gal4 ;UAS-GFP  
 
B) NOS2 expressing clone (white arrow) marked with GFP showing an increase in 
the intensity of nuclear localisation of Mi-2 in the salivary gland of larva. 
Genotype: hsFLP/UAS-NOS2; Act5c>y
+
>Gal4 ; UAS-GFP 
 
Blue: DAPI, Green: GFP, Red: rabbit anti-Mi-2 antibody (Brehm et al, 2000)   
(Secondary antibody used: goat anti-rabbit Cy5).   
Scale Bar = 50 µm 
 
Mi-2  
GFP + NOS DAPI 
MERGE 
GFP  
Mi-2  MERGE 
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A)                                                     Ai)                                                                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 B) Bi) 
 
 
 
 
 
 
 
 
  
DAPI 
DAPI 
Mi-2 MERGE (Mi-2 + DAPI) 
DAPI 
MERGE (Mi-2 + DAPI) Mi-2 
Figure 4.5 (ii) High magnification image of Mi-2 protein expression in wild type and 
NOS2 expressing clones in salivary gland cells.  
 
A) Wild type salivary gland. Nucleolus is marked with white arrow. 
 
B) NOS2 expressing clone cell. Nucleolus is marked with white arrow. 
Blue: DAPI, Green: GFP, Red: rabbit anti-Mi-2 antibody (Brehm et al, 2000)   
(Secondary antibody used: goat anti-rabbit Cy5).  Scale Bar = 50 µm 
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Figure 4.6. Quantification of Mi-2 expression in wild type and NOS2 
expression single cell clones 
 
GFP = Ratio of average intensity of Mi-2 expression in GFP marked control 
clone cells versus the average intensity of Mi-2 expression in 10 non adjacent 
wild type cells.  
Genotype:  hsFLP/+; Act5c>y
+
>Gal4 ;UAS-GFP 
 
NOS2 = Ratio of average intensity of Mi-2 in GFP marked clone cells (expressing 
NOS2) verses the same in 10 non adjacent wild type cells.  
Genotype: hsFLP/UAS-NOS2; Act5c>y
+
>Gal4;UAS-GFP 
 
Data for both genotypes was obtained from 10 salivary glands from 10 animals.  
Error bars indicate standard deviation. Raw data available in Appendix: B.2 
Analysis undertaken using Velocity Image Analysis Software. 
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4.2.4. Analysis of effect of Simj expression on NOS induced phenotype 
As Simj is a regulatory component of the NuRD complex (Discussed in Section 4.1.2), 
the effect of NOS on Simj expression was determined. Unfortunately 
immunohistochemistry with an anti-Simj antibody proved unsuccessful (data not 
shown). Thus a UAS-simj-GFP fusion was used in this purpose.  
To analyse the effects of Simj expression on the NOS induced growth phenotype, NOS2 
expression was induced in whole salivary glands of larvae containing GFP tagged UAS-
simj-GFP (Kim et al., 2004) under the control of salivary gland specific c147-GAL4 
driver. As the simj-GFP was already fused with UAS sequence, using the c147-GAL4 
driver would simultaneously up regulate the expression of UAS-NOS2 and UAS-simj-
GFP. By co-expressing UAS-NOS2 and UAS-simj-GFP simultaneously in the same 
salivary gland, it could be determined whether expressing Simj alters the NOS induced 
phenotype on salivary gland size.  
           Animals co-expressing UAS-simj-GFP and UAS-NOS2 showed small sized 
salivary glands, reasonably  similar to those expressing UAS-NOS2 only (Figure No 4.7 
A and B).  
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                    A)                                                                 B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Salivary gland of UAS-simj-GFP and UAS-NOS2 
co expressed third instar larvae showed small size. 
A) DAPI stained Salivary gland of UAS-NOS2 expressed third instar 
larva. 
Genotype: UAS-NOS2 / + ; c147-GAL4 / +. 
B) Salivary gland of third instar larva co-expressing GFP tagged UAS-
simj and UAS-NOS2. 
Genotype: UAS-NOS2 / UAS-simj-GFP ; c147-GAL4 / +. 
 Scale bar = 20μm  
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4.2.5. Visualization of Dref protein in single cell clones expressing NOS 
To analyse if NO could alter Dref localisation, NOS2 expressing clones were generated. 
In this experiment the nuclear localisation of Dref protein was visualized by using a 
mouse anti-Dref antibody (Hirose et al., 2002) in combination with horse anti mouse 
Cy5 secondary antibodies. GFP marked clones expressing NOS2 were generated in a 
similar way to section 4.2.2.  
The intensity of nuclear localisation of Dref protein in the NOS2 expressing clones was 
compared with that of non adjoining wild type cells present in the same salivary gland. 
Similarly the amount of nuclear expression of Dref protein in the GFP marked control 
clones cells was compared with that of the non adjoining non-clone cells of that 
particular salivary gland. The intensity of nuclear localisation of Dref protein in the 
NOS2 expressing clones was compared to that of 10 non adjacent wild type cells of that 
salivary gland.  
The NOS2 expressing clones showed no obvious change in the intensity of nuclear 
accumulation of Dref protein when compared to the surrounding wild type cells (Fig 
4.8.i A and B).  Localisation pattern of Dref protein was not noticeably altered in NOS2 
expressing clone cells compared to the wild type cells as shown in the high 
magnification images (Fig 4.8.ii A and B). The perinuclear pattern of localisation of 
endogenous Mi-2 observed in wild type and NOS2 expressing clone cells (Section 4.2.3, 
Fig 4.5.ii A and B) was not shown by Dref protein in anti-Dref antibody stained wild 
type and NOS2 expressing clone cells (Fig 4.8.ii A and B).  
For a quantitative analysis of the response of Dref protein to NOS expression in single 
cell clones the image analysis software velocity was used. This demonstrated Dref 
levels in the NOS2 expressing clone cells compared to that of non-adjacent surrounding 
cells. A 0.944333: 1 (+ 0.22356 /- 0.22356) ratio of Dref expression in NOS2 expressing 
clones versus surrounding wild type cells was recorded (Fig 4.9). Control GFP marked 
clones showed no significant difference in Dref expression compared to surrounding 
wild type cells. A 0.96333:1 (+ 0.48026 / - 0.48026) ratio of Dref expression in control 
GFP clones versus surrounding wild type cells was observed (Fig 4.9). The ratio of Dref 
expression in the clone cell verses the non adjacent wild type cells of both the 
experimental (NOS2) and control (GFP) genotypes was found to be very similar (Fig 
4.9).  
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GFP + 
NOS 
Dref  MERGE 
DAPI 
Figure 4.8.(i). Dref protein in NOS2 expressing clones in salivary glands.  
Clones were generated using a 4min heat shock at 38
o
C between 24- 48hr AEL.  
 
A) GFP marked control clone (white arrow) showing no noticeable change in the intensity of 
Dref protein expression. 
Genotype: hsFLP/+; Act5c>y
+
>Gal4 ;UAS-GFP 
 
B) NOS2 expressing clone marked with GFP (white arrow) showing no noticeable change in 
the intensity of Dref protein expression.  
Genotype: hsFLP / UAS-NOS2; Act5c>y
+
>Gal4;UAS-GFP  
 
Blue: DAPI, Green: GFP, Red: mouse anti-Dref antibody (Hirose et al, 2002)  
(Secondary antibody used: Horse anti-mouse Cy5).  
 Scale Bar = 50 µm 
 
  
 Dref 
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           A) 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
  
MERGE (DAPI+ Dref) Dref 
A) High magnification of anti-Dref stained nuclei from wild type salivary gland. 
Nucleolus is marked with white arrow. 
 
B) High magnification of anti-Dref stained nuclei of NOS2 expressing clone cell. 
Nucleolus is marked with white arrow. 
 
Blue: DAPI, Green: GFP, Red: mouse anti-Dref antibody (Hirose et al, 2002)  
(Secondary antibody used: Horse anti-mouse Cy5).  
 Scale Bar = 50 µm 
 
Figure 4.8.(ii). High magnification image of Dref protein expression in wild type and 
NOS2 expressing clones in salivary glands. 
67 DAPI 
DAPI 
MERGE (DAPI+Dref) Dref 
DAPI 
Dref MERGE (DAPI+Dref) 
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Figure 4.9. Ratio of average Dref expression in GFP and NOS2 
expressing single cell clones compared non adjacent to wild type cells. 
GFP = Ratio of average intensity of Dref expression in GFP marked control clone 
cells versus the average intensity of Dref expression in 10 non adjacent wild type 
cells.  
Genotype:  hsFLP/+; Act5c>y
+
>Gal4 ;UAS-GFP 
 
NOS2 = Ratio of average intensity of Dref in GFP marked clone  
cells expressing NOS2 versus average intensity in 10 non adjacent wild type  cells.  
Genotype: hsFLP/UAS-NOS2 ; Act5c>y
+
>Gal4;UAS-GFP  
 
Data for both genotypes was obtained from 10 salivary glands from 10 animals.  
Error bars indicate standard deviation. Raw data available in Appendix B.3  
Analysis performed using Velocity Image Analysis Software. 
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4.2.6. Simultaneous visualization of both Mi-2 and Dref proteins in single cell 
clones expressing NOS  
It has been reported that Mi-2 and Dref proteins negatively regulate each others 
functions and the binding of Mi-2 and Dref to the polytene chromosomes is mutually 
exclusive (Hirose et al., 2002). Therefore the effect of NOS on the localisation of both 
the proteins at the same time, in single cell clones was determined. GFP marked clones 
expressing NOS2 were generated as in section 4.2.2.  
The experimental salivary glands were stained with a combination of rabbit polyclonal 
anti-Mi-2 and mouse monoclonal anti-Dref antibodies mixed in an appropriate dilution 
(Described in Section 2.2.2).    
            Different control samples were used to compare the localisation of both the 
proteins. Salivary glands from wild type (y, w) third instar larvae not expressing NOS2 
were double stained with both the antibodies to use as control samples. The localisation 
pattern of both the proteins in NOS2 expressing clones was compared with that of the 
single stained cells of wild type third instar salivary glands. Several salivary glands 
from wild type (y, w) third instar larvae were singly stained with Mi-2 and Dref 
antibodies separately and the protein localisation pattern of this individual antibody 
stained salivary glands was compared to that of the double stained y, w salivary glands.  
            Salivary glands of wild type third instar larva when singly stained with mouse 
anti-Dref antibody, showed nuclear, cytoplasmic and cell membrane associated Dref 
protein (Fig 4.10 A), whereas Mi-2 protein was observed to be localised exclusively in 
the nuclei of the wild type third instar salivary glands when stained with rabbit anti-Mi-
2 antibody (Fig 4.10 B).  However, no nuclear staining of Dref protein was observed in 
the wild type third instar larvae when double labelled with both anti-Dref and anti-Mi-2 
antibodies simultaneously (Fig 4.11 A). When this double staining procedure was used, 
anti-Dref staining was observed in the cytoplasm and cell membranes and weakly in the 
nuclei (Fig 4.11 A). However the nuclei of fat body cells of these double labelled 
animals did show anti-Dref staining in the nuclei (Fig 4.11 A). The localisation of anti-
Dref staining observed in double labelled wild type salivary glands (Fig 4.11 A), was 
different to that of wild type salivary gland cells singly labelled with anti-Dref antibody 
(Fig 4.10 A).  
The double labelled wild type cells surrounding the NOS2 expressing clone cells did 
show prominently cytoplasmic but weak nuclear staining of anti-Dref antibody whereas 
anti-Mi-2 staining was exclusively nuclear (Fig 4.11 B). This accumulation pattern of 
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anti-Dref and anti-Mi-2 staining (Fig 4.11 B) was similar to the wild type double 
labelled salivary gland cells (Fig 4.11 A), whereas, NOS2 expressing clones of the 
double stained larvae showed a markedly different pattern of anti-Dref and anti-Mi-2 
staining from their surrounding wild type cells (Fig 4.11 B). GFP marked NOS2 
expressing clones, when double stained with anti-Dref and anti-Mi-2 antibodies, 
showed a novel pattern of Dref staining. The anti-Dref antibody recognized Dref protein 
in the nuclei of the NOS2 expressing clone cells (Fig 4.11 B) which was not seen in 
NOS2 clone surrounding wild type cells (Fig 4.11 B) and in wild type double stained 
salivary gland cells (Fig 4.11 A). The anti-Mi-2 staining was predominantly nuclear in 
NOS2 expressing clones which was similar to that of the surrounding wild type cells 
(Fig 4.11 B). However the level of anti-Mi-2 staining was higher in NOS2 expressing 
clones compared with the surrounding wild type cells (Fig 4.11 B). 
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  A)                                                             B) 
 
 
 
  
DAPI MERGE 
Mi-2 
Figure 4.10. Salivary glands of wild type third instar larvae stained with 
anti-Dref and anti-Mi-2 antibody 
 
A) Dref protein was found in the nucleus, cytoplasm and cell membrane of wild 
type third instar salivary gland when stained with mouse anti-Dref antibody (Hirose et 
al, 2002). (Secondary antibody used: horse anti-mouse Cy5) 
 
B) Localisationof Mi-2 protein in wild type third instar salivary gland was 
predominantly nuclear when stained with rabbit anti-Mi-2 antibody (Brehm et al, 
2000). (Secondary antibody used: goat anti-rabbit Cy5). 
 
Blue: DAPI, Red: horse anti-mouse Cy5 (A), goat anti-rabbit Cy5 (B).  
Scale Bar = 50µm 
Dref 
DAPI MERGE 
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Figure 4.11. Double antibody staining of salivary glands with both 
rabbit anti-Mi-2 and mouse anti-Dref antibodies. 
 
A) Wild type third instar salivary gland stained with anti-Dref and anti-Mi-2 
antibodies. In the salivary gland cells anti-Dref staining is localised to the 
cytoplasm (indicated by yellow Alexa 555 secondary antibody). In the nuclei, the 
accumulation of anti-Mi-2 is clearly indicated by red Cy5. This nuclear exclusion 
of anti-Dref staining does not occur in the fat body cells (small white arrows). 
Genotype: y,w ; + /+ ; +/+ 
 
B) Third instar salivary gland with GFP marked NOS2 expressing clone cells (small 
white arrows). The nuclei of the clone cells show high levels of both anti-Mi-2 and 
anti-Dref staining whereas the nuclei of the surrounding wild type cells show 
predominantly anti-Mi-2 staining (Red block arrow). Very low level of anti-Dref 
staining is observed in the cytoplasm of the wild type cells (red block arrow).  
Genotype: hsFLP/UAS-NOS2 ; Act5c>y
+
>Gal4;UAS-GFP 
  
Blue: DAPI, Green: GFP  
Yellow: mouse anti-Dref (Hirose et al, 2002), Red: rabbit anti-Mi-2 (Brehm et al, 
2000). 
Secondary antibodies:  
For Mi-2: goat anti rabbit Cy5 
For Dref: goat anti mouse Alexa 555 
Scale Bar = 20 µm 
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4.2.7. Down regulation of Mi-2 expression in YFP tagged Mi-2
CPTI-000232
 using 
RNAi approach 
To determine whether Mi-2 was required for NO signalling to inhibit growth, the levels 
of Mi-2 were reduced by targeted RNAi. A UAS-RNAi-Mi-2 construct containing stock 
from VDRC (Vienna drosophila RNAi Center) (Dietzl et al., 2007) was used for this 
purpose. The efficiency of RNAi dependent reduction of Mi-2 expression was examined 
by expressing UAS-RNAi-Mi-2 in animals heterozygous for the YFP tagged Mi-2
CPTI-
000232
 allele. RNAi expression was driven in salivary glands with the c147-Gal4 driver. 
The nuclear expression of the YFP tagged Mi-2
CPTI-000232
 in UAS-RNAi-Mi-2 expressed 
flies was less than control YFP tagged Mi-2
CPTI-000232
 salivary glands (Fig 4.12 A and B).  
The expression of RNAi-Mi-2 did not completely eliminate, but did down regulate, the 
expression of YFP tagged Mi-2
CPTI-000232 
as shown in Figure 4.12.  
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                A)                                                       B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12. RNAi-Mi-2 reduces the expression of YFP tagged Mi-2
CPTI-
000232
.
 
A) Salivary gland of a third instar control larva showing expression of YFP tagged 
Mi-2
CPTI-000232 
Genotype: c147-GAL4 / + ; YFP-Mi-2
CPTI-000232
/ + 
 
B) Salivary gland of a third instar experimental larva expressing UAS-RNAi-Mi-2 
shows reduced expression of YFP tagged Mi-2
CPTI-000232 
as compared
 
with the control 
animal (A). 
Genotype: c147-GAL4 / + ; YFP-Mi-2
CPTI-000232
/ UAS-RNAi-Mi-2. 
(Scale bar = 20 µm)      
Images acquired and processed using identical settings. 
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4.2.8. Down regulation of Mi-2 expression by using Mi-2 transheterozygous 
mutants 
 As expression of RNAi-Mi-2 did not eliminate expression of YFP tagged Mi-2, Mi-2 
mutants were used to reduce Mi-2 expression. Stocks carrying two different Mi-2 alleles 
(Described in section 4.1.5.2) were used. Each allele was balanced over TM6B to allow 
identification of non-balancer larvae. When kept as separate stocks no non-Tubby larvae 
were observed in either of the mutant stocks. However, non-Tubby third instars were 
recovered when the mutant stocks balanced with TM6B were crossed with each other. 
In order to test whether this allelic combination reduced the expression of Mi-2 protein 
in salivary glands of the third instar larvae, the transheterozygous Mi-2 animals were 
subjected to immunohistochemistry with rabbit an anti-Mi-2 antibody (Brehm et al., 
2000). The expression of Mi-2 protein in these salivary glands was found to be 
significantly less when compared with that of the wild type third instar larva (Fig 4.13 
A and B).  
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Mi-2  Mi-2  
DAPI DAPI MERGE MERGE 
Figure 4.13. Antibody staining of Mi-2 protein in third instar salivary 
glands. 
A) Salivary gland of wild type third instar larva showing nuclear localisation of 
Mi-2 protein. 
B) Salivary gland of third instar Mi-2 transheterozygote mutant larva showing less 
Mi-2 protein compared to A 
Genotype: P{lacW}Mi-2
j3D4
/ P{EPgy2}Mi-2
EY08138
 Su(Tpl)
EY08138
 
Blue: DAPI, Red: rabbit anti-dMi-2 antibody (Brehm et al, 2000)   
(Secondary antibody used: goat anti-rabbit Cy5).   
Scale Bar = 50 µm.   
Images acquired and processed using identical settings. 
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4.2.9. Study of the phenotype imparted by NOS in a Mi-2 down regulated 
background 
The results of this thesis indicate Mi-2 as a target of NO signalling (Sections 3.2.2, 3.2.3, 
4.2.1, 4.2.2 and 4.2.3). NO is known to control organ size (Kuzin et al., 1996). To test 
whether Mi-2 is required for the NO induced reduced growth phenotype, NOS was 
expressed in salivary glands expressing reduced levels of Mi-2. As previously shown, 
Mi-2 levels can be reduced by targeted RNAi or by using transheterozygotes of two Mi-
2 alleles (Section 4.2.7 and 4.2.8). Hence, both RNAi-Mi-2 animals and 
transheterozygous Mi-2 mutants were exploited as Mi-2 down regulated systems to 
examine the Mi-2 dependency of NO induced reduced growth phenotypes. 
A functional relationship between Mi-2 and cell proliferation has been discussed above 
(Section 4.1.1). Another aim of this experiment was to determine whether a decrease of 
Mi-2 content alters the growth of the salivary glands.  
The average volume of DAPI stained nuclei from five different genotypes was 
calculated (Fig 4.14). Expression of UAS-NOS2 in the salivary glands using the c147-
GAL4 driver showed the expected small sized nuclei (Fig 4.14, Genotype: NOS2). 
When UAS-RNAi-Mi-2 and UAS-NOS2 were co-expressed with c147-GAL4, the 
nuclei of salivary glands again showed a small size phenotype reasonably similar to that 
when UAS-NOS2 was driven alone (Fig No: 4.14, Genotype NOS2RNAi-Mi-2). 
Salivary glands of Mi-2 transheterozygous mutants also exhibited a reduced growth 
phenotype when UAS-NOS2 was expressed (Fig 4.14, NOS2Mi-2 transheterozygous 
mutant). The average volume of the salivary gland nuclei of the Mi-2 transheterozygous 
mutants (Fig 4.14, Mi-2transheterozygous mutant) was found to be within a close 
statistical range to that of the wild type salivary gland nuclei (Fig 4.14, WT). 
 Tub-GAL4 driven expression of the UAS-RNAi-Mi-2 construct was undertaken to 
determine whether any growth phenotype or lethality would be caused by the reduction 
in Mi-2 levels in the whole animal. Expression of UAS-RNAi-Mi-2 via Tub-GAL4 
neither induced any growth phenotype nor caused any lethality (data not shown). Adult 
flies carrying UAS-RNAi-Mi-2 driven by Tub-GAL4 showed normal fertility (data not 
shown).  
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Figure 4.14. Average volume of DAPI stained larval salivary gland 
nuclei. 
WT = Genotype: y, w ; + / + ; + / +  
 
NOS2 = Genotype: UAS-NOS2 / + ; c147-GAL4 / +. 
 
NOS2RNAi-Mi-2 =  Genotype: UAS-NOS2 / + ; c147-GAL4 / + ; UAS-RNAi-
Mi-2 / +. 
 
NOS2Mi-2 transheterozygous mutant = Genotype: UAS-NOS2 / +; c147-
GAL4 / + ; P{lacW}Mi-2
j3D4
/ P{EPgy2}Mi-2
EY08138
 Su(Tpl)
EY08138
 
 
Mi-2transheterozygous mutant = Genotype: +/+ ; +/+ ; P{lacW}Mi- 2
j3D4
/ 
P{EPgy2}Mi-2
EY08138
 Su(Tpl)
EY08138
 
 
WT = y, w ; +/+ ; +/+  
 
Data derived from 80 DAPI stained nuclei from 8 different salivary glands of 8 
different female animals of each of the above genotypes.   
Data analysed and processed using Image analysis software Velocity.  
Raw data available in Appendix No: B.4. 
Error bars indicate standard deviation.  
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4.3 Discussion 
One primary aim of the experiments presented in this chapter was to determine the 
effects of NO on the Mi-2/NuRD complex and its associated proteins.  
As Mi-2 was suspected to be a possible target of the growth control activity of NO 
(Discussed in Sections 3.2.2 and 3.2.3) and Mi-2/NuRD was itself reported to play an 
essential role in transcriptional repression and growth control (Discussed in Section 
4.1.1), the other important aspect of this chapter was to determine whether the 
antiproliferative action of NO is through Mi-2/NuRD.  
 
     4.3.1. NO alters Mi-2 localisation 
The previous ex vivo results of SNAP treatment found an increase in the YFP tagged 
Mi-2
CPTI-000232 
expression after SNAP exposure (Section 3.2.2 and Section 3.2.3). So by 
using Mi-2
CPTI-000232 
fly stock, a detailed study was undertaken to confirm whether NO 
alters Mi-2 localisation in vivo.  
In order to determine this, two different approaches were undertaken: 
One approach was to use c147-GAL4 to drive NOS2 expression in whole salivary 
glands of YFP tagged Mi-2
CPTI-000232
 larvae (Section 4.2.1). The size of the NOS2 
expressing experimental salivary gland nuclei were found to be much smaller than that 
of the control nuclei (Fig 4.3) which is consistent with previous reports (Kuzin et al., 
1996), (Kimber, 2005) and (Scott, 2009). Confocal images acquired of five NOS2 
expressing third instar larvae showed a consistent increase in the nuclear localisation of 
YFP tagged Mi-2
CPTI-000232
 when compared with the salivary glands of their 
corresponding control animals (Fig 4.3). Although the size of the salivary gland nuclei 
were small, the increase of the intensity of YFP tagged Mi-2
CPTI-000232
 localisation 
observed in the NOS2 expressing animals (Fig 4.3) demonstrated that NO modified Mi-
2 localisation.
 
         
To further investigate the alteration of Mi-2 localisation in response to NOS2, the 
FRT/GAL4 expression system was used. In this approach NOS2 was expressed in single 
cells of the salivary glands. mRFP marked single cell clones expressing NOS2 in the 
salivary glands of Mi-2
CPTI-000232 
animals showed an increase in YFP tagged Mi-2 
nuclear localisation when compared with that of the non adjacent wild type cells not 
expressing NOS2 (Fig 4.4). The immediate adjoining wild type cells of the mRFP 
marked NOS2 expressing clone cell also showed an increase in the YFP tagged Mi-2 
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(Fig 4.4). The increase in YFP tagged Mi-2
CPTI-000232 
localisation in the immediate 
adjacent wild type cells is likely to be a result of NO diffusion (Haley, 1998). 
 
 
Immunohistochemical analysis performed using an anti-Mi-2 antibody showed an 
increase in Mi-2 expression in NOS2 expressing single cell clones compared with the 
non-adjacent wild type cells (Fig 4.5.i B). No increase in the nuclear accumulation of 
endogenous Mi-2 in cells immediately adjacent to NOS2 expressing clones may be a 
result of the very short half life of NO (Haley, 1998) limiting its diffusion to those cells 
immediately neighboring the source of NO. 
Unlike the anti-Mi-2 stained wild type cells (Fig 4.5.ii A), NOS2 expressing clone cells 
showed a uniform distribution of Mi-2 protein throughout the nucleus (including the 
nucleolus) (Fig 4.5.ii B). However, nuclei of both wild type and NOS2 expressing clone 
cells also showed perinuclear localisation of Mi-2 protein (Fig 4.5.ii A and B). The ratio 
of the average intensity of endogenous Mi-2 in the clone cells verses that of the non 
adjacent wild type cells was found to be higher in NOS2 expressing cells compared to 
that of control cells as calculated using image analysis software velocity (Fig 4.6). 
Although the average ratios were different, there was some overlap in the standard 
deviations. The range in data may have been minimized by analysing higher number of 
salivary glands. However, the recovery of NOS2 expressing clones in the salivary gland 
is not trivial. NOS2 expressing clones were only observed in approximately 10% of 
salivary glands dissected. The very brief heat shock (4-5mins) driving expression of 
FLP was used as longer heat shocks resulted in the death of the majority of the UAS-
NOS2 containing larvae (data not shown). The low recovery of salivary gland clones 
expressing NOS2 is presumably due to larval death caused by the expression of NOS2 in 
other tissues, as NOS2 expression, when limited to the salivary gland, has no effect on 
viability (data not shown). The increase in Mi-2 expression observed by using anti-Mi-2 
antibody in response to NOS2 expression (Fig 4.5) demonstrated that NOS acts to up 
regulate the nuclear concentration of Mi-2 protein.   
 
4.3.2. Simj does not alter the NOS mediated growth control 
Expression of NOS2 reduces cell proliferation and limb size of Drosophila (Kuzin et al., 
1996). As Simj has been reported to act as the regulatory component of Mi-2/NuRD 
(Discussed in 4.1.2) and Mi-2/NuRD was confirmed as a probable target of NO 
(Sections 4.2.1, 4.2.2 and 4.2.3), it was determined whether animals expressing UAS-
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NOS2 or co-expressing UAS-NOS2 and UAS-simj showed any alteration to the reduced 
growth phenotype that resulted from NOS2 expression alone (Fig 4.7). Co-expression of 
UAS-NOS2 and UAS-simj did not noticeably alter the reduced growth observed when 
compared to NOS2 expression alone (Fig 4.7). These data suggested that Simj does not 
alter the growth control activity of NO.  
 
4.3.3. NOS does not noticeably affect the localisation of Dref 
As NO had been shown to alter the nuclear localisation of Mi-2 (Sections 4.2.1, 4.2.2 
and 4.2.3) and Mi-2 has previously been shown to genetically and physically interact 
with Dref (Hirose et al., 2002), the localisation of Dref protein in cells expressing high 
levels of NO was determined. The localisation of Dref in NOS2 expressing single cell 
clones did not appear to be noticeably different when compared with the non-adjacent 
wild type cells (Fig 4.8 i). In addition, the quantitative analysis of the average ratio of 
Dref localisation in the NOS2 expressing clone cells verses the corresponding non 
adjacent wild type cells was similar to that of the control clones (Figure 4.9). These data 
demonstrate that NOS does not modify Dref expression or localisation. No noticeable 
alteration in the localisation pattern of Dref protein was observed in NOS2 expressing 
clone cells compared to the wild type cells as shown in the high magnification images 
(Fig 4.8.ii A and B). The perinuclear pattern of localisation of endogenous Mi-2 
observed in wild type and NOS2 expressing clone cells (Section 4.2.3, Fig 4.5.ii A and 
B) was not mimicked by Dref protein in anti-Dref antibody stained wild type and NOS2 
expressing clone cells (Fig 4.8.ii A and B).  
 
4.3.4. Regulation of growth by NO does not act through Mi-2 
Previous data from this thesis showed that Mi-2 is a target of NO (Sections 3.2.2, 3.2.3, 
4.2.1, 4.2.2 and 4.2.3). Therefore whether the growth regulating role of NO is dependent 
on Mi-2 was determined. In order to examine this, the effect of NO was investigated in 
UAS-NOS2 and UAS-RNAi-Mi-2 co-expressing flies. The salivary gland nuclei of the 
UAS-NOS2 and UAS-RNAi-Mi-2 co-expressing animals showed a reduced size similar 
to those expressing only UAS-NOS2 (Fig 4.14). Moreover NOS2 expression in Mi-2 
transheterozygous mutant larvae also resulted in small salivary gland nuclei (Fig 4.14). 
These results indicate that NO mediated growth regulation does not act through Mi-2. 
Mi-2/NuRD plays important role in mediating malignancy caused by extreme cell 
proliferation as reviewed in (Zhang et al., 1999) and therefore Mi-2/NuRD may be 
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required for growth or proliferation.  Thus it was expected that Mi-2 transheterozygous 
mutants, where the amount of Mi-2 protein was very low (Fig 4.13), would show an 
alteration in the nuclear size compared to those of wild type salivary glands. The 
quantitative analysis did not show any difference in nuclear size of salivary gland nuclei 
in Mi-2 transheterozygous mutants compared to wild types (Fig 4.14). This unpredicted 
observation coincides with the recent finding that the major portion of Drosophila Mi-2 
is actually part of a complex termed dMec (dMEP-1 complex). This complex mediates 
transcriptional repression of proneural genes (Kunert et al., 2009, Kunert N, 2009) 
however there is no data demonstrating a role for dMec in the control of cell 
proliferation.    
 
4.3.5. A novel function of NO in the disruption of the in vivo Mi-2/Dref protein 
complex  
The localisation pattern of Mi-2 protein both in single stained (Fig 4.10 B) and double 
stained (with anti-Dref) wild type salivary glands was predominantly nuclear (Fig 4.11 
A). In the single stained wild type salivary glands, along with the nuclear localisation 
some cytoplasmic and cell membrane bound traces of anti-Dref staining were also 
observed (Fig 4.10 A), whereas in the double stained wild type salivary glands the 
distribution of anti-Dref staining was found to be exclusively cytoplasmic but weakly 
nuclear nuclear (Fig 4.11 A).  
Interestingly the anti-Dref mouse monoclonal antibody used in this study was raised 
against bacterially purified recombinant Dref protein consisting of amino acids 16-608 
(Hirose et al., 1996). This region overlaps the Mi-2 interacting region of the Dref 
protein (amino acids 16-145) (Hirose et al., 2002). Therefore, when anti-Mi-2 
antibodies interact with Mi-2/Dref to form a Dref /Mi-2/anti-Mi-2 antibody complex, 
they may mask the epitope sites of the anti-Dref antibody. In double stained wild type 
salivary glands, it can be suggested that epitope sites of the anti-Dref mouse monoclonal 
antibody are probably masked in the Dref /Mi-2/anti-Mi-2 antibody complex. Hence, 
the anti-Dref antibodies can not recognize the epitope sites present on the Dref protein 
of the nuclear Mi-2 / Dref / anti-Mi-2 antibody complex (Fig 4.11 A). As Mi-2 
localisation is higher in the nucleus than the cytoplasm (Fig 4.10 A) it can be speculated 
that there is insufficient cytoplasmic Mi-2 protein for the formation of Dref /Mi-2 
complex in the cytoplasm. Hence in the cytoplasm of the double stained wild type 
salivary glands the epitope sites of anti-Dref antibody are left unmasked. Consequently 
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anti-Dref antibody can bind to the epitope sites present on the cytoplasmic Dref protein 
leading to the visualization of the cytoplasmic Dref protein in the double antibody 
stained wild type salivary glands (Fig 4.11 A). As the localisation pattern of double 
labelled Mi-2 and Dref staining observed in wild type cells surrounding NOS2 
expressing clones (Fig 4.11 B) was found to be similar to that of the wild type salivary 
glands (Fig 4.11 A), it can be inferred that same phenomenon of Mi-2/Dref/anti-Mi-2 
antibody interaction was repeated in the wild type cells surrounding the NOS2 clone 
(Fig 4.11 B). However, in cells expressing NOS2 and double labelled with anti-Mi-2 
and anti-Dref antibodies, a unique staining pattern was revealed. In these cells nuclear 
Dref staining can be observed (Fig 4.11B). This indicates that the Mi-2 / Dref / anti-Mi-
2-antibody complex has been disrupted allowing access of anti-Dref antibodies to their 
binding sites.  
A search on Drosophila genome database revealed that more than 150 cell proliferation 
related, DRE sequence containing genes, may act as targets of the transcription 
regulatory activity of Dref (Matsukage et al., 2008). The DNA binding activity of Dref, 
which acts as the key for the transcriptional control of several DNA proliferation related 
genes, can be regulated by the intracellular redox state through the active participation 
of the redox sensitive Cys59 and /or Cys62 amino acids of Dref (Choi et al., 2004). 
High levels of NO induced by NOS2, interact with the thiol groups of proteins leading 
to the initiation of NO responsive gene expression (Eberhardt and Beck, 2001). NO, 
which plays fundamental role in cell proliferation (Villalobo, 2006) also functions in 
altering the transcription factors which are responsive to intracellular redox status to 
promote cell signalling (Eberhardt and Beck, 2001). All these results suggest that NOS2 
could be involved in the alteration of Dref protein leading to the potential reorganisation 
of Mi-2/Dref complex in NOS2 expressing clone cells.  
As a consequence of the probable disruption of the Mi-2/Dref complex by NO, Dref 
epitopes are not masked in Mi-2/Dref complex resulting in the visualization of nuclear 
Dref by anti-Dref staining in NOS2 expressing clone cells (Fig 4.11 B). The entirely 
different pattern of Dref staining in the NOS2 expressing clones from that of the 
surrounding wild type cells (Fig 4.11 B) supports the concept of the disruption of Mi-
2/Dref complex by NOS. In summary the present study has proposed a novel function 
of NOS in the reorganisation of Mi-2/Dref protein complex.  
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Chapter 5: Effect of FOXO on Mi-2/NuRD and associated proteins 
 
5.1. Introduction 
 
5.1.1. FOXO: The forkhead family transcription regulators 
 
FOXO is a member of the forkhead family of transcription factors. In humans this 
family consists of four orthologues: namely FOXO1 (previously known as FKHR), 
FOXO2, (previously known as AF6q21), FOXO3a (previously known as FKHRL1), 
and FOXO4 (previously known as AFX) (Jacobs et al., 2003). The only FOXO gene in 
Drosophila is a homologue of DAF-16/FOXO family of transcription factors and is 
closely related with hFOXO3a (human FOXO gene) and (Junger et al., 2003). 
 
5.1.2. Developmental roles of FOXOs 
A sequence of five amino acids  present in the DNA binding domain of FOXO (α helix 
3) enables sequence specific interaction between FOXO and its DNA binding sites. 
FOXOs have numerous roles in development such as cell proliferation, apoptosis, 
metabolism, cell cycle progression and relief from oxidative stress (Andreas Barthel, 
2005). FOXOs are targets of protein kinase B (PKB)/Akt, in the repression of cell 
proliferation leading to growth arrest (Medema, 2003). In cells of the hematopoietic 
system activation of FOXO factors induce the activation of several proapotopic genes to 
trigger apoptosis (Medema, 2003). It has been reported that mammalian FOXO4 and 
DAF-16 inhibit the cell cycle at the G1 and G2 phases. FOXO4 and FOXO3a trigger the 
transcription of GADD45 mRNAs resulting in suppression of cell cycle progression at 
G2 phase in mouse (Yoko Furukawa-Hibi et al., 2002). Akt phosphorylates and retains 
FOXO3a in the cytoplasm, whereas the dephosphorylation of FOXO3a leads to the 
movement and activation of FOXO3a into the nucleus where it induces expression of 
several target genes (Fig 5.1). These include Fas ligand genes vital for cell death hence 
apoptosis or programmed cell death is promoted (Anne Brunet et al., 1999). Under 
stressful conditions, FOXO family members can induce apoptosis by activating the 
transcription of numerous pro-apoptopic genes (Dansen and Burgering, 2008). Lethal 
hyperplasia / germ line tumour in C. elegans  which is caused by mutations in the 
tumour suppressor gld-1 (Francis et al., 1995) is suppressed by a gld-1 specific 
proliferation decrease controlled by DAF-16 (Julie M. Pinkston, 2006). Mice carrying 
null mutations for the FoxO family orthologues, FoxO1, FoxO3a, and FoxO4, show a 
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mild cancer predisposition indicating that FOXOs act as tumour suppressors (Paik et al., 
2007). 
 
Figure 5.1. Insulin signaling pathway in Drosophila (taken from (Neufeld, 2003)). The 
FOXO protein mediates a transcriptional response to insulin signaling. Under conditions of 
abundant nutrients, FOXO is phosphorylated by Akt and retained in an inactive state in the 
cytoplasm. When insulin levels fall, FOXO is dephosphorylated and translocates into the 
nucleus, where it stimulates transcription of 4E-BP (Thor) and presumably other negative 
regulators of growth. In addition, active FOXO increases expression of the insulin receptor 
gene, which may result in increased insulin sensitivity under low insulin conditions (Neufeld, 
2003). 
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5.1.3. Previous research in the laboratory on FOXO 
Previously in our laboratory Affymetrix gene arrays were used to identify 
transcriptional changes induced in Drosophila S2 cells following exposure to NO 
(Kimber, 2005). These data indicated that many genes which were up regulated by NO 
are also functional targets of the transcription factor dFOXO. The previous data of our 
laboratory also showed that Thor (4E-BP) which is a member of 4E binding protein 
(4E-BP) family (Bernal and Kimbrell, 2000) is up regulated by NO in vivo and is also a 
transcriptional target of FOXO (Kimber, 2005).When not phosphorylated by Akt, 
FOXO enters nucleus where it induces the transcription of Thor (4E-BP) (Puig et al., 
2003). Data from our laboratory has indicated that Thor transcription is activated by NO 
in a FOXO dependent manner  (Kimber, 2005) (Scott, 2009).  
 
5.1.4. Perspective of the present chapter 
During the present study, a genetic screen for targets of NO, using the NO donor SNAP, 
revealed Mi-2 as a target of NO (Section 3.3.2). An increase in Mi-2 expression was 
also observed in whole salivary glands and in single cell clones expressing UAS-NOS2 
(Section 4.3.1). Thus, as Mi-2 is a probable target of NO, the action of NO on Mi-2 may 
be regulated by FOXO. Therefore, several experiments were undertaken to determine 
whether expression of UAS-FOXO changes expression of Mi-2 protein.  
 
Dref activity is known to be negatively regulated by Mi-2 (Hirose et al., 2002) and acts 
as a transcriptional regulatory factor of several cell proliferation and apoptosis related 
genes (Matsukage et al., 2008). These two functional properties of Dref indicated that 
the function of Dref protein may act under the direct control of FOXO signalling. It was 
therefore decided to study the effect of FOXO expression on the expression and 
localisation of Dref protein.  
As Simj has been demonstrated to be a regulatory subunit for the Mi-2 containing 
NuRD complex (Kon et al., 2005), the effects of FOXO expression on Simj were also 
determined.  
To achieve these aims, UAS-FOXO was expressed in the whole salivary glands of YFP 
tagged Mi-2
CPTI-000232
 larvae by using the c147-GAL4 driver. The effect of UAS-FOXO 
on the localisation of endogenous Mi-2 and Dref proteins was analysed in GFP marked 
single cell clones by using the FRT-GAL4 system (Described in 4.1.4).  
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5.2. Results 
5.2.1. Analysis of the effect of FOXO expression in the whole salivary glands of 
YFP tagged Mi-2
CPTI-000232. 
The results of SNAP treatments to salivary glands showed an increase of YFP tagged 
Mi-2
 CPTI-000232 
expression (Section 3.3.2). YFP tagged Mi-2
 CPTI-000232 
larvae also
 
showed 
an increase in Mi-2 expression when NOS was expressed in the whole salivary glands 
and also in NOS expressing single cell clones (Section 4.3.1). Therefore it was decided 
to analyse YFP tagged Mi-2
 CPTI-000232 
expression in whole salivary glands of animals 
expressing FOXO under the control of the c147-GAL4 driver.  
Five pairs of salivary glands from wandering third instar larvae of experimental (UAS-
FOXO expressing) and control animals were imaged on the confocal microscope. The 
nuclei of the salivary glands from the third instar larvae expressing UAS-FOXO were 
considerably smaller in size as compared to the control (Fig 5.2). The YFP tagged Mi-2
 
CPTI-000232
 expression in these 5 experimental larvae was compared with that of the 
corresponding control larvae. Two of the five different salivary glands expressing 
FOXO showed an increase in the nuclear expression of the YFP tagged Mi-2
 CPTI-000232 
(Fig 5.2 Bi). The remaining three larvae did not show any noticeable change as 
compared to that of the control larvae (Fig 5.2 Bii). The YFP expression from all the 
larvae was analysed using imaging analysis software Velocity. 
(http://www.cellularimaging.com/products/Volocity). Quantification analysis of YFP 
fluorescent intensity of five salivary glands of each genotype (32 control and 33 UAS-
FOXO expressing nuclei) demonstrated a 1.3 fold average increase of YFP tagged Mi-2 
expression in UAS-FOXO up regulated animals (see appendix B.5. for raw data). 
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                         Ai)                                                         Bi) 
 
 
 
 
 
 
 
 
 
 
                               Aii)                                                       Bii) 
                                 
 
 
 
 
                         
                   
Figure 5.2. Expression of YFP tagged Mi-2
CPTI-000232
 in third instar salivary 
glands. 
Ai and Aii) salivary glands of control larva of genotype c147-GAL4 / +; YFP-Mi-2
 CPTI-
000232 
/ + 
Bi) and Bii) salivary glands of larvae. Genotype c147-GAL4 / UAS-FOXO; YFP-Mi-2
 CPTI-
000232 
/ + 
Bi) salivary gland over expressing FOXO showing higher expression of YFP tagged Mi-2 
than the corresponding control Ai) 
Bii) Salivary gland over expressing FOXO showing no noticeable change in the expression 
of YFP tagged Mi-2 compared to the corresponding control Aii). 
Scale bars = 20 µm. 
Ai and Bi: Images acquired and processed using identical settings.     
Aii and Bii: Images acquired and processed using identical settings.  
Raw data is available in Appendix B.5.    
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5.2.2. Visualization of endogenous Mi-2 protein in single cell clones expressing 
FOXO  
Expression of UAS-FOXO in the whole salivary glands of YFP tagged Mi-2 
CPTI-000232 
larvae using the c147-GAL4 driver made the salivary glands smaller in size. However, 
the change in expression of Mi-2 may have been due to the reduced salivary gland size. 
Therefore the effect of FOXO signalling on endogenous Mi-2 expression, when the size 
of the salivary gland is minimally affected was determined. In order to undertake this, 
induction of UAS-FOXO expression was achieved in single cells of salivary glands 
using the FLP/FRT technique (Discussed in section 4.1.4). UAS-FOXO expressing GFP 
marked single cell clones were generated using the same hsFLP stock and in a similar 
protocol as described in section 4.2.3. The hsFLP carrying fly stock was crossed with 
animals containing UAS-FOXO and thus GFP marked, UAS-FOXO expressing clones 
could be recovered. Endogenous Mi-2 protein was visualised with a rabbit anti-Mi-2 
antibody (Brehm et al., 2000). Control clones expressing only GFP were also generated. 
20 salivary glands (10 of the experimental and 10 of control animals) were imaged on 
the confocal microscope.   
The intensity of Mi-2 expression in the clone cells were compared to that of 10 non-
adjacent wild type cells in each experimental (FOXO expressing) and control salivary 
glands. No obvious difference in Mi-2 expression was observed in the confocal images 
(Fig 5.3). The images were subsequently analysed using the image analysis software 
velocity. This demonstrated Mi-2 levels in the FOXO expressing clone cells compared 
to that of non-adjacent surrounding cells. A 0.91: 1 (+ 0.26 /- 0.26) ratio of Mi-2 
expression in FOXO expressing clones versus surrounding wild type cells was recorded 
(Fig 5.4). Control GFP marked clones showed no difference in Mi-2 expression 
compared to surrounding wild type cells. A 0.97:1 (+ 0.37 /- 0.37) ratio of Mi-2 
expression in control GFP clones versus surrounding wild type cells was deduced. This 
quantitative analysis did not reveal any noticeable change in the nuclear accumulation 
of Mi-2 in FOXO expressing clone cells (Figure 5.4).  
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            A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
            B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Antibody staining of Mi-2 protein expression in wild type and 
FOXO expressing clones of salivary gland cells.  
Clones were generated using a 4min heat shock at 38
o
C between 24- 48hr AEL.  
A) GFP marked control clone (white arrow) showing no noticeable change in the    
      intensity or localisation of Mi-2. 
      Genotype: hsFLP / + ; Act5c>y
+
>Gal4;UAS-GFP / +  
B) FOXO expressing clone (white arrow) marked with GFP showing no noticeable      
    change in the intensity or localisation of  Mi-2. 
Genotype:  hsFLP / + ; Act5c>y
+
>Gal4 / UAS-FOXO ;UAS-GFP / +  
Blue: DAPI, Green: GFP, Red: Rabbit anti-Mi-2 antibody (Brehm et al 2000)   
(Secondary antibody used: goat anti-rabbit Cy5).   
Scale Bars = 50 µm 
 
DAPI 
GFP + 
FOXO 
Mi-2 
MERGE 
DAPI GFP 
Mi-2 MERGE 
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Figure 5.4. Quantification of Mi-2 expression in wild type and FOXO 
expressing single cell clones. 
 
GFP = Ratio of average intensity of Mi-2 expression in GFP marked control 
clone cells Versus the average intensity of Mi-2 expression in 10 non adjacent 
wild type cells. 
Genotype:  hsFLP / + ; Act5c>y
+
>Gal4; UAS-GFP / + 
 
dFOXO = Ratio of average intensity of Mi-2 localisation in GFP marked clone  
cells over expressing FOXO Versus average intensity of Mi-2 expression in 10 
non adjacent wild type cells.  
Genotype:  hsFLP / + ; Act5c>y
+
>Gal4 / UAS-FOXO ;UAS- GFP / +  
 
Data for both genotypes was obtained from 10 salivary glands from 10 animals.  
Error bars indicate standard deviation.  
 
Raw data available in Appendix B.6.  
Analysis undertaken using Velocity Image Analysis Software. 
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5.2.3. Analysis of the effect of co expression of UAS-FOXO and UAS-simj on 
salivary gland growth 
Whether over expressing Simj could suppress or enhance FOXO induced inhibition of 
growth of the salivary glands, could be studied by up regulating both UAS-FOXO and 
UAS-simj at the same time in the same animal. 
To determine if over expression of Simj would influence the reduced growth phenotype 
induced by increased levels of FOXO, both genes were co-expressed in the whole 
salivary glands using the c147-GAL4 driver. 
UAS-simj-GFP (Kim et al., 2004)  and UAS-FOXO were driven simultaneously using 
the c147-GAL4 driver and the phenotypic effect on salivary gland size was determined.  
            Salivary glands of UAS-simj-GFP and UAS-FOXO co-expressed third instar larvae, 
showed reasonably similar size to that of the flies where UAS-FOXO was driven alone 
(Fig 5.5).  
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Figure 5.5. Salivary gland of UAS-simj-GFP and UAS-FOXO co 
expressed third instar larvae showed small size. 
A) DAPI stained Salivary gland of FOXO expressed third instar larva. 
Genotype: + / + ; c147-GAL4 / UAS-FOXO ; + / +. 
B) Salivary gland of GFP tagged UAS-simj and UAS-FOXO co expressed 
third instar larva. 
Genotype: UAS-simj / + ; c147-GAL4 / UAS-FOXO ; + / +. 
Scale Bar =  20µm 
   
 
 
DAPI + UAS-FOXO UAS-simj-GFP + UAS-FOXO 
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5.2.4. Visualization of Dref protein in a single cell clones expressing FOXO 
The FLP/FRT technique previously described (Section 4.1.4) was used to induce GFP 
marked FOXO over expressing clones. The control genotypes were generated similarly 
as in 5.2.2. The nuclear localisation of Dref protein was visualized by using a mouse 
anti-Dref antibody (Hirose et al., 2002) in combination with goat anti-mouse Alexa 555 
secondary antibodies. The intensity of nuclear localisation of Dref protein in the GFP 
marked FOXO over expressing clones was compared to that of the non-adjacent wild 
type cells of that particular salivary gland. Similarly the amount of nuclear expression 
of Dref in the GFP marked control clones cells was compared to that of the non adjacent 
non-clone cells of that particular salivary gland. 20 confocal images (10 from each of 
the experimental and control genotypes) of salivary glands were analysed. No obvious 
change in the expression of Dref protein was found in the images of UAS-FOXO 
expressing clone cells when visually compared to that of the nonadjacent wild type cells 
(Fig 5.6 B). However, a minority showed an increase in the expression of Dref protein 
when compared to non adjacent wild type cells (Fig 5.6 C). To accurately analyse the 
response of Dref protein to FOXO over expression in single cell clones, the image 
analysis software velocity was used. This quantitative analysis did demonstrate an 
increase in Dref protein expression in some FOXO expressing clone cells compared to 
the non adjoining wild type cells. A 1.35: 1 (+ 1.10 /- 1.10) ratio of Dref expression in 
FOXO expressing clones versus surrounding wild type cells was recorded (Fig 5.7). 
Control GFP marked clones showed no significant difference in Dref expression 
compared to surrounding wild type cells. A 0.38:1 (+1.19 / - 1.19) ratio of Dref 
expression in control GFP clones versus surrounding wild type cells was observed (Fig 
5.7).Although there was a large variation in the levels of Dref expression between 
clones (Fig 5.7).     
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Figure 5.6. Antibody staining of Dref protein expression in 
wild type and FOXO expressing single cell clones in salivary 
gland cells.  
 
Clones were generated using a 4min heat shock at 38
o
C between 
24- 48hr AEL.  
 
A) GFP marked control clone (white arrow) showing no noticeable 
change in the   intensity or localisation of Dref. 
Genotype: hsFLP / + ; Act5c>y
+
>Gal4;UAS-GFP 
  
B) UAS-FOXO expressing clone (white arrow) marked with GFP 
showing no noticeable change in the intensity or localisation of 
Dref. 
 
C) UAS-FOXO expressing clone (white arrow) marked with GFP 
showing a small increase in the intensity of Dref accumulation  
Genotype: hsFLP / +; Act5c>y
+
>Gal4 / UAS-FOXO; UAS- GFP  
 
Scale Bar = 50 µm 
 
Blue: DAPI, Green: GFP, Yellow: mouse anti-Dref antibody 
(Hirose et al 2002)   
(Secondary antibody used: goat anti-mouse Alexa 555).   
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Figure 5.7. Quantification of Dref expression in wild type and UAS-
FOXO expressing single cell clones. 
 
GFP = Ratio of average intensity of Dref expression in GFP marked control clone 
cells Versus the average intensity in 10 non-adjacent wild type cells.  
Genotype:  hsFLP / + ; Act5c>y
+
>Gal4 ; UAS-GFP  
 
dFOXO = Ratio of average intensity of Dref expression in GFP marked clone  
cells over expressing FOXO Versus the average intensity in 10 non-adjacent wild 
type cells.  
Genotype:  hsFLP / + ; Act5c>y
+
>Gal4 / UAS-FOXO ; UAS-GFP.  
 
Data for both genotypes was obtained from 10 salivary glands from 10 animals.  
Error bars indicate standard deviation. Raw data available in Appendix: B.7 
Analysis undertaken using Velocity Image Analysis Software. 
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5.2.5. Simultaneous visualization of Mi-2 and Dref proteins in single cell clones 
expressing UAS-FOXO 
It has been reported that the anti-Dref antibody can co-immunoprecipitate Mi-2 from 
Drosophila embryos which confirms the existence of an  in vivo Mi-2/Dref complex 
(Hirose et al., 2002). The same report also showed that both proteins negatively regulate 
each others functions and the binding of Mi-2 and Dref to the polytene chromosomes is 
mutually exclusive (Hirose et al., 2002).  Thus the effect of increased FOXO expression 
on both the proteins at the same time in single cells was determined. GFP marked 
FOXO expressing clones were generated in an identical way described in section 5.2.2, 
A mixture of rabbit polyclonal anti-Mi-2 (Brehm et al., 2000) and mouse monoclonal 
anti-Dref antibodies was prepared following the dilution described in section 2.2.2. The 
salivary glands of experimental and control animals were stained with this mix of 
antibodies. 
Further control samples were used to compare the localisation of both the proteins. 
Salivary glands from y, w third instar larvae were double stained with both antibodies 
and with anti-Mi-2 and anti-Dref antibodies separately. The antibody localisation in 
these single stained y, w salivary glands was compared to that of the double stained y, w 
salivary glands.  
Salivary gland of wild type third instar larva when stained with anti-Dref antibody alone 
showed not only nuclear staining but also staining in the cytoplasm and cell membranes 
(Fig 5.8 A). The accumulation of anti-Mi-2 staining in single stained animals was found 
to be exclusively in the nuclei of wild type third instar larvae (Fig 5.8 B). However anti-
Dref staining was observed only in the cytoplasm and cell membranes of y, w larvae 
double labelled with both anti-Dref and anti-Mi-2 antibodies (Fig 5.9 A). In these 
double stained larvae, anti-Mi-2 staining was exclusively in the nucleus (Fig 5.9 A). 
Similar to the double stained wild type cells from y, w animals, anti-Dref staining was 
exclusively cytoplasmic and cell membrane associated and anti-Mi-2 staining was 
predominantly in the nuclei of the double stained wild type cells surrounding UAS-
FOXO expressing clones (Fig 5.9 B and C).  Although the non adjacent wild type cells 
of the double stained larva showed two entirely different localisation patterns of anti-
Dref and anti-Mi-2 staining, both the proteins were observed to be simultaneously 
localised in the nuclei of UAS-FOXO expressing clone cells (Fig 5.9 B and C, Fig 5.10, 
5.11, 5.12). An increase in the level of anti-Mi-2 staining was sometimes observed in 
UAS-FOXO expressing clone cells (Fig 5.9 B and C, 5.10, 5.12). However this increase 
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of anti-Mi-2 staining was not found in all UAS-FOXO expressing clone cells (Fig 5.11). 
In UAS-FOXO expressing clone cells, anti-Mi-2 staining showed a perinuclear pattern 
of distribution (Fig 5.10 vii, 5.11 vii and 5.12 vii), reasonably similar to wild type and 
NOS2 expressing clone cells (Section 4.2.3, Fig 4.5. ii A and B). However, the 
perinuclear localisation of anti-Dref staining observed in UAS-FOXO expressing clone 
cells (Fig 5.10 v, 5.11 v and 5.12 v) did not mimic the anti-Dref staining in wild type 
and NOS2 expressing clone cells (Section 4.2.5, Fig 4.8.ii.A and B).   
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DAPI MERGE 
Mi-2 
Figure 5.8. Images showing salivary glands of y, w wild type third 
instar larvae singly stained with anti-Dref and dMi-2 antibodies. 
 
A) A noticeable amount of Dref protein was found in the nuclei, cytoplasm 
and cell membranes of the wild type third instar salivary gland when stained with 
mouse anti-Dref antibody (Hirose et al, 2002). (Secondary antibody used: horse 
anti-mouse Cy5). 
 
B) Localisation of Mi-2 protein observed in wild type third instar salivary glands 
was predominantly nuclear when stained with rabbit anti-Mi-2 antibody (Brehm et 
al, 2000). (Secondary antibody used: goat anti-rabbit Cy5). 
 
Compared to the Dref stained salivary gland (A) the traces of cytoplasmic and cell 
membrane bound Mi-2 protein (B) observed was cosiderably less.  
Blue: DAPI, Red: goat anti rabbit Cy5 and horse anti-mouse Cy5. 
Scale bar = 20µm 
 
Dref 
DAPI MERGE 
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 Figure 5..9. Localisation of anti-Dref and anti-Mi-2 staining in double 
labelled third instar salivary glands. 
 
A) Wild type (y, w) third instar salivary gland double stained with anti-
Dref and anti-Mi-2 antibodies. Dref (yellow) is observed solely in the  
cytoplasm and cell membranes of the salivary gland cells but is observed 
in the nuclei of the associated fat body. Accumulation of anti-Mi-2 staining 
is exclusively nuclear (indicated by red Cy5).  
 
B) Salivary gland with UAS-FOXO expressing clone cell (white arrow) 
along with non adjacent wild type cells. The nucleus of the UAS-FOXO 
expressing clone cell shows both anti-Mi-2 and anti-Dref staining. 
Surrounding wild type cells show anti-Mi-2 staining predominantly in the 
nuclei (red) with traces of cytoplasmic anti-Dref staining (yellow).A higher 
level of anti-Mi-2 staining was observed in the UAS-FOXO expressing 
clone cell compared to the surrounding wild type cells. 
 
C) High magnification of (B). Nuclear accumulation of both anti-Mi-2 and 
anti-Dref staining is observed in the UAS-FOXO expressing clone cell 
(white arrow). Surrounding wild type cells show anti-Mi-2 staining 
predominantly in the nuclei (red) with cytoplasmic and cell membrane 
associated accumulation of anti-Dref staining (yellow). An increased level 
of anti-Mi-2 staining was observed in the UAS-FOXO expressing clone 
cell.  
 
Scale Bar = 50µm 
Yellow: mouse anti-Dref (Hirose et al, 2002), Red: rabbit anti-Mi-2 
(Brehm et al, 2000). 
Secondary antibodies:  
For Mi-2: goat anti rabbit Cy5, For Dref: goat anti mouse Alexa 555 
97 
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Figure 5.10. High magnification image of single cell clone in salivary gland 
over expressing FOXO.  
marked with iii) GFP (green) and stained with: i) mouse anti-Dref antibody 
(yellow), ii) rabbit anti-Mi-2 antibody (red), iv) DAPI blue.  
Merged images for Dref and DAPI (v), Dref and Mi-2 (vi), and Mi-2 and DAPI 
(vii).  
Secondary antibodies: Alexa 555 goat anti-mouse, Cy5 goat anti-rabbit. 
Scale bar = 10m. 
 
 
 (i) Dref (ii) Mi-2 (iii) GFP 
(iv) DAPI (v) MERGE (Dref + DAPI) (vi) MERGE (Dref + Mi-2) 
 
(vii) MERGE (Mi-2 + DAPI) 
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(i)Dref (ii) Mi-2 (iii) GFP 
(iv) DAPI (v) MERGE (Dref + DAPI)  (vi) MERGE (Dref + Mi-2) 
(vii) MERGE (Mi-2+DAPI) 
Figure 5.11. High magnification image of single cell clone in salivary gland 
over expressing FOXO  
marked with iii) GFP (green) and stained with: i) mouse anti-Dref antibody 
(yellow), ii) rabbit anti-Mi-2 antibody (red), iv) DAPI blue. 
Merged images for Dref and DAPI (v), Dref and Mi-2 (vi), and Mi-2 and DAPI 
(vii).  
Secondary antibodies: Alexa 555 goat anti-mouse, Cy5 goat anti-rabbit. 
Scale bar = 10m. 
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(i) Dref (ii) Mi-2 (iii) GFP 
(iv) DAPI (v) MERGE ( Dref + DAPI) (vi) MERGE (Dref + Mi-2 
(vii) MERGE (Mi-2 + 
DAPI) 
Figure 5.12. High magnification image of single cell clone in salivary gland 
over expressing FOXO  
marked with iii) GFP (green) and stained with: i) mouse anti-Dref antibody 
(yellow), ii) rabbit anti-Mi-2 antibody (red), iv) DAPI blue.  
Merged images for Dref and DAPI (v), Dref and Mi-2 (vi), and Mi-2 and DAPI 
(vii).  
Secondary antibodies: Alexa 555 goat anti-mouse, Cy5 goat anti-rabbit. 
Scale bar = 10m. 
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5.3. Discussion  
5.3.1. FOXO does not noticeably alter Mi-2 localisation  
Expression of UAS-FOXO driven by c147-GAL4 in the whole salivary glands of YFP 
tagged Mi-2
CPTI-000232 
animals reduced the size of the salivary glands (Fig 5.2 Bi and 
Bii). This result coincides with the previous finding that ectopic expression of FOXO 
and the human FOXO3a results in a reduction of organ size (Junger et al., 2003). The 
decrease of salivary gland size also agrees with the previous report that FOXO reduces 
cell size by inhibiting cell proliferation (Kramer et al., 2003). Increased expression of 
FOXO in the whole salivary glands of YFP tagged Mi-2
CPTI-000232 
does not consistently 
modify the localisation of the YFP tagged Mi-2 protein (Fig 5.2). However, 
quantification analysis of these data using the image analysis software velocity, 
demonstrated a 1.3 fold average increase of YFP tagged Mi-2 expression in UAS-
FOXO expressing animals (Section 5.2.1).  
No noticeable change in the localisation of Mi-2 protein was observed in the marked 
UAS-FOXO expressing single cell clones (Fig 5.3). The image analysis software 
Velocity was used to analyse and calculate the intensity of Mi-2 protein in UAS-FOXO 
expressing and wild type clone cells compared to Mi-2 levels in surrounding non-clone 
cells. These data were presented graphically showing the ratio of the average intensity 
of Mi-2 expression in the clone cell verses that of the non adjoining wild type cells for 
both the control and experimental genotypes (Fig 5.4). These data reveal that the ratio of 
the average level of Mi-2 protein in FOXO over expressing clone cells versus the non 
adjacent wild type does not significantly differ from that of the control genotype (Fig 
5.4). Thus, it can be proposed that, the level of Mi-2 protein is not altered by increased 
levels of FOXO expression.  The standard deviations of the data may have been reduced 
by obtaining data from higher number of salivary glands. 
 
5.3.2. Simj does not alter FOXO mediated reduced sized salivary gland phenotype 
It has been reported that expression of FOXO using a hsGAL4 driver results into 
reduction of body size which was thought to be a consequence of decrease in cell size 
and cell number (Kramer et al., 2003). Previous findings from the lab also showed that 
induction of FOXO expression causes a reduction in the size of the salivary gland 
(Kimber, 2005).  Simj, the regulatory component of NuRD complex (Kon et al., 2005) 
when co-expressed with FOXO, the salivary gland showed a reduced growth phenotype 
reasonably similar with that of animals expressing only UAS-FOXO (Fig 5.5). These 
MERGE 
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data suggest that the over expression of Simj cannot enhance or suppress FOXO 
induced growth arrest. 
 
5.3.3. FOXO does not markedly alter the expression of Dref  
The localisation and concentration of Dref protein did not consistently change in FOXO 
expressing single cell clones as compared with the non adjacent wild type cells (Fig 5.6 
B). The intensity of Dref protein these clone cells was analysed using the image analysis 
software velocity. The ratio of the average amount of Dref protein in clone cells verses 
that of the non-adjoining wild type cells of was analysed (Fig 5.7). Although the images 
did not show any consistent change of Dref localisation in FOXO expressing clone cells 
(Fig 5.6), the quantitative analysis revealed that the ratio of the average intensity of Dref 
protein in clone cells versus the non adjacent wild type cells of the experimental 
genotype varied greatly between animals (Fig 5.7). The standard deviation of the data 
may have been reduced by obtaining data from higher number of salivary glands.   
 
5.3.4. A novel pattern of localisation of Mi-2 and Dref protein was observed in 
FOXO expressing clone cells 
The localisation pattern of anti-Mi-2 staining in both single and double stained wild 
type salivary glands was observed to be nuclear (Fig 5.8 B and Fig 5.9 A). Along with 
the nuclear accumulation, some cytoplasmic and cell membrane associated anti-Dref 
staining was also observed in wild type salivary glands when singly labelled with anti-
Dref antibody (Fig 5.8 A). However, wild type salivary glands double stained with anti-
Dref and anti-Mi-2 antibodies showed exclusively cytoplasmic anti-Dref staining 
(without any nuclear labelling) (Fig 5.9 A). Interestingly the anti-Dref mouse 
monoclonal antibody used in this study was raised against bacterially purified 
recombinant Dref protein consisting of amino acids 16-608 (Hirose et al., 1996) which 
overlaps the Mi-2 interacting region of the Dref protein (amino acids 16-145) (Hirose et 
al., 2002). The existence of an in vivo Dref/Mi-2 complex has been reported (Hirose et 
al., 2002).Therefore, epitope sites of the anti-Dref mouse monoclonal antibody are 
probably masked in the Dref /Mi-2/anti-Mi-2 antibody complex formed in the double 
labelled cells. It can be speculated that anti-Dref antibodies can not recognize their own 
epitope sites on Dref in the Dref /Mi-2/anti-Mi-2 antibody complex formed in the 
nucleus and hence visualization of Dref protein is not possible in nucleus of the double 
stained wild type salivary glands (Fig 5.9 A). Unlike the anti-Dref monoclonal antibody, 
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the anti-Mi-2 polyclonal antibody can recognize its epitope sites and label the nuclear 
Mi-2 protein. Hence visualization of Mi-2 protein is possible in the nuclei of the double 
stained wild type salivary glands (Fig 5.9 A). However, as anti-Dref staining was 
observed in the cytoplasm of the wild type double labelled cells (Fig 5.9 A), it is 
hypothesized that Mi-2 protein may not form complex with Dref in the cytoplasm or 
may have a different conformation. This hypothesis does not contradict the evidence 
showing that localisation of anti-Mi-2 staining is higher in the nucleus than the 
cytoplasm as shown in singly stained wild type salivary glands (Fig 5.8 B). Hence, in 
the cytoplasm of the double stained wild type salivary glands, the epitope binding sites 
of anti-Dref antibody are left unmasked leading to the recognition by anti-Dref antibody 
(Fig 5.9 A). This same interaction between Mi-2, Dref and anti-Mi-2 antibodies 
presumably has also occurred in the wild type cells surrounding the UAS-FOXO 
expressing clones, as the distribution pattern of Dref and Mi-2 staining shown by these 
cells (Fig 5.9 B and C) is reasonably similar with that of the double stained wild type 
salivary gland cells (Fig 5.9 A). 
Interestingly high levels of both anti-Dref and anti-Mi-2 staining were observed in the 
nuclei of double stained UAS-FOXO expressing clone cells (Fig 5.9 B and C, Fig 5.10, 
Fig 5.11, Fig 5.12). The level of anti-Mi-2 staining was increased in some double 
stained UAS-FOXO expressing clones (Fig 5.9 B and C, Fig 5.10 ii, Fig 5.12 ii). 
However, this alteration in anti-Mi-2 staining was not consistently observed in all 
double stained UAS-FOXO expressing clones (Fig 5.11 ii), which supports the previous 
quantitative analysis data acquired from UAS-FOXO expressing clones singly stained 
with anti-Mi-2 antibody (Section 5.2.2, Fig 5.4). Anti-Mi-2 staining in double stained 
UAS-FOXO expressing single cell clones was sometimes, nucleoplasmic (Fig 5.10 vii) 
but mostly perinuclear (Fig 5.11 vii, 5.12 vii). Some cytoplasmic anti-Dref staining was 
observed in FOXO expressing clone cells (Fig 5.10 i, Fig 5.11 i, Fig 5.12 i). However, 
anti-Dref staining was also found to be nuclear membrane associated and perinuclear 
(Fig 5.10 vi, Fig 5.11 vi, Fig 5.12 vi). The fact that this perinuclear distribution of Dref 
staining (Fig 5.10 vi, Fig 5.11 vi, Fig 5.12 vi) was not seen in wild type cells and NOS2 
expressing clone cells when singly stained with anti-Dref antibody (Section 4.2.5, Fig 
4.8.ii. A and B) suggests, this localisation pattern of Dref protein is uniquely mediated 
by FOXO. This distinct localisation of anti-Dref staining in UAS-FOXO expressing 
clone cells (Fig 5.10 vi, Fig 5.11 vi, Fig 5.12 vi) can be analysed from the perspective of 
the previously reported functional relationships between FOXO, myc and Dref.  
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The presence of a functional Myc binding site ( 5′-CACGTG canonical E-box) between 
-78 to -73 nucleotide sequences of the Dref promoter suggests that Dref  is a target of 
Myc (Dang Thi Phuong Thao, 2007). Myc induces cell growth by promoting G1/S 
progression (Johnston et al., 1999). The absence of myc represses cellular growth and 
reduces the size of wing cells (Johnston et al., 1999). This growth arrest, coupled with a 
reduction of organ size, was also observed when a N-terminal Dref fragment (Dref 1-125) 
was expressed in salivary glands. This fragment was shown to inhibit the transcriptional 
regulatory activity of wild type Dref in a dominant negative manner (Hirose et al., 1999). 
Dref is known to regulate the transcription of several cell proliferation related genes 
(Matsukage et al., 2008) and Myc functions in the regulation of normal growth  
(Johnston et al., 1999). 
A decrease in the transcription of Dref was found in dm
4
/y hemizygous mutants of myc, 
which suggests that Myc is essential for normal Dref gene expression (Dang Thi 
Phuong Thao, 2007). Therefore, Myc may regulate its target genes via the DRE/Dref 
pathway (Dang Thi Phuong Thao, 2007). 
Myc has been identified as a target of FOXO, as myc mRNA levels are controlled by 
FOXO in a tissue specific manner and FOXO can inhibit or increase myc expression 
(Teleman et al., 2008).  
All these reports suggest a direct or indirect functional link between FOXO and myc and 
a functional relationship between Myc and Dref. These links may explain the unique 
localisation of Dref protein observed in FOXO expressing clones in the present study 
(Fig 5.10 vi, Fig 5.11 vi, Fig 5.12 vi). The tendency of Dref protein to localize in the 
perinuclear space and in the cytoplasm observed in FOXO expressing clones (Fig 5.10 
vi, Fig 5.11 vi, Fig 5.12 vi) may be a result of high levels synthesis of Dref protein, 
induced by FOXO via a Myc dependent pathway.  
The perinuclear distribution of anti-Mi-2 staining observed in UAS-FOXO expressing 
clone cells (Fig 5.11 vii, Fig 5.12 vii) was also observed in wild type cells and NOS2 
expressing clone cells when those were stained with anti-Mi-2 antibody (Section 4.2.3, 
Fig 4.5.ii. A and B). Therefore, there is no evidence that FOXO induces any change in 
Mi-2 expression or localisation. 
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Chapter 6: Interaction between Simj, Mi-2 and Dref 
 
6.1. Introduction 
 
6.1.1. The functional link between Simj and Mi-2/NuRD 
Mi-2, a member of Snf2 family of ATPases, promotes chromatin remodelling by ATP 
hydrolysis (Brehm et al., 2000). The evolutionary conserved, SWI family ATP 
dependent chromatin remodelling complexes (SWI/SNF, ISWI, CHD and IN080) are 
reported to be required for the normal development of embryos and play several other 
developmental roles such as telomere regulation, chromosome segregation, DNA 
replication during cell division (Crabtree, 2010) and maintenance of higher order X 
chromosome structure in Drosophila (Renate Deuring et al., 2000). ATP dependent 
chromatin remodelling enzymes control chromatin structure and play several cell 
specific roles during development (Crabtree, 2010). The ATP hydrolysis driven 
chromatin regulating activity of Mi-2 is physically linked with the deacetylase enzyme 
complex in a multi subunit histone deacetylase complex, purified from Xenopus laevis 
(Wade et al., 1998). Therefore, Mi-2 is  a part of  NuRD (Yi Zhang et al., 1998), NURD 
(Xue et al., 1998) or NRD (Tong et al., 1998) complex which is known to couple 
histone decaetylase and chromatin remodelling ATPase activity (Wade, 2007).  
A confocal microscopic study reported that the MBD2/3 associated mammalian Simj 
protein family members (66kDa) are involved in DNA methylation mediated 
transcriptional repression (Brackertz et al., 2002). Interestingly, Mi-2/NuRD achieves 
gene silencing through DNA methylation (Zhang et al., 1999). Simj which is a zinc-
finger containing protein acts as a functional link between Mi-2/NuRD and methylated 
DNA binding proteins MBD2 and MBD3, for methylation mediated gene silencing and 
hence acts as a regulatory component of NuRD (Kon et al., 2005). Therefore, these data 
suggest that the two core NuRD components Simj and Mi-2 share a common functional 
sphere of DNA methylation. Considering this relationship between Simj and Mi-2, the 
experiments of this chapter were designed to determine the effect of Simj on Mi-2 
expression. The response of Mi-2 in both Simj up regulated and down regulated third 
instar larvae would be determined.  
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6.1.1.1. Use of Simj up regulated system 
To achieve high expression of Simj, GFP tagged UAS-simj cDNA containing flies (Kim 
et al., 2004) were used. These flies were generated by constructing UAS-simj vector, 
containing a 2.7-kb simj cDNA fused to the GFP coding sequence (Kim et al., 2004). 
Over expression of GFP tagged UAS-simj would be induced by exploiting the 
UAS/GAL4 technique (Section 2.1.2). The salivary gland specific c147-GAL4 driver 
would be used to over express the GFP tagged UAS-simj gene in the whole salivary 
glands of third instar larvae. UAS-simj-GFP would be over expressed in single cells of 
salivary glands using FRT/Flp technique (Described in Section 4.1.4) followed by anti-
Mi-2 staining of these single cells to determine response of endogenous Mi-2 to the up 
regulation of Simj levels.  
 
6.1.1.2. Use of Simj down regulated system 
Reduction of Simj expression was achieved by generating simj transheterozygous 
mutants. Two different simj alleles used in this study, were supplied by Bloomington 
stock centre. 
One of these mutant lines (Flybase id FB2010_02, genotype: 
P{ry[+t7.2]=PZ}simj[01814] ry[506]/TM3, ry[RK] Sb[1] Ser[1]) carries an insertion of 
P{PZ} (Bellen et al., 2004) in a plus orientation at 10667498 location of 3L 
chromosome in the first intron of simj.  
The other mutant line (Flybase id FB2010_02, genotype: w[1118]; 
P{w[+mGT]=GT1}simj[BG00403]/TM6B, P{w[+mC]=35UZ}DB1, Tb[1]) carries an 
insertion of P{GT1}(Lukacsovich et al., 2001) in a minus orientation at 10672162 
position of 3L chromosome in the first intron of simj.  
 
6.1.2. The functional link between Simj, Mi-2 and Dref 
Drosophila Dref functions as a transcription regulatory factor (Hirose et al., 1996). A 
reduction in salivary gland size and endoreplication was observed with the expression 
of N-terminal Dref fragment (Dref 1-125). This fragment was shown to inhibit 
transcriptional regulatory activity of wild type Dref in a dominant negative manner. 
This suggested the requirement of Dref for DNA replication, cell proliferation, and 
differentiation leading to proper development (Hirose et al., 1999).  
NuRD associated Simj is known to control development through the regulation of 
ecdysone-responsive genes in Drosophila (Kon et al., 2005). These reports suggest that 
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a common functional link (regulation of development) exists between Simj and Dref. 
Thus it was decided to determine the effect of Simj on the localisation of Dref. 
Mi-2 has been revealed to negatively regulate Dref activity by preventing Dref-DNA 
binding (Hirose et al., 2002). As Dref function is under the negative control of Mi-2 
(Hirose et al., 2002), it would be interesting to find out how Dref would respond both in 
up and down regulated Mi-2 flies.  
 
6.1.3. How Simj affects either of the proteins when Mi-2/Dref complex is disrupted? 
 
The in vivo existence of a Mi-2/Dref complex has been reported (Hirose et al., 2002). 
The present study has revealed a novel function of NOS in the probable disruption of 
the in vivo Mi-2/Dref complex (discussed in Section 4.3.5). The experiments of this 
chapter would also focus on the investigation of the effect of Simj on both of the 
proteins after the potential disruption of the Mi-2/Dref complex by NOS.   
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6.2. Results 
6.2.1. Localisation of Dref protein in the whole salivary glands over expressing Mi-
2 
The aim of this experiment was to visualize the localisation of Dref protein in larvae 
expressing high levels of Mi-2. Induction of Mi-2 expression was achieved by crossing 
UAS-Mi-2 carrying flies (Hirose et al., 2002) with c147-GAL4 containing flies. The 
salivary glands of these third instar larvae were then stained with mouse monoclonal 
anti-Dref antibody (Hirose et al., 2002). Control flies were generated by crossing wild 
type flies with c147-GAL4. 
Confocal images of anti-Dref antibody stained salivary glands dissected from 10 
different experimental and control animals, were analysed. However, no consistent 
change in the Dref protein distribution was observed in the experimental salivary glands 
when compared with their corresponding control samples. Some UAS-Mi-2 expressing 
flies showed more intense localisation of Dref protein in the nucleus (Fig 6.1 Bi and Bii) 
whereas others did not show any noticeable changes in Dref localisation (Fig 6.1 Biii) 
when compared with the corresponding control flies (Fig 6.1 Aiii). 
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Figure 6.1. Dref localisation in the nuclei of salivary glands from wild 
type and UAS-Mi-2 expressing larvae  
 
Salivary glands from A) wild type B) UAS-Mi-2 expressing third instar larvae. 
 
Ai) Dref protein associated with the nuclei of salivary glands of a third instar wild 
type larva. 
Bi) Dref protein associated with the nuclei of salivary glands of a third instar larva 
over expressing Mi-2.  
Scale Bar = 20 µm, Images acquired and processed using identical settings. 
 
Aii) High magnification image of the nucleus of control (wild type) salivary gland 
showing anti-Dref staining within the nucleus. 
Bii) High magnification image of the nucleus of Mi-2 expressing salivary gland 
showing more intense staining of Dref protein in the nucleus and possibly in the 
polytene chromosomes, as compared to that of control larva. 
Scale Bar= 10 µm, Images acquired and processed using identical settings. 
 
Aiii) Dref protein associated with the nuclei of salivary glands from a third instar 
wild type larva. 
Biii) Dref protein associated with the nuclei of salivary glands from a third instar 
larva over expressing Mi-2. This larva did not show any obvious change in Dref 
expression as compared with the control sample (Aiii). 
Scale Bar= 20 µm. 
All images acquired and processed using identical settings. 
Red: mouse anti-Dref antibody (Hirose et al, 2002). 
Secondary antibody used: Horse anti-mouse Cy5. 
 
Genotype of Ai) Aii) Aiii): y,w / + ; c147-GAL4 / + ; + / + 
Genotype of Bi) Bii) Biii): UAS-Mi-2 ; c147-GAL4  
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6.2.2. Expression of Dref protein in whole salivary glands of Mi-2 
transheterozygous mutants  
Expression of Dref protein in Mi-2 down regulated flies was examined in this 
experiment. 
Salivary glands of Mi-2 transheterozygous third instar larvae (Discussed in section 
4.1.5.2) were stained with anti-Dref antibodies and were used as the experimental 
samples for this experiment. These larvae showed very low levels of Mi-2 protein (Fig 
4.1.3). Control flies were generated as in section 6.2.1, processed and imaged in parallel 
under identical conditions. 
Confocal images of anti-Dref antibody stained salivary glands dissected from 10 
different experimental and control animals were analysed. Salivary glands of Mi-2 
transheterozygous third instar larvae showed higher accumulation of nuclear Dref 
protein (Fig 6.2 B) compared with that of the control larvae (Fig 6.2 A). 
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Dref Dref 
Figure 6.2. Expression of Dref protein in the salivary gland nuclei of 
wild type and Mi-2 transheterozygous mutants.  
 
A) Control third instar larvae stained with anti-Dref antibody. 
Genotype: y,w / + ; c147-GAL4 / + ; + / + 
 
B) Salivary gland of third instar larvae from Mi-2 transheterozygous mutants 
showed higher accumulation of Dref in the nucleus compared to that of wild type 
larvae. 
Genotype: Mi-2
j3D4
/ Mi-2
EY08138
 Su(Tpl)
EY08138
 
 
Images acquired and processed using identical settings 
Red: mouse anti-Dref antibody (Hirose et al, 2002). 
Secondary antibody used: Horse anti-mouse Cy5. 
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6.2.3. Analysis of the phenotypic effect of Simj expression on salivary gland size          
simj has been reported to play several developmental roles (discussed in section 6.1.1). 
Therefore, the phenotypic effect of simj over expression on salivary gland size was 
determined. To achieve this, GFP tagged UAS-simj containing flies (Kim et al., 2004) 
(described in 6.1.1.1) were used. Induction of GFP tagged UAS-simj expression was 
accomplished in the whole salivary glands by the c147-GAL4 driver. Two different 
control samples were used:  
Third instar larvae of UAS-simj-GFP animals in which simj expression was not induced 
by GAL4 and third instar larvae of wild type (y, w) animals. Surprisingly larvae 
carrying UAS-simj-GFP showed low levels of GFP (and thus presumably low levels of 
ectopic Simj expression) in the absence of GAL4 (Fig 6.5 Aii). The experimental and 
control third instar salivary glands were stained with DAPI and were imaged on Zeiss 
AxioPhot Microscope at 40x.  
The average size of DAPI stained nuclei of c147 driven UAS-simj larvae was found to 
be smaller than that of the larvae where expression of UAS-simj was not driven (Fig 6.3, 
genotype: simj). The salivary gland nuclei of wild type larvae were shown to be the 
largest in size (Fig 6.3, genotype: WT). The analysis shows a substantial change in the 
average nuclei size among these three genotypes. A one-way ANOVA analysis of the 
three genotypes revealed statistical significant differences among all three genotypes 
(Fig. 6.3). A post hoc Tukey analysis shows the difference in nuclear size between Simj 
and wild type, c147 driven Simj and wild type, and Simj and c147 driven Simj animals. 
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Figure 6.3. Average size of DAPI stained larval salivary gland nuclei 
 
WT Genotype: y,w ; +/+; +/+. 
 
Simj: Genotype: UAS-simj-GFP / + ; +/+ ; +/+ 
 
c147 + simj: Genotype: UAS-simj-GFP / + ; c147/+ ; +/+ 
Data was derived approximately from 120 DAPI stained nuclei from 30 different 
salivary glands of 30 different female animals of each of the above genotypes.   
Data from images acquired and processed using Zeiss AxioPhot Microscope with 
40x objective. * indicates P<0.05, n=90 -144, error bars indicate standard deviation. 
n represents number of nuclei. 
Raw data available in Appendix No: B.8 
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6.2.4. Analysis of the phenotypic effect of Simj over expression on the whole 
organism  
This experiment was designed to study the effect of inducing simj over expression in the 
whole animal. UAS-simj-GFP expression was induced ubiquitously by the Tub-GAL4 
driver. Simultaneously wild type flies were also crossed with Tub-GAL4 driver as 
controls.  
Third instar salivary glands of both the experimental and control progeny were stained 
with DAPI and were imaged on the confocal microscope. The third instar larvae of Tub-
GAL4 driven UAS-simj flies appeared to be sick (data not shown). No adults from these 
larvae were recovered. The salivary glands of these third instar larvae were radically 
reduced in size to control larvae (Fig 6.4).  
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 A)                                B) 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAPI DAPI 
Figure 6.4. DAPI stained nuclei of salivary glands from Tub-GAL4 driven 
UAS-simj and wild type third instar. 
A) DAPI stained salivary gland of wild type third instar larvae. 
Genotype: y, w / +; +/+; Tub-GAL4/+ 
B) DAPI stained salivary gland nuclei of Tub-GAL4 driven UAS-simj larvae showed 
a drastic reduction in size. 
Genotype: UAS-simj / +; Tub-GAL4/+ 
Images acquired and processed using identical settings 
Blue: DAPI. 
Scale bar = 20 µm. 
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6.2.5. Analysis of expression of Mi-2 protein in the salivary glands of larvae with 
different levels of Simj expression 
The aim of this experiment was to study the response of Mi-2 in third instar salivary 
glands to different levels of Simj expression. To achieve this, localisation of 
endogenous Mi-2 protein was examined both in Simj up regulated and Simj down 
regulated animals. 
Up regulation of Simj in whole salivary glands was achieved by inducing GFP tagged 
UAS-simj expression with the c147-GAL4 driver as described in section 6.2.3.  
A reduction in the amount of endogenous Simj was achieved using the allelic 
combination of simj described in 6.1.1.2. It was important to identify the 
transheterozygous simj animals at their larval stage. Each allele was balanced over 
TM6B to allow identification of non-balancer larvae. Both the mutants carrying TM6B 
balancer were maintained as two separate stocks. When kept as separate stocks no non-
Tubby larvae were observed in either of the mutant stocks. Non-Tubby third instars 
were recovered when the mutant stocks balanced with TM6B, were crossed with each 
other. The heteroallelic combination of simj alleles used, allowed the recovery of third 
instar larvae.  However third instar larvae containing this allelic combination of simj 
were extremely unhealthy (data not shown). 
Third instar larvae of wild type flies were used as one control genotype. Third instar 
larvae of animals containing UAS-simj but no GAL4 driver were used as another 
control sample. Surprisingly, these flies carrying UAS-simj-GFP showed some non 
GAL4 dependent expression of simj-GFP (as judged by GFP expression) (Fig 6.5Aii) 
and thus presumably have higher levels of Simj than wild type animals. c147-GAL4 
driven expression of UAS-simj-GFP produced larvae expressing high levels of Simj in 
their salivary glands (Fig 6.5Aiii). Therefore, four different genotypes each expressing 
different levels of Simj were used. 
These were:  simj
01814
  / simj
BG00403
, wild type, UAS-simj-GFP and UAS-simj-GFP; 
c147GAL4. Although, immunohistochemistry with an anti-simj antibody in third instar 
salivary glands of simj transheterozygous mutants was unsuccessful (data not shown), it 
was assumed that this simj allelic combination would contain the lowest level of 
endogenous Simj among these four genotypes. 
Salivary glands of all these four genotypes were stained with rabbit anti-Mi-2 antibody 
(Brehm et al., 2000). 
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Salivary gland of wild type larvae showed maximal levels of Mi-2 protein (Fig 6.5 Bi). 
Salivary glands of UAS-simj-GFP containing flies but not driven by GAL4 showed 
lower levels of GFP tagged simj (Fig 6.5 Aii, image taken at 24% laser excitation) 
compared to c147-GAL4 driven UAS-simj-GFP larva (Fig 6.5 Aiii, image taken at 0.1% 
laser excitation). The level of Mi-2 expression of UAS-simj-GFP containing larvae (Fig 
6.5 Bii) was similar to that of the wild type salivary glands (Fig 6.5 Bi). The amount of 
Mi-2 protein was noticeably reduced in the salivary glands of c147 driven UAS-simj-
GFP larvae (Fig 6.5 Biii) which showed high content of Simj expression (Fig 6.5 Aiii).  
It was assumed that the transheterozygous simj animals (described above) and the c147 
driven UAS-simj-GFP expressing larvae would contain the least and highest amount of 
Simj protein respectively. As the content of Mi-2 protein was observed to decrease with 
increased levels of Simj (Fig 6.5 Biii), it was expected that the simj mutants would show 
an increase in the level of Mi-2 compared to the c147 driven UAS-simj-GFP larvae. 
Unexpectedly most simj mutants showed lower levels of Mi-2 (Fig, 6.6 Ai and Bi). In 
some simj transheterozygous mutants, the level of Mi-2 was not noticeably different to 
wild type (Fig 6.6 Aii and Bii). 
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  Figure 6.5. Mi-2 expression in salivary glands of wild type and larvae 
expressing different levels of simj. 
 
Ai) Salivary gland of wild type third instar larva, did not show any GFP 
expression (image acquired at 24% laser excitation).  
(Bi) wild type salivary gland stained with anti-Mi-2 antibody. 
Genotype: y, w; +/+; +/+ 
 
Aii) Salivary gland of UAS-simj-GFP containing third instar larva (expression 
not driven by GAL4) showed low levels of GFP tagged simj expression (image 
acquired at 24% laser excitation).  
(Bii) Staining with anti-Mi-2 of this genotype showed no noticeable difference 
compared to the wild type (compare to Bi). 
Genotype: UAS-simj-GFP / +; + / +; + / + 
 
Aiii) Elevated levels of GFP tagged Simj protein was found when UAS-simj-
GFP expression was driven by c147-GAL4 (image acquired at 0.1% laser 
excitation).  
(Biii) anti-Mi-2 staining showed lower levels of Mi-2 compared to the other two 
genotypes (Compare with Bi and Bii). 
Genotype: UAS-simj-GFP / + ; c147-GAL4 / + ; + / + 
 
Red: rabbit anti-Mi-2 antibody (Brehm et al 2000), Blue: DAPI, Green: GFP 
Scale bar = 50 µm. 
Images (Bi), (Bii) and (Biii) were acquired and processed using identical settings. 
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Figure 6.6. Expression of Mi-2 protein in animals expressing high levels of 
exogenous simj and simj transheterozygous mutants 
 
Ai) Mi-2 expression in c147 driven UAS-simj-GFP salivary gland.  
Bi)  Mi-2 expression in simj transheterozygous mutant (showing lower levels of 
Mi-2 protein compared to Ai).  
Images undertaken and processed using identical settings. 
 
Aii) Mi-2 expression in c147 driven UAS-simj-GFP salivary gland. 
Bii) Mi-2 expression in simj transheterozygous mutant (showing approximately 
similar levels of Mi-2 protein compared to Aii).  
Images undertaken and processed using identical settings. 
 
Genotype of Ai and Aii: UAS-simj-GFP / +; c147-GAL4 / + ; + / +. 
Genotype of Bi and Bii:  + / +; + / +; P{PZ}simj01814 ry506 / P{GT1}simjBG00403 
Red: rabbit anti-Mi-2 antibody (Brehm et al 2000), Blue: DAPI, Green: GFP 
Scale bar = 50 µm. 
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6.2.6. Effect of Simj expression on Mi-2 localisation in single cell clones  
 
The existence of a Mi-2/Dref complex (Hirose et al., 2002) has been confirmed in vivo 
by the results of this study (Section 4.3.5). The aim of this experiment was to determine 
the effect of Simj expression on Mi-2/Dref complex. Using the Flp/FRT technique, 
expression of UAS-simj-GFP was induced in the single cell clones in a similar way as 
described in Section 4.2.2. These clones were stained with anti-Mi-2 antibody to study 
the response of Mi- in the Mi-2/Dref complex to Simj expression.  
A novel function of NOS in the disruption of Mi-2/Dref complex has been revealed by 
the present investigation (Section 4.3.5). Therefore it was decided to study the effect of 
Simj expression on both of the proteins after the disruption of the Mi-2/Dref complex 
by NOS. Simultaneous expression of UAS-NOS2 and UAS-simj-GFP in single cell 
clones was achieved using the Flp/FRT technique similar to section 4.2.2, to induce 
disruption of Mi-2/Dref complex. These clones were stained with anti-Mi-2 antibodies 
to examine the response of Mi-2 to simj over expression, when the in vivo Mi-2/Dref 
complex is disrupted by NOS. 
Cells from salivary glands from four different genotypes were stained with the rabbit 
anti-Mi-2 antibody: wild type (Fig 6.7 A), UAS-simj-GFP expressing clones (Fig 6.7 C), 
clones simultaneously expressing UAS-NOS2 and UAS-simj-GFP (Fig 6.7 D) and 
UAS-NOS2 expressing clones (as in Section 4.2.3) (Fig 6.7 B). Confocal images were 
acquired of salivary glands from 10 different animals of each genotype.  
As described previously (Section 4.2.3) the distribution of Mi-2 in wild type salivary 
gland cells was found to be mainly nucleoplasmic however low levels of Mi-2 were also 
found in the nucleolus (Fig 6.7 A). Cells expressing NOS2 showed a uniform 
distribution of Mi-2 in the nucleoplasm as well as in the nucleolus (Fig 6.7 B and 
section 4.2.3). However clone cells expressing either simj alone or simj and NOS2 
simultaneously showed a markedly non-nucleolar distribution of Mi-2 (Fig 6.7 C and D).  
A quantitative examination of the levels of Mi-2 in single cells of all four genotypes 
was performed using the image analysis software velocity. For the quantitative analysis, 
wild type GFP marked clone cells, (neither expressing UAS-NOS2 nor UAS-simj-GFP) 
as described in section 4.2.3 were used as controls. For each genotype the intensity of 
nuclear staining of Mi-2 protein in the clone cells was compared to that of 10 non 
adjacent wild type cells of that particular salivary gland (Fig 6.8).  
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The average ratio of Mi-2 levels in clone cells verses the non adjacent wild type cells 
was found to be similar in wild type controls, in those expressing simj only and in  those 
co expressing simj and NOS2 (Fig 6.8). However the average ratio of Mi-2 expression 
in NOS2 only expressing clone cells verses the non adjoining wild type cells was found 
to be higher (Fig 6.8). 
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Figure 6.7: Distinctly non-nucleolar localisation of Mi-2 protein in 
clone cells over expressing simj alone or co-expressing simj and 
NOS2. 
 
Clones were generated using a 4min heat shock at 38
o
C between 24- 48hr AEL   
 
A) Salivary gland of wild type third instar larva stained with anti-Mi-2 
antibody. Image shows nucleoplasmic distribution of Mi-2 protein. Low levels 
of Mi-2 protein can be seen in the nucleolus (marked with white arrow). 
Genotype: y,w ; + / + ; + / + 
 
B) NOS2 only expressing clone cell stained with anti-Mi-2 antibody shows 
uniform distribution of Mi-2 protein both in nucleoplasm and in nucleolus 
(nucleolus is marked with white arrow) 
Genotype: hsFLP / UAS-NOS2; Act5c>y
+
>Gal4; UAS-GFP. 
 
 C) Mi-2 is absent from the nucleolus in UAS-simj-GFP expressing clone cell 
(nucleolus is marked with white arrow).  
Genotype: UAS-simj / +; UAS-mRFP / + ; MKRS, hsFLP / Act5c>y
+
>Gal4 
 
D) Mi-2 protein in a UAS-simj-GFP and UAS-NOS2 co-expressing clone cell 
is absent from the nucleolus (white arrow).  
Genotype: UAS-simj-GFP / UAS-NOS2; UAS-mRFP / + ; MKRS, hsFLP / 
Act5c>y
+
>Gal4 
 
Blue: DAPI, Green: GFP, Red: rabbit anti-Mi-2 antibody (Brehm et al, 2000)   
(Secondary antibody used: goat anti-rabbit Cy5).  
Scale Bar = 50 µm.  
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Figure 6.8. Quantification of Mi-2 expression 
 
GFP = Ratio of average intensity of Mi-2 expression in GFP marked control clone 
cells Versus the average intensity of Mi-2 expression in 10 non adjacent wild type 
cells.  
Genotype:  hsFLP / +; Act5c>y
+
>Gal4 ; UAS-GFP  
 
NOS2 = Ratio of average intensity of Mi-2 localisation in GFP marked clone  
cells (expressing NOS2) V that in 10 non adjacent wild type  cells.  
Genotype: hsFLP/ UAS-NOS2; Act5c>y
+
>Gal4; UAS- GFP 
 
Simj = Ratio of average intensity of Mi-2 localisation in GFP marked clone  
cells (expressing simj) V that in 10 non adjacent wild type  cells. 
Genotype: UAS-simj / + ; UAS-mRFP / + ; MKRS, hsFLP / Act5c>y
+
>Gal4 
 
Simj + NOS2 = Ratio of average intensity of Mi-2 localisation in GFP marked 
clone cells (expressing simj and  NOS2) V that in 10 non adjacent wild type cells. 
Data for both genotypes was obtained from 10 salivary glands from 10 animals.  
Genotype: UAS-simj / UAS-NOS2; UAS-mRFP / +; MKRS, hsFLP / 
Act5c>y
+
>Gal4 
 
Error bars indicate standard deviation. Raw data available in Appendix: B.9 
Analysis undertaken using Velocity Image Analysis Software. 
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6.2.7. Effect of Simj expression on Dref localisation  
As described in section 4.3.5, NOS2 expression disrupts the Mi-2 / Dref complex. To 
determine if over expression of Simj could alter the localisation of Dref in either cells 
containing the Mi-2 / Dref complex or after this complex had been disrupted, clones of 
Simj expressing cells were generated in an otherwise wild type background or in cells 
co-expressing NOS2 similar to section 6.2.6. To control for the effects of simj over 
expression alone, the localisation of Dref was compared to NOS2 expressing cells. 
Salivary glands from animals of genotypes: wild type (Fig 6.9 A), GFP marked UAS-
Simj (Fig 6.9 C), clones simultaneously expressing UAS-NOS2 and UAS-simj-GFP 
(Fig 6.9 D) and clones expressing NOS2 alone (Fig 6.9 B) were stained with an anti-
Dref antibody (Hirose et al., 2002). 
Nucleoplasmic but not nucleolar distribution of Dref protein was found both in control 
(Fig 6.9 A) and in only NOS2 expressing (Fig 6.9 B) single cell clones. Nuclear 
membrane associated Dref was observed in simj only expressing clone cells (Fig 6.9 C) 
whereas accumulation of Dref protein was distinctly peri-nuclear in case of clones 
simultaneously expressing simj and NOS2 (Fig 6.9 D).    
I did not attempt to quantify this data as Dref localisation was not confined to a discrete 
area of cell. 
  
 129 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9. Dref localisation in clones expressing simj and or NOS2  
 
Clones were generated using a 4min heat shock at 38
o
C between 24- 48hr AEL.  
 
A) Wild type salivary glands. Dref was observed in the nucleoplasm but not in the 
nucleolus (white arrow). 
Genotype: y,w ; + / + ; + / + 
 
B) NOS2 expressing clone cell. Dref was observed in the nucleoplasm but not in 
the nucleolus (white arrow). 
Genotype: hsFLP/UAS-NOS2; Act5c>y
+
>Gal4; UAS- GFP. 
 
C) simj expressing clone cell. Dref is associated with the nuclear membrane (white 
arrow).  
Genotype: UAS-simj-GFP / + ; UAS-mRFP / +; MKRS, hsFLP / Act5c>y
+
>Gal4 
 
D) simj and NOS2 co-expressing clone. Dref localisation is perinuclear (white 
arrow). 
Genotype: UAS-simj-GFP / UAS-NOS2; UAS-mRFP / +; MKRS, hsFLP / 
Act5c>y
+
>Gal4 
 
Blue: DAPI, Green: GFP, Red: mouse anti-Dref antibody (Hirose et al, 2002)   
(Secondary antibody used: horse anti-mouse Cy5).  Scale Bar = 50 µm 
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6.3. Discussion 
6.3.1. Increased Mi-2 content does not consistently change the localisation of Dref 
protein 
Expression of UAS-Mi-2 in salivary glands did not result in any consistent change in 
the nuclear localisation of Dref (Fig 6.1). In some cases the nuclear localisation of Dref 
increased in the Mi-2 over expressing larvae (Fig 6.1 Bi and Bii). However, in some 
salivary glands, expression of high levels of Mi-2 did not cause any noticeable 
difference in the nuclear content of Dref (Fig 6.1 Biii). It was expected that an increase 
in Mi-2 content would increase the probability of Dref / Mi-2 binding and therefore may 
increase Dref levels in the nucleus. However, as Dref has been reported to bind either 
with Mi-2 or with DNA (Hirose et al., 2002), it is surprising to occasionally observe 
higher levels of Dref apparently bound to the polytene chromosomes in Mi-2 over 
expressing animals(Fig 6.1 Bi and Bii). The apparent difference may be due to small 
variations in the developmental stages of different animals. 
 
 6.3.2. Reduction in Mi-2 content leads to the up regulation of the nuclear 
accumulation of Dref 
Animals transheterozygous for Mi-2 alleles showed a reduction in the amount of Mi-2 
protein (Chapter 4, Fig 4.13). When these larvae were stained with anti-Dref antibodies 
they showed increased nuclear accumulation of Dref protein (Fig 6.2). This data is 
consistent with the report that Mi-2 negatively regulates the function of Dref by 
preventing its binding with DNA (Hirose et al., 2002). It can be speculated that the 
reduced amount of Mi-2 protein in the mutants was insufficient to inhibit Dref / DNA 
binding. Consequently, Dref bound to DNA leading to an increase in the nuclear 
accumulation of Dref (Fig 6.2).  
 
6.3.3. Organ autonomous Simj over expression significantly affects growth and size 
of salivary glands 
The salivary gland size of c147 driven UAS-simj third instar larvae did not appear to be 
noticeably altered compared to the two control genotypes (Section 6.2.3, Data not 
shown). However, a one way ANOVA analysis revealed that the average nuclei size of 
c147 driven UAS-simj larvae is significantly reduced when compared to both the 
control genotypes used for this experiment (Fig 6.3). Simj has been reported to play 
developmental roles by regulating expression of ecdysone related genes (Kon et al., 
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2005) however there are no reports of proliferation and growth defects in simj mutants. 
Therefore, a novel function of Simj in growth regulation has been demonstrated in this 
thesis (Section 6.2.3).  
Unlike c147 driven UAS-simj animals, the salivary glands of larvae where Tub-GAL4 
was driving UAS-simj expression, appeared to be noticeably reduced in size (Fig 6.4 B). 
However, these animals were sluggish and did not go on to produce pupae (data not 
shown). This indicates that simj expression affects the autonomous growth of salivary 
glands and ubiquitous expression of Simj affects the viability of the animals.  
 
6.3.4. Up regulation of Simj leads to a reduction in Mi-2 level 
Larvae which expressed high levels of Simj protein (c147 driven UAS-simj-GFP) (Fig 
6.5 Aiii) showed decreased levels of Mi-2 (Fig 6.5 Biii) compared to the corresponding 
controls (Fig 6.5 Bi and Bii). These data suggest that an increase in Simj results in the 
reduction of Mi-2 expression or accumulation. It was therefore expected that UAS-simj-
GFP containing larvae, which were not driven by c147 (but do have some ectopic simj-
GFP expression) (Fig 6.5 Aii) would show a higher nuclear accumulation of Mi-2 than 
wild type larvae. Surprisingly the amount of Mi-2 protein found in these (Fig 6.5 Bii) 
did not differ noticeably from that of wild type larvae (Fig 6.5 Bi). However, the 
amount of simj-GFP expressed by the UAS-simj-GFP containing larvae which were not 
driven by c147-GAL4 (Fig 6.5 Aii, image taken at 24% laser excitation) was 
considerably less than that of the c147-GAL4 driven UAS-simj-GFP larvae (Fig 6.5 Aiii, 
image taken at 0.1% laser excitation). Therefore, perhaps insufficient extra Simj protein 
was produced in UAS-simj-GFP containing larvae, when not driven by GAL4 to reach a 
threshold level sufficient to down regulate Mi-2.   
Although immunohistochemistry with an anti-simj antibody was unsuccessful (data not 
shown), simj mutants (Described in 6.1.1.2) were believed to contain less Simj. 
Considering the difference of Mi-2 levels shown by wild type (6.5 Bi) and c147-GAL4 
driven UAS-simj larvae (6.5 Bii) it was assumed that third instar larvae of these simj 
mutants would show high accumulation of nuclear Mi-2. Surprisingly these simj 
mutants did not show any consistent results (Fig 6.6). The third instar larvae of the 
mutants appeared to be weak (data not shown). Similarly the salivary glands of the 
mutants were small in size (Fig 6.6). In simj null mutant embryos, a subset of 
pericardial cells are missing (Kim et al., 2004). This evidence suggest that reduction of 
Simj in the mutants used in the present study may affect their developmental progress. 
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Therefore translation of Mi-2 protein in these improperly developed and unhealthy third 
instar larvae may be effected. Thus, these simj mutant larvae were not used further to 
investigate the role of Mi-2 regulation.  
 
6.3.5. Simj affects localisation of both proteins after disruption of the Mi-2/Dref 
complex 
Images of anti-Mi-2 stained wild type cells show that the distribution of Mi-2 is mostly 
nucleoplasmic, although low levels of nucleolar Mi-2 were also observed (Fig 6.7 A and 
section 4.2.3). Similarly, the distribution of Dref protein in wild type cells was 
nucleoplasmic but distinctly non nucleolar (Fig 6.9 A). This suggests that a large 
proportion of nuclear Mi-2 stays attached in an in vivo complex with Dref. This is in 
agreement with the previous report of a Mi-2/Dref complex (Hirose et al., 2002).  
Clone cells expressing NOS2 showed a uniform distribution of Mi-2 both in 
nucleoplasm and in nucleolus (Fig 6.7 B and section 4.2.3). However Dref was 
homogeneously distributed in the nucleoplasm but absent from the nucleolus in NOS2 
expressing clone cells (Fig 6.9 B). These data suggest a reorganisation of the in vivo Mi-
2/Dref complex by NOS and is further supported by the data of double antibody 
staining (Section 4.3.5).     
Interestingly clone cells over expressing simj showed a distinctly non nucleolar 
distribution of Mi-2 (Fig 6.7 C) unlike the wild type cells (Fig 6.7 A) and the NOS2 
expressing clone cells (Fig 6.7 B). To be more specific, in simj expressing clone cells, 
Mi-2 was found to be distributed in the nuclear area spanning from nucleoplasm to the 
nuclear membrane, but excluded from the nucleolar space (Fig 6.7 C). Similarly a major 
change in Dref protein distribution was observed in simj expressing clone cells (Fig 6.9 
C) compared to that of wild type (Fig 6.9 A) and to NOS2 expressing clone cells (Fig 
6.9 B). The accumulation of Dref protein was exclusively nuclear membrane associated 
in simj expressing clone cells (Fig 6.9 C). The novel localisation of Mi-2 and Dref in 
simj expressing clone cells suggests that when the Mi-2/Dref complex exists, simj 
possibly mediates movement of the complex towards nuclear membrane. In Simj only 
over expressing clone cells, Mi-2 remained evenly distributed from nucleoplasm to 
nuclear membrane (Fig 6.7 C) whereas Dref was associated with the nuclear membrane 
(Fig 6.9 C). This suggests that, compared to Mi-2, Dref is probably more susceptible to 
the effect of simj expression. 
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The perinuclear distribution of Dref was observed only in simj and NOS2 co-expressing 
clone cells (Fig 6.9 D). In addition, Mi-2 was observed to be distributed in a distinctly 
non-nucleolar pattern in these clones simultaneously co-expressing simj and NOS2 (Fig 
6.7 D). Considering all these data it can be hypothesized that within simj and NOS2 co-
expressing clones, simj triggers the movement of Mi-2 and Dref when the Mi-2/Dref 
complex is disrupted by NOS. The data are consistent with the proposition that the 
disruption to the Dref / Mi-2 complex results in a perinuclear localisation of Dref in simj 
and NOS2 co-expressing clones (Fig 6.9 D). However, in clone cells only expressing 
UAS-simj, the Dref / Mi-2 complex, favours the nuclear membrane associated 
localisation of Dref (Fig 6.9 C).  
The decrease in Mi-2 levels associated with an up regulation of Simj protein content in 
whole salivary glands (Fig 6.5 Biii) was not observed in the quantitative analysis of 
Simj over expressing clone cells (Fig 6.8). It was observed that the ratio of Mi-2 
concentration in the clone cell verses the non clone cells is similar to that of the control 
clones (Fig 6.8).  The concentration of nuclear Mi-2 in the GAL4 driven UAS-simj and 
UAS-NOS2 co-expressing clone cells was similar to the non GAL4 expressing cells 
(Fig 6.8). This may be due to the fact that UAS-simj-GFP is expressed even in the 
absence of GAL4 as shown in Figure 6.5Aii. Therefore, the surrounding cells of GAL4 
driven UAS-simj clones as well as UAS-simj and UAS-NOS2 co-expressing clones also 
have increased levels of Simj protein. Thus in this experiment, the clone cells and the 
non-adjacent comparators both express above endogenous levels of Simj, potentially 
masking any changes to Mi-2.   
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Chapter 7: General Discussion 
 
7.1. Introduction 
 
The work presented in this thesis has investigated some in vivo protein targets of NO. 
The present study has confirmed Mi-2 as a target of NO. Moreover, the present study 
has examined NO action on several of its associated proteins. 
 
7.2. NO alters localisation of Mi-2    
Previously in our laboratory ex vivo experiments, involving treatment with the NO 
donor SNAP, identified Mi-2 as a probable target of NO (Lasala, 2007). During the 
present study, SNAP treatment, performed for a shorter time, confirmed an increase in 
the nuclear localisation of YFP tagged Mi-2
CPTI-000232 
(Section 3.2.3). Nuclear 
accumulation of YFP tagged Mi-2
 CPTI-000232
 was consistently increased when Nitric  
Oxide levels were up regulated in whole salivary glands via expression of NOS2 under 
the control of c147-GAL4 driver (Section 4.2.1). The NOS2 gene, which was used to 
control Nitric Oxide levels during the present study, encodes a constitutively active 
mouse macrophage nitric oxide synthase protein (Section 1.3). The size of the NOS2 
expressing salivary gland nuclei were smaller than that of the control nuclei (Section 
4.2.1) which supports previous reports (Kuzin et al., 1996), (Kimber, 2005) and (Scott, 
2009).  
To avoid any physiological changes resulting from reduced growth of the whole 
salivary gland, expression of NOS2 was induced in single cells of salivary glands by 
exploiting a Flp/FRT technique (Section 4.1.4). Up regulation of NO levels in these 
single cells resulted in an increase in the nuclear accumulation of YFP tagged Mi-2
 CPTI-
000232
 compared to the non adjoining wild type cells (Section 4.2.2). Increase in the 
nuclear localisation of Mi-2
 CPTI-000232
 in the wild type cells immediately adjacent to the 
NOS2
 
expressing clone as shown in figure 4.4 is probably a result of NO diffusion 
(Haley, 1998).  
The wild type Mi-2 protein was shown to behave similarly using a rabbit anti-Mi-2 
antibody (Brehm et al., 2000). These data revealed an increase in the endogenous Mi-2 
level in NOS2 expressing single cell clones compared to the non adjacent wild type cells 
(Section 4.2.3). This finding was confirmed by performing quantitative analysis of 
nuclear protein levels using image analysis software velocity (Section 4.2.3). However, 
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in contrast to the wild type cells of the YFP tagged Mi-2
 CPTI-000232
 larvae (Section 4.2.2), 
there was no noticeable alteration in the endogenous Mi-2 level of the wild type cells 
immediately adjacent to NOS2 expressing clone (Section 4.2.3). Taken together, all 
these data strongly suggest that nuclear accumulation of Mi-2 is altered by NO, hence 
Mi-2 is a target of NO.  
 
7.3. Regulation of growth by NO does not act through Mi-2 
To examine whether the growth regulatory activity of NO is controlled by Mi-2, the 
phenotypic effects of NOS expression on animals with reduced levels of Mi-2 was 
determined. Two different approaches were used to down regulate Mi-2. Levels of Mi-2 
were reduced by targeted RNAi (Dietzl et al., 2007) and by using animals 
transheterozygous for Mi-2 alleles. The efficiency of RNAi dependent reduction of Mi-2 
levels was examined by expressing UAS-RNAi-Mi-2 in the salivary glands of animals 
heterozygous for the YFP tagged Mi-2
CPTI-000232
 allele (Section 4.2.7). The expression of 
RNAi-Mi-2 under the control of c147-GAL4 driver did not completely eliminate, but 
did reduce, the expression of YFP tagged Mi-2
CPTI-000232
 (Figure 4.12).  
As targeted RNAi did not completely remove the expression of YFP tagged Mi-2
CPTI-
000232
, another approach using Mi-2 transheterozygous mutants was exploited to down 
regulate the levels of Mi-2. A Mi-2 allelic combination (Section 4.1.5.2) which showed 
a reduction in Mi-2 content, as judged by immunohistochemistry with an anti-Mi-2 
antibody (Section 4.2.8), was used as a Mi-2 down regulated system. Hence both RNAi-
Mi-2 and transheterozygous Mi-2 mutant animals were used to examine the Mi-2 
dependency of NO induced growth phenotypes.   
The purpose of these experiments was to examine whether a decrease in Mi-2 content 
prevented the NOS dependent inhibition of growth and whether it leads to an alteration 
in salivary gland size.   
c147-GAL4 induced expression of UAS-NOS2 was achieved in the salivary glands of 
UAS-RNAi-Mi-2 and Mi-2 transheterozygous mutants. The average volume of DAPI 
stained nuclei of (A) y,w; +/+; +/+, (B) UAS-NOS2 / + ; c147-GAL4 / +,  (C) UAS-
NOS2 / + ; c147-GAL4 / + ; UAS-RNAi-Mi-2 / +, (D) Mi-2
j3D4
/ Mi-2
EY08138
 and (E) 
UAS-NOS2 / + ; c147-GAL4 / + ; Mi-2
j3D4
/ Mi-2EY08138 animals were calculated using 
image analysis software velocity (Section 4.2.9). All these NOS expressing genotypes 
showed a small nuclear size (Section 4.2.9). This evidence suggests that, the NO 
induced growth phenotype is not controlled by Mi-2. As a functional connection 
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between Mi-2/NuRD and cell proliferation was reviewed in (Xue et al., 1998), an 
alteration in the nuclear size in Mi-2 transheterozygous mutants may have been 
predicted. However the nuclear size of Mi-2 transheterozygous mutants did not show 
any significant difference compared to that of wild type salivary glands (Section 4.2.9). 
These data are consistent with the recent finding that only a minor portion of 
Drosophila Mi-2 is associated with the NuRD complex, whereas the major fraction is a 
part of a novel ATP dependent chromatin remodelling complex called Drosophila dMec. 
This complex mediates transcriptional repression of proneural genes however there is 
no reported data indicating a role for dMec in the control of cell proliferation (Kunert et 
al., 2009, Kunert N, 2009).  
 
7.4. A novel function of NO in the reorganisation of the in vivo Mi-2/Dref complex  
Dref and Mi-2 genetically and physically interact with each other. In Drosophila, 
binding of Mi-2 and Dref to polytene chromosomes is mutually exclusive (Hirose et al., 
2002). Anti-Dref antibodies coimmunoprecipitate Mi-2 from Drosophila embryo, which 
suggests the existence of an in vivo Dref/Mi-2 complex (Hirose et al., 2002). These data 
indicate that Dref associates with Mi-2 in Drosophila.  
The cell cycle switch from cell proliferation to differentiation is probably regulated by 
Dref (Matsukage et al., 2008). NO is also known to control this switch during 
neurogenesis (Gibbs, 2003). These data suggest that Dref protein localisation may be 
controlled by NO during the switch of cell cycle from proliferation to differentiation.  
To determine an interaction between NO and Dref, visualization of Dref protein was 
achieved using a mouse anti-Dref antibody (Hirose et al., 2002) in NOS2 expressing 
single cell clones. The quantitative analysis of Dref nuclear levels did not reveal any 
noticeable alteration in NOS2 expressing clone cells compared to the non adjacent wild 
type cells (Section 4.2.5). However, NOS2 expressing clones when double stained with 
both anti-Dref and anti-Mi-2 antibodies showed an unique nuclear localisation of anti-
Dref staining, which was entirely different from that of the surrounding wild type cells 
(Section 4.2.6). A cytoplasmic and cell membrane bound distribution of anti-Dref 
staining was found in wild type cells surrounding NOS2 expressing clones, whereas 
anti-Mi-2 localisation was distinctly nuclear within them (Fig 4.11 B). As a possible 
explanation of this, it is hypothesized that the epitope sites for anti-Dref antibody were 
masked in an in vivo Mi-2/Dref/anti-Mi-2 antibody complex (Section 4.3.5). As a 
consequence of this, anti-Dref antibodies were unable to recognize nuclear Dref protein 
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(Section 4.3.5).  Therefore, formation of an in vivo Mi-2/Dref complex was confirmed 
by the data of double antibody staining shown by wild type cells surrounding NOS2 
expressing clone (Section 4.3.5).  
The entirely different pattern of Dref localisation observed in double stained NOS2 
expressing clone cells, compared to surrounding wild type cells, suggests a functional 
role of NO in the reorganisation of the Mi-2/Dref complex (Section 4.3.5). As the 
function of Dref is known to be regulated by the intracellular redox state (Choi et al., 
2004) and NO is reported to alter transcription factors which are responsive to 
intracellular redox state (Eberhardt and Beck, 2001), it can be suggested that NO acts in 
the alteration of Dref by regulating the intracellular redox state, followed by the 
reorganisation of in vivo Mi-2/Dref complex (Section 4.3.5). This disruption of Mi-
2/Dref complex ultimately results in growth arrest (section 4.3.5). Therefore, the present 
study has provided evidence in support of NO mediated reorganisation of Mi-2/Dref 
complex as a possible growth control mechanism of NO.     
 
7.5. Increased FOXO expression does not markedly alter the expression of Mi-2 or 
Dref in single cell clones 
Previously in our laboratory an Affymetrix gene array analysis on Drosophila S2 cells 
revealed that a common set of genes are targeted both by NO and the transcription 
factor FOXO (Kimber, 2005). As this present study has confirmed Mi-2 as a probable 
target of NO (Sections 3.3.2 and 4.3.1), it was hypothesized that the action of NO on 
Mi-2 may be under the direct control of FOXO transcriptional activity. To determine 
this, expression of UAS-FOXO was induced under the control of c147-GAL4 driver in 
the whole salivary gland of YFP tagged Mi-2
CPTI-000232
 animals (Section 5.2.1). The size 
of the salivary glands expressing UAS-FOXO was reduced compared to the 
corresponding control salivary glands (Section 5.2.1). This result coincides with the 
previous finding that ectopic expression of FOXO and human FOXO3a bring about 
reduction in organ size (Junger et al., 2003). The quantification analysis of this data 
using the image analysis software velocity, demonstrated a 1.3 fold average increase of 
YFP tagged Mi-2 
CPTI-000232
 expression in UAS-FOXO up regulated animals (Section 
5.2.1). 
To avoid any physiological changes resulting from the reduced growth of the whole 
salivary gland, nuclear accumulation of endogenous Mi-2 was examined in FOXO 
expressing single cell clones in salivary glands. An accurate quantitative analysis of 
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these data showed no noticeable change in nuclear concentration of Mi-2 in response to 
FOXO expression (Section 5.2.2). Nuclear localisation of Dref was also not noticeably 
altered in response to FOXO expression in most of the single cell clones (Section 5.2.4). 
Although some FOXO expressing clone cells showed an increase in nuclear Dref 
accumulation (Section 5.2.4).  
 
7.6. FOXO mediated growth arrest disrupts the in vivo Mi-2/Dref complex 
Formation of an in vivo Mi-2/Dref complex (Hirose et al., 2002) was confirmed by data 
acquired from the double anti-Mi2 and anti-Dref antibody staining of NOS2 over 
expressing clones (Section 4.3.5). FOXO has been demonstrated to be a probable target 
of NO (Scott, 2009). Therefore, the response of both Mi-2 and Dref proteins to FOXO 
was determined by staining FOXO expressing single cell clones simultaneously with 
anti-Dref and anti-Mi-2 antibodies (Section 5.2.5). The surrounding wild type cells of 
these FOXO expressing clones showed similar localisation pattern for both the 
antibodies (Section 5.2.5) as observed in those, surrounding NOS2 expressing clone 
cells (Section 4.3.5). As previously observed (Section 4.3.5), the masking of anti-Dref 
epitope sites in Mi-2/ Dref / anti-Mi-2 antibody complex, prevented the recognition of 
nuclear Dref protein by anti-Dref antibodies in the double labelled wild type cells 
surrounding FOXO expressing clone cell (Section 5.3.4).  
However clones over expressing FOXO, when double labelled with both anti-Dref and 
anti-Mi-2 antibodies, showed a perinuclear distribution of both anti-Mi-2 and anti-Dref 
staining (Section 5.2.5). This perinuclear localisation of anti-Mi-2 staining was also 
observed in wild type and NOS2 expressing clone cells when singly stained with anti-
Mi-2 antibody (Section 4.2.3). These data suggest that the perinuclear distribution of 
Mi-2 is not an effect of FOXO up regulation (Section 5.3.4). However, the perinuclear 
distribution of anti-Dref staining is a result of FOXO signalling (Section 5.2.5), as this 
was not mimicked either by NOS2 expressing cells or by wild type cells when singly 
stained with anti-Dref antibodies (Section 4.2.5). These data support the hypothesis that, 
the perinuclear distribution pattern of anti-Dref staining is mediated uniquely by FOXO 
(Section 5.3.4). As well as the perinuclear localisation, a cytoplasmic accumulation of 
anti-Dref staining was also observed in double labelled FOXO expressing clones 
(Section 5.2.5). The cytoplasmic anti-Dref staining may be a result of high levels of 
Dref expression induced by FOXO.  As the expression of Dref has been shown to be 
regulated by myc (Dang Thi Phuong Thao et al., 2007) and FOXO has been 
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demonstrated to control myc expression (Teleman et al., 2008), this FOXO induced Dref 
expression may be through a myc dependent pathway (Section 5.3.4). Therefore, the 
alteration of Dref may be a possible growth control mechanism imparted by FOXO.   
 
7.7. Simj does not alter NO and FOXO mediated reduced sized salivary gland 
phenotype  
Simj is the regulatory component of Mi-2/NuRD (Kon et al., 2005). In Drosophila, Simj 
functions in the regulation of ecdysone responsive genes (Kon et al., 2005). NO affects 
the ecdysone induced protein 75 (E75) (Section 4.1.2). Therefore, it was hypothesized 
that a functional link may exist between NO and Simj. Hence, the effect of  Simj over 
expression on NO induced growth arrest was determined by co-expressing UAS-simj 
(Kim et al., 2004) and UAS-NOS2 in whole salivary glands under the control of c147-
GAL4 driver. The salivary glands simultaneously over expressing UAS-simj and UAS-
NOS2 showed a reduced size reasonably similar to that of those only expressing UAS-
NOS2 (Section 4.2.4).  
As FOXO is a probable target of NO (Scott, 2009), the effect of UAS-simj expression 
on the FOXO induced reduced salivary gland size phenotype was determined (Section 
5.2.3). Simultaneous expression of UAS-FOXO and UAS-simj in the whole salivary 
gland did not result in any noticeable alteration in salivary gland size compared to that 
of those expressing only UAS-FOXO (section 5.2.3). These data suggest that, Simj does 
not modify NO or FOXO inhibited growth in salivary glands.  
 
7.8. Simj affects sub cellular distribution of both the proteins after disruption of 
the Mi-2/Dref complex 
The effect of Simj expression on the Mi-2/Dref complex was determined by generating 
UAS-simj expressing single cell clones and staining them separately with anti-Dref and 
anti-Mi-2 antibodies (Section 6.2.6 and 6.2.7). This study has provided further evidence 
in support of a function of NO in the reorganisation of Mi-2/Dref complex (Section 
6.3.5). When UAS-NOS2 was co-expressed with UAS-simj, the expression of NOS 
would cause disruption to the Mi-2/Dref complex and the response of both the proteins 
to Simj over expression could be examined. To achieve this, UAS-NOS2 and UAS-simj 
co-expressing clones were stained with anti-Dref and anti-Mi-2 antibodies separately 
(Section 6.2.6 and 6.2.7).  
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Clones expressing only UAS-simj showed a distinctly non-nucleolar distribution of 
anti-Mi-2 staining which was not observed in wild type cells or in those expressing only 
NOS2 (Section 6.2.6). UAS-simj expressing clones stained with anti-Dref antibodies 
also showed a distinctly nuclear membrane associated localisation of Dref. This pattern 
of Dref expression was not seen in either wild type cells or in clones only expressing 
NOS2 (Section 6.2.7). These data demonstrate that, both the non-nucleolar distribution 
of Mi-2 and nuclear membrane associated localisation of Dref are the unique effects of 
Simj over expression (Section 6.3.5). UAS-simj and UAS-NOS2 co-expressing clones 
again showed a non-nucleolar distribution of Mi-2 and a distinctly perinuclear 
distribution of Dref proteins. Again, this pattern was not observed in wild type cells or 
clones only expressing NOS2 (Section 6.2.6 and 6.2.7). This supports the hypothesis 
that Simj imparts its effect on both the proteins when they exist as a Mi-2/Dref complex 
as well as after the NO induced disruption of the complex (Section 6.3.5).   
 
7.9. Increased Simj content leads to a reduction in Mi-2 levels  
The two core components of NuRD, Simj and Mi-2, function in DNA methylation 
(Section 6.1.1). Salivary glands expressing high levels of UAS-simj (Kim et al., 2004) 
under the control of c147-GAL4 driver showed a decrease in Mi-2 content compared to 
the corresponding control genotypes (section 6.2.5). A transheterozygous allelic 
combination of simj alleles was used as Simj down regulated system to study the 
response of Mi-2 protein in the salivary glands (Section 6.1.1.2). Unfortunately 
immunohistochemistry with an anti-Simj antibody was unsuccessful (data not shown). 
This prevented the study of Simj content in these transheterozygous mutants. However, 
it was assumed that the mutants would contain less Simj protein. Although up 
regulation of Simj expression resulted in a reduction in Mi-2 levels (section 6.2.5), anti-
Mi-2 staining of simj transheterozygous mutants did not result in a consistent alteration 
of endogenous Mi-2 levels (Section 6.2.5). This may be a result of the apparent 
weakness observed in the third instar larvae of the mutants (data not shown). The 
salivary glands of the simj mutants were also small (Fig 6.6). In simj null mutant 
embryos, a subset of pericardial cells are missing (Kim et al., 2004). This suggests that 
the reduction of Simj levels in the transheterozygous mutants may affect their 
developmental progress followed by a reduction in the expression of Mi-2 (Section 
6.3.4). The decrease in Mi-2 levels associated with an up regulation of Simj protein 
content in whole salivary glands (Section 6.2.5) was not repeated in the quantitative 
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analysis of UAS-simj expressing clone cells (Section 6.2.6). This may be due to the fact 
that the UAS-simj is expressed even in the absence of GAL4 (Fig 6.5Aii). Therefore, 
the non GAL4 expressing cells surrounding either Gal4, UAS-simj or Gal4, UAS-NOS2, 
and GAL4, UAS-simj co expressing clone cells also have increased levels of Simj 
protein. Thus in this experiment, the clone cells and the non-adjacent comparators both 
express above endogenous levels of Simj potentially masking any changes to Mi-2 
(Section 6.3.5).   
One caveat to these data (discussed in 7.1-7.9) is that some of the variation in the levels 
of proteins observed in salivary gland cells could be due to differences in the amount of 
endoreplication in different cells. The process of polytenization in salivary gland cells is 
achieved by an endo cell cycle in which there is only a synthesis phase (S Phase), a Gap 
phase (G pahse). Cytokinesis, nuclear division and segregation of chromosomes do not 
occur (Smith and Orr-Weaver, 1991). Polytene DNA replication or endoreplication in 
larval salivary gland cells is a discontinuous process and works in a cyclic manner  
(Pearson, 1974). Differences in the amount of polytenization may cause a variation in 
the amounts and nuclear accumulation of Mi-2 or other proteins in different salivary 
gland cells. This may lead to a variation in the quantity of observed proteins found in 
different salivary glands dissected from different third instar larvae or between cells of 
different genotypes from the same animal. These differences may explain the relatively 
large standard deviations observed when the expression data is quantified. 
Overexpression of a target gene (NOS2 / FOXO/ simj) (discussed in 7.1-7.9) can 
enhance the normal function of that gene. Another way of studying the function of a 
particular gene is to generate loss of function cell clones which would be homozygous 
mutant for the gene of interest. The homozygous mutant cells can be marked by 
expression of a fluorescent marker (GFP/ YFP). For salivary glands, this method 
requires the recovery of the mutant clones prior to the end of cell division of the salivary 
gland primordia which occurs at 8 hours AEL before the beginning of polytenization.     
 
7.10. Organ autonomous Simj over expression significantly affects growth and size 
of salivary glands 
A one-way ANOVA analysis revealed that the nuclear size of cells expressing UAS-
simj under the control of c147-GAL4 is significantly reduced compared to both the 
control genotypes. A post hoc Tukey analysis showed a significant difference between 
the nuclear size of UAS-simj and wildype, c147 driven UAS-simj and wild type, as well 
 143 
as UAS-simj and c147 driven UAS-simj animals (Section 6.2.3). Although functional 
roles for Simj in development have been reported (Kon et al., 2005), no reports of 
proliferation or growth defects of simj mutants have been published. From the evidence 
of this present study (Section 6.2.3), it can be proposed that Simj does function in 
growth regulation. Tub-GAL4 driven UAS-simj larvae were noticeably reduced in size 
(Section 6.2.4). However, these animals were sluggish and did not go on to produce 
pupae (data not shown). Hence, from the results of this study it can be suggested that 
Simj expression affects the autonomous growth of salivary glands and ubiquitous 
expression of Simj affects the viability of the animals.  
 
7.11. Future work 
Several other aspects that may be worth investigating are noted below.  
The present study has identified a function of NO on the disruption of the Mi-2/Dref 
complex in vivo, possibly through alteration of the transcription factor Dref (Section 
4.3.5). Hence, it would be interesting to investigate whether the antiproliferative action 
of NOS is Dref dependent. To determine this, NOS induced growth inhibition could be 
studied in Dref mutants or in animals expressing RNAi-Dref. This could also be 
achieved by the simultaneous expression of the dominant negative Dref protein (Dref 1-
125) (Hirose et al., 1999) and NOS in the same animals.  
The present study has also provided evidence in support of alteration of Mi-2 expression 
by NOS by both ex vivo and in vivo experiments (Section 4.3.1). It would be revealing 
to study whether the effect of NOS on Mi-2 is controlled by Dref. To achieve this, 
animals expressing NOS and RNAi-Dref or dominant negative Dref could be subjected 
to immunohistochemistry with an anti-Mi-2 antibody.  
To further investigate the Mi-2/Dref complex and its disruption by NO, Fluorescence 
Resonance Energy Transfer (FRET) could be exploited to measure the real time 
dynamics of the formation and disruption of this complex. 
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Appendices 
 
A. Fly stock used 
 
A.1. Bloomington stocks, http://flystocks.bio.indiana.edu/ 
 
Genotype Comments 
y[1] w[*]; P{w[+mC]=GAL4-Act5C(FRT.CD2).P}S Ubiquitous expression of GAL4 in FLP-
generated clones 
w[1118]; P{w[+mW.hs]=GawB}C147 GAL4 expressed in larval brain and salivary 
glands 
w[1118]; P{w[+mC]=UAS-myr-mRFP}1 P{UAS-myr-mRFP} expresses membrane – 
targeted monomeric RFP 
y[1] w[*]; P{w[+mC]=UAS-foxo.P}2 Expresses wild type foxo under UAS control. 
P{ry[+t7.2]=PZ}simj[01814] ry[506]/TM3, ry[RK] Sb[1] 
Ser[1] 
Insertional mutant simj[01814], created by 
Berkeley Drosophila Genome Proj 
y[1] w[*]; P{w[+mC]=lacW}Mi-2[j3D4] 
Su(Tpl)[j3D4]/TM3, Sb[1] Ser[1] 
Insertional mutant Mi-2[j3D4] created by 
Berkeley Drosophila Genome Proj 
w[1118]; P{w[+mGT]=GT1}simj[BG00403]/TM6B, 
P{w[+mC]=35UZ}DB1, Tb[1] 
Insertional mutant simj[BG00403], created by 
Berkeley Drosophila Genome Proj 
y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}Mi-
2[EY08138] Su(Tpl)[EY08138]/TM3, Sb[1] Ser[1] 
Insertional mutant Mi-2[EY08138] created by 
Berkeley Drosophila Genome Proj 
 
 
A.2. Fly stocks from CPTI (Cambridge protein trap insertion project) 
 
 
Stock Genotype Comments 
CPTI-000232 + / + ; + / + ; YFP-Mi-2 / TM3, Sb Expresses YFP tagged nuclear Mi-2. (Homozygous 
survives) 
 
 
A.3. Fly stocks Vienna Drosophila RNAi center (VDRC), 
http://stockcenter.vdrc.at/control/main 
 
 
Trans- 
formant 
ID 
Construct 
ID 
Genotype Inserted 
Chromo- 
some 
Comments 
10766 4511 + / +; + /+; UAS-RNAi-Mi-2 / 
UAS-RNAi-Mi-2 
3 Expresses RNAi-Mi-2 under the 
control of UAS/GAL4 system 
 
 
 
A.4. Fly stocks from other sources 
 
Genotype Chromosome Comments and Reference 
UAS-Mi-2  - Expresses Mi-2 under the control of UAS/GAL4 
system. A kind gift from Prof Fumiko Hirose 
(Hirose, Ohshima et al. 2002) 
UAS-simj-GFP / UAS-simj-GFP; +/+ ; 
+/+ 
1 Expresses simj under the control of UAS/GAL4 
system. A kind gift from Prof Yongsok Kim 
(Kim, Park et al. 2004). 
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B. DATA acquired on image analysis software Velocity  
B.1. Analysis of YFP tagged Mi-2CPTI-000232 expression in the whole salivary glands expressing NOS2  
 
UAS-NOS2 over expression in whole salivary gland of YFP tagged Mi-2 (CPTI-000232) 
      
Cont A      
Name Voxel Count Centroid Z (µm) Volume (µm³) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 24 25286 72.7202 4126.2 58.1848 1.47E+06 
Object 23 33842 70.52 5522.38 47.2505 1.60E+06 
Object 26 33326 69.127 5438.18 54.5769 1.82E+06 
Object 25 34088 68.8204 5562.53 47.8206 1.63E+06 
      
Expt A      
Name Voxel Count Centroid Z (µm) Volume (µm³) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 38 5592 67.5515 912.51 88.4158 494421 
Object 39 4356 67.1038 710.818 83.469 363591 
Object 35 4732 65.2918 772.174 62.0448 293596 
Object 34 4029 62.4629 657.458 87.5791 352856 
Object 23 5244 61.398 855.723 65.8837 345494 
      
Cont B      
Name Voxel Count Centroid Z (ｵ m) Volume (ｵ m ｳ) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 14 48009 23.6452 7834.17 27.4566 1.32E+06 
Object 13 40161 22.212 6553.53 35.6303 1.43E+06 
Object 11 34222 20.062 5584.39 30.4014 1.04E+06 
Object 8 40384 19.6048 6589.92 33.9002 1.37E+06 
Object 12 40755 19.2837 6650.46 32.3408 1.32E+06 
Object 6 38822 17.1346 6335.03 32.122 1.25E+06 
Object 5 38930 16.7788 6352.65 36.2336 1.41E+06 
Object 3 36595 16.5754 5971.62 39.7923 1.46E+06 
Object 2 40844 15.1677 6664.98 35.2538 1.44E+06 
      
Expt B      
Name Voxel Count Centroid Z (µm) Volume (µm³) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 75 8682 78.1031 1416.74 99.3401 862471 
Object 73 6854 76.7321 1118.45 94.7342 649308 
Object 74 10636 75.8938 1735.6 110.449 1.17E+06 
Object 70 4972 74.8226 811.338 99.9 496703 
Object 71 10885 74.1077 1776.23 108.081 1.18E+06 
Object 72 8385 73.2964 1368.28 87.9336 737323 
Object 66 4393 72.2864 716.856 77.8318 341915 
Object 69 13606 71.9327 2220.25 107.846 1.47E+06 
Object 65 6262 71.8764 1021.84 95.0584 595256 
Object 68 8828 70.8916 1440.57 95.5185 843237 
Object 67 10428 68.8899 1701.66 90.0054 938576 
      
Cont D      
Name Voxel Count Centroid Z (µm) Volume (µm³) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 12 12095 18.4377 1973.68 26.1866 316727 
Object 14 16249 17.2592 2651.53 27.0101 438887 
Object 18 19626 15.6824 3202.6 28.636 562011 
Object 8 29564 13.9267 4824.29 34.3688 1.02E+06 
Object 16 24332 13.4331 3970.53 24.7734 602786 
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Object 9 35545 12.3959 5800.28 34.1995 1.22E+06 
Object 6 28760 10.5038 4693.1 29.3227 843322 
      
Exp D      
Name Voxel Count Centroid Z (ｵ m) Volume (ｵ m ｳ) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 87 7111 23.072 1160.38 52.1519 370852 
Object 73 6432 21.9123 1049.58 53.6171 344865 
Object 84 9515 21.8581 1552.67 54.4465 518058 
Object 40 9602 21.8521 1566.87 55.5796 533675 
Object 68 10281 21.0288 1677.67 46.7469 480605 
Object 49 4421 20.71 721.425 50.4734 223143 
Object 81 11427 20.5185 1864.67 61.5428 703250 
Object 75 8232 19.9922 1343.31 59.1067 486566 
Object 82 9380 19.8525 1530.64 57.6813 541051 
Object 56 10172 19.2706 1659.88 41.1826 418909 
Object 69 10844 18.375 1769.54 56.9453 617515 
Object 25 9173 16.9642 1496.86 50.8822 466742 
Object 70 15079 16.8109 2460.61 53.8735 812358 
Object 47 10503 16.3195 1713.89 46.0021 483160 
Object 31 3905 15.4146 637.223 46.9478 183331 
Object 72 23872 15.2709 3895.47 52.5885 1.26E+06 
Object 57 18353 15.0972 2994.87 48.5359 890780 
Object 83 14298 14.9 2333.17 47.5562 679958 
Object 34 12415 14.5551 2025.9 51.4091 638244 
      
Cont C      
Name Voxel Count Centroid Z (ｵ m) Volume (ｵ m ｳ) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 38 24052 69.1717 3924.84 100.58 2.42E+06 
Object 37 37702 65.6699 6152.26 72.8587 2.75E+06 
Object 33 41509 65.281 6773.5 46.3347 1.92E+06 
Object 31 28792 64.1171 4698.32 84.035 2.42E+06 
Object 34 46799 63.9385 7636.72 68.5846 3.21E+06 
Object 36 37007 63.355 6038.85 82.3135 3.05E+06 
Object 32 35243 62.9906 5751 62.3102 2.20E+06 
Object 35 38485 62.3911 6280.03 89.4056 3.44E+06 
Object 24 44339 61.8734 7235.3 84.0482 3.73E+06 
Object 30 37449 61.6228 6110.98 57.2681 2.14E+06 
Object 25 38850 60.9841 6339.6 48.0253 1.87E+06 
Object 28 34456 60.7114 5622.58 54.4179 1.88E+06 
      
Expt C      
Name Voxel Count Centroid Z (µm) Volume (µm³) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 31 7021 66.6341 1145.7 102.134 717085 
Object 25 8763 61.1262 1429.96 108.968 954887 
Object 24 8646 56.336 1410.87 77.7735 672430 
      
Cont E      
Name Voxel Count Centroid Z (ｵ m) Volume (ｵ m ｳ) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 17 12077 17.9459 1970.74 40.7311 491910 
Object 19 18715 16.7601 3053.94 34.0026 636359 
Object 24 37402 12.1436 6103.31 56.443 2.11E+06 
Object 23 20998 12.0024 3426.48 38.1291 800635 
Object 25 39482 11.0084 6442.73 54.4412 2.15E+06 
Object 21 25581 10.7952 4174.34 38.7038 990083 
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Object 11 27351 10.7 4463.17 51.5613 1.41E+06 
Object 18 40722 10.6698 6645.07 48.1523 1.96E+06 
      
ExPt E      
Name Voxel Count Centroid Z (ｵ m) Volume (ｵ m ｳ) Mean (Ch3-T1) Sum (Ch3-T1) 
Object 66 2010 23.1527 327.995 42.6473 85721 
Object 99 3154 23.0964 514.674 56.2067 177276 
Object 52 2271 23.0828 370.585 44.6579 101418 
Object 72 2457 22.9426 400.937 44.5124 109367 
Object 67 2004 22.8443 327.015 51.2705 102746 
Object 68 1628 22.7942 265.659 41.1886 67055 
Object 89 3781 22.6432 616.989 52.5483 198685 
Object 95 1797 22.4752 293.237 43.9944 79058 
Object 62 2387 22.3498 389.514 52.3293 124910 
Object 61 2630 22.1924 429.167 62.7631 165067 
Object 39 2966 21.3958 483.996 49.9326 148100 
Object 82 2216 21.3542 361.61 54.3466 120432 
Object 56 4700 21.0109 766.952 43.4587 204256 
Object 87 2376 20.9621 387.719 51.6768 122784 
Object 88 2170 20.9567 354.104 52.0802 113014 
Object 58 1520 20.6697 248.036 36.2434 55090 
Object 78 2864 20.3097 467.351 55.0115 157553 
Object 98 6531 19.8352 1065.74 55.2773 361016 
Object 37 1989 17.3846 324.568 37.1257 73843 
Object 44 4871 16.4584 794.856 45.761 222902 
Object 54 4177 16.1415 681.609 33.5154 139994 
      
Ratio of average intensity of YFP tagged Mi-2 in Experimental A/ Control A 1.49 
Ratio of average intensity of YFP tagged Mi-2 in Experimental B/ Control B 2.8 
Ratio of average intensity of YFP tagged Mi-2 in Experimental C / Control C 1.36 
Ratio of average intensity of YFP tagged Mi-2 in Experimental D / Control D 1.78 
Ratio of average intensity of YFP tagged Mi-2 in Experimental E / Control E 1.06 
      
Average value of the ratio of 5 experimental / 5 control salivary glands 1.698 
 
B.2. Visualization of Mi-2 protein in single cell clones expressing NOS 
B.2. (i) Visualization of Mi-2 protein in GFP marked control clone cells 
Img 
No 1 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
4092 1656.41 34.772 28 72.7454 297674 378.674 314.201 16.6041 
Wt 1 Object 
1 
5458 2209.35 2.60993 28 65.0321 354945 68.382 110.547 12.229 
Wt 2 Object 
1 
8552 3461.78 2.58022 28 72.4279 619403 124.685 256.809 12.7595 
Wt 3 Object 
1 
4474 1811.04 2.57957 28 124.283 556043 154.652 145.929 11.0637 
Wt 4 Object 
1 
6170 2497.57 2.14765 28 69.1929 426920 467.617 183.999 8.26629 
Wt 5 Object 
1 
8758 3545.17 2.58518 28 71.726 628176 124.667 256.836 12.5776 
Wt 6 Object 
1 
1579 639.166 2.51235 28 145.775 230178 58.7809 219.764 9.9658 
Wt 7 Object 
1 
8071 3267.07 1.45979 28 73.6724 594610 401.164 79.4567 21.4443 
Wt 8 Object 
1 
10317 4176.24 1.81749 28 89.5717 924111 220.697 69.515 16.2537 
Wt 9 Object 
1 
7587 3071.16 2.93752 28 135.307 1.03E+06 457.254 305.664 6.50534 
Wt 10 Object 
1 
8820 3570.26 2.56814 28 71.3404 629222 124.665 256.807 12.5022 
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Img 
No 2 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
4044 1636.98 13.3133 24 64.9577 262689 240.738 414.567 15.6681 
Wt 1 Object 
1 
5676 2297.6 0.690803 24 125.473 712182 297.18 108.212 4.34056 
Wt 2 Object 
1 
9346 3783.18 0.598866 24 95.6898 894317 368.616 309.44 10.4607 
Wt 3 Object 
1 
8157 3301.89 0.585142 24 59.862 488294 418.809 396.729 7.59605 
Wt 4 Object 
1 
9095 3681.58 0.540077 24 75.9956 691180 301.144 251.594 11.3282 
Wt 5 Object 
1 
5865 2374.1 0.537084 24 144.682 848558 257.609 54.8382 5.21091 
Wt 6 Object 
1 
9101 3684.01 0.763433 24 79.7734 726018 304.95 364.678 6.56291 
Wt 7 Object 
1 
9808 3970.2 0.743679 24 86.0366 843847 322.587 439.163 7.3023 
Wt 8 Object 
1 
8323 3369.08 0.756218 24 94.7053 788232 360.92 490.65 7.38604 
Wt 9 Object 
1 
2051 830.228 0.592882 24 40.5685 83206 459.175 323.476 23.1853 
Wt 10 Object 
1 
1418 573.995 0.311707 24 68.3709 96950 216.028 118.757 21.1128 
           
Img 
No 3 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
10284 4162.88 43.2556 24 74.4185 765320 314.22 383.824 9.33411 
Wt 1 Object 
1 
9714 3932.15 0.328907 24 56.1457 545399 322.867 80.3292 12.8418 
Wt 2 Object 
1 
6234 2523.47 0.281842 24 57.0202 355464 185.006 91.2129 18.5265 
Wt 3 Object 
1 
1360 550.517 0.159559 24 40.5632 55166 220.242 13.1868 20.189 
Wt 4 Object 
1 
9137 3698.58 0.460873 24 90.5354 827222 268.247 126.321 6.98544 
Wt 5 Object 
1 
4018 1626.45 0.486809 24 31.6936 127345 249.026 461.306 11.4278 
Wt 6 Object 
1 
8697 3520.47 0.544441 24 58.912 512358 202.235 376.907 10.9339 
Wt 7 Object 
1 
4685 1896.45 0.528922 24 65.2525 305708 259.702 306.286 9.41067 
Wt 8 Object 
1 
9143 3701.01 0.515476 24 69.233 632997 300.051 233.476 7.43793 
Wt 9 Object 
1 
4271 1728.87 0.46125 24 31.2067 133284 248.817 461.18 11.3409 
Wt 10 Object 
1 
9534 3859.28 0.331026 24 56.676 540349 322.796 80.308 12.9776 
           
Img 
No 4 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
2095 848.039 11.3041 28 57.7804 121050 234.395 374.538 22.8449 
Wt 1 Object 
1 
7249 2934.34 0.67361 28 78.8822 571817 355.462 448.744 11.8291 
Wt 2 Object 
1 
5848 2367.22 0.58567 28 129.605 757932 253.172 12.1636 9.83635 
Wt 3 Object 
1 
7362 2980.08 0.559223 28 52.2816 384897 413.646 356.065 12.1254 
Wt 4 Object 
1 
5829 2359.53 0.757934 28 107.897 628934 292.208 66.7854 7.77715 
Wt 5 Object 
1 
10181 4121.18 0.6464 28 70.0202 712876 238.563 142.908 13.1806 
Wt 6 Object 
1 
8124 3288.53 0.50517 28 67.9354 551907 296.176 211.783 15.4978 
Wt 7 Object 
1 
9011 3647.58 0.679836 28 70.9859 639654 299.606 324.61 9.7715 
Wt 8 Object 
1 
8075 3268.69 0.601981 28 79.0031 637950 317.11 397.716 11.3391 
Wt 9 Object 
1 
5043 2041.36 0.543526 28 46.7103 235560 402.853 210.307 22.8057 
Wt 10 Object 
1 
3843 1555.61 0.456154 28 70.7442 271870 322.129 143.14 13.2763 
           
Img 
No 5 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
Mean 
(ChS1-
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
 149 
T2) T3) 
Clone 
Cell 
Object 
1 
4448 1800.51 70.8921 22 128.343 570871 116.379 237.168 10.0899 
Wt 1 Object 
1 
9466 3831.76 1.45817 22 80.0567 757817 317.876 436.112 12.9452 
Wt 2 Object 
1 
10312 4174.21 1.43735 22 101.333 1.04E+06 317.113 296.548 13.0702 
Wt 3 Object 
1 
8793 3559.33 1.60696 22 107.226 942834 202.673 276.163 12.0254 
Wt 4 Object 
1 
4404 1782.7 1.32879 22 45.9832 202510 422.568 383.997 19.168 
Wt 5 Object 
1 
1602 648.476 1.68851 22 137.604 220442 80.8533 129.657 8.60924 
Wt 6 Object 
1 
10328 4180.69 1.20149 22 93.1072 961611 247.761 154.328 15.8171 
Wt 7 Object 
1 
1562 632.285 0.652369 22 87.4257 136559 217.456 71.765 23.8566 
Wt 8 Object 
1 
4490 1817.51 0.924722 22 72.3784 324979 133.123 379.306 18.3421 
Wt 9 Object 
1 
1532 620.141 1.04373 22 46.8584 71787 157.152 10.7748 23.3923 
Wt 10 Object 
1 
8710 3525.74 1.28634 22 97.9255 852931 223.001 434.709 13.397 
           
Img 
No 6 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
1196 484.131 25.3286 20 46.5351 55656 137.286 168.003 12.3428 
Wt 1 Object 
1 
5845 2366.01 1.76185 20 133.855 782384 260.566 329.001 10.3938 
Wt 2 Object 
1 
9208 3727.32 1.8889 20 87.6718 807282 377.286 357.744 16.2217 
Wt 3 Object 
1 
5259 2128.8 2.26868 20 163.816 861508 397.006 314.516 7.95722 
Wt 4 Object 
1 
8189 3314.84 1.74918 20 51.2258 419488 229.999 270.608 11.1508 
Wt 5 Object 
1 
3418 1383.58 1.14716 20 67.1916 229661 56.1987 120.935 10.0506 
Wt 6 Object 
1 
4450 1801.32 2.38517 20 143.404 638148 144.678 227.928 5.59753 
Wt 7 Object 
2 
2703 1094.15 1.15982 20 52.2445 141217 314.991 270.971 11.2105 
Wt 8 Object 
1 
1122 454.176 2.72014 20 89.0624 99928 259.054 204.25 2.92959 
Wt 9 Object 
1 
7981 3230.64 1.75053 20 51.5195 411177 229.924 270.499 11.0107 
Wt 10 Object 
1 
2052 830.633 1.13304 20 2.26657 4651 174.636 329.541 19.2446 
           
Img 
No 7 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
10653 4312.25 26.2662 27 64.8706 691067 165.19 323.095 14.9699 
Wt 1 Object 
1 
10296 4167.74 0.730963 27 63.4495 653276 268.236 256.218 14.8137 
Wt 2 Object 
1 
11453 4636.08 1.27984 27 63.761 730255 370.229 303.538 13.2058 
Wt 3 Object 
1 
4615 1868.11 0.612351 27 59.7582 275784 312.854 399.133 13.6498 
Wt 4 Object 
1 
11217 4540.55 1.2917 27 121.664 1.36E+06 122.728 94.1002 10.5354 
Wt 5 Object 
1 
6151 2489.87 1.22257 27 124.104 763364 30.9379 226.955 11.6547 
Wt 6 Object 
1 
10965 4438.54 1.38523 27 106.398 1.17E+06 126.074 229.861 9.49375 
Wt 7 Object 
1 
10848 4391.18 1.28844 27 122.905 1.33E+06 122.731 94.0536 10.8046 
Wt 8 Object 
1 
6296 2548.57 1.03161 27 96.4423 607201 464.275 487.661 16.5723 
Wt 9 Object 
1 
9577 3876.69 1.30866 27 89.9552 861501 400.565 410.282 10.543 
Wt 10 Object 
1 
4873 1972.55 3.78617 27 26.7338 130274 454.938 308.635 22.589 
           
Img 
No 8 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
 150 
Clone 
Cell 
Object 
1 
5038 2039.34 38.6935 30 66.5286 335171 211.32 415.574 23.319 
Wt 1 Object 
1 
9566 3872.24 4.74127 30 92.3503 883423 316.835 360.309 7.07903 
Wt 2 Object 
1 
9895 4005.41 5.01193 30 104.992 1.04E+06 268.334 437.284 9.66741 
Wt 3 Object 
1 
9820 3975.06 3.93697 30 79.2488 778223 230.51 325.717 13.2418 
Wt 4 Object 
1 
8054 3260.19 4.18674 30 74.2208 597774 375.627 319.645 10.0538 
Wt 5 Object 
1 
8553 3462.18 5.11049 30 72.0569 616303 348.917 473.304 7.63627 
Wt 6 Object 
1 
5226 2115.44 2.73421 30 41.3781 216242 415.178 427.291 19.4432 
Wt 7 Object 
1 
8230 3331.44 4.14909 30 99.0128 814875 374.973 147.877 8.8164 
Wt 8 Object 
1 
9337 3779.54 2.93917 30 68.2329 637091 202.764 115.858 16.367 
Wt 9 Object 
1 
8801 3562.57 3.77196 30 69.7973 614286 296.746 99.2607 15.3018 
Wt 10 Object 
1 
8425 3410.37 2.85923 30 52.7828 444695 231.646 182.532 23.1774 
           
Img 
No 9 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
10729 4343.01 47.4342 24 93.4281 1.00E+06 273.679 194.85 8.24355 
Wt 1 Object 
1 
5033 2037.32 4.52533 24 85.5015 430329 216.591 114.988 9.90145 
Wt 2 Object 
1 
9386 3799.38 3.32506 24 79.4683 745889 258.677 37.2264 8.38547 
Wt 3 Object 
1 
8725 3531.81 4.43381 24 80.6878 704001 155.643 188.08 9.27473 
Wt 4 Object 
1 
9582 3878.71 2.32624 24 59.9517 574457 296.667 277.456 21.971 
Wt 5 Object 
1 
7348 2974.41 2.3997 24 46.5048 341717 137.498 75.7805 18.5558 
Wt 6 Object 
1 
9415 3811.11 2.34041 24 56.0797 527990 332.705 111.069 15.6049 
Wt 7 Object 
1 
4735 1916.69 4.73178 24 51.6644 244631 205.574 274.954 9.50433 
Wt 8 Object 
1 
6823 2761.89 1.55152 24 33.8534 230982 338.473 195.441 32.9963 
Wt 9 Object 
1 
6931 2805.61 1.97288 24 41.7125 289109 146.972 304.105 28.7097 
Wt 10 Object 
4 
1094 442.842 1.64077 24 31.3391 34285 122.561 215.083 32.4378 
           
Img 
No 10 
Name Voxel 
Count 
Volume 
(µm³) 
Mean 
(Ch3-T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
Cell 
Object 
1 
5621 2275.33 13.9448 24 74.8605 420791 114.139 379.704 33.1875 
Wt 1 Object 
1 
8690 3517.64 4.47169 24 82.4487 716479 44.8358 206.962 11.5329 
Wt 2 Object 
1 
9977 4038.61 4.20487 24 101.475 1.01E+06 65.3157 266.602 10.8927 
Wt 3 Object 
1 
9658 3909.48 3.25802 24 110.841 1.07E+06 402.467 380.829 9.74622 
Wt 4 Object 
3 
1708 691.384 1.48888 24 71.6885 122444 88.5082 272.907 38.3226 
Wt 5 Object 
1 
11673 4725.13 3.02467 24 88.0451 1.03E+06 327.923 382.979 13.7417 
Wt 6 Object 
1 
9931 4019.99 1.99325 24 78.6832 781403 214.195 388.646 32.0811 
Wt 7 Object 
1 
6326 2560.71 3.81473 24 110.328 697936 372.008 289.82 8.184 
Wt 8 Object 
1 
7243 2931.91 4.21317 24 119.088 862554 337.183 336.153 8.41419 
Wt 9 Object 
1 
12235 4952.63 4.73813 24 96.6506 1.18E+06 213.501 353.161 8.94508 
Wt 10 Object 
1 
10936 4426.8 4.61924 24 95.2054 1.04E+06 108.008 334.046 9.80907 
           
Average intensity of Mi-2 localization in 10 non adjacent wild 
type cells of img No 10 
     
 Img 
No 1 
  91.832        
 Img   87.115        
 151 
No 2 
 Img 
No 3 
  55.723        
 Img 
No 4 
  77.4        
 Img 
No 5 
  86.98        
 Img 
No 6 
  84.225        
 Img 
No 7 
  87.51        
 Img 
No 8 
  75.4        
 Img 
No 9 
  56.67        
 Img 
No 10 
  95.44        
           
Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non 
adjacent wild type cells 
   
 Img 
No 1 
 0.79 
 Img 
No 2 
 0.75 
 Img 
No 3 
 1.33 
 Img 
No 4 
 0.75 
 Img 
No 5 
 1.47 
 Img 
No 6 
 0.55 
 Img 
No 7 
 0.74 
 Img 
No 8 
 0.88 
 Img 
No 9 
 1.65 
 Img 
No 10 
 0.79 
           
Average value of the ratio Clone cells V wild type cells acquired from Img No 
1 to Img No 10 
0.97    
Standared deviation of the average value    0.371    
 
B.2. (ii) Visualization of Mi-2 protein in single cell clones expressing NOS2 
 
Img 
No 1 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 14604 5911.58 15.0083 35 109.514 1.60E+06 388.622 331.901 10.571 
Wt 1 13013 5267.56 0.277876 35 81.7953 1.06E+06 91.5113 326.69 10.577 
Wt 2 11808 4779.78 0.200119 35 61.8786 730663 126.049 275.419 13.9563 
Wt 3 14353 5809.98 0.242179 35 73.2347 1.05E+06 200.526 322.928 12.6651 
Wt 4 10953 4433.68 0.219483 35 71.7126 785468 259.34 365.517 29.3118 
Wt 5 6531 2643.69 0.261522 35 74.9677 489614 54.0167 373.733 25.46 
Wt 6 10606 4293.22 0.142749 35 56.929 603789 255.974 252.923 25.2065 
Wt 7 9152 3704.65 0.217767 35 61.8911 566427 76.5605 230.75 21.8563 
Wt 8 11809 4780.19 0.405453 35 85.9881 1.02E+06 453.31 282.159 14.2975 
Wt 9 4304 1742.22 0.152649 35 42.8483 184419 190.482 232.072 39.6578 
          
Img 
No 2 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 12749 5160.69 13.0549 35 87.2923 1.11E+06 384.352 337.584 27.9031 
Wt 1 15440 6249.98 0.433873 35 23.0842 356420 63.1302 177.32 15.5132 
Wt 2 8334 3373.53 0.314015 35 16.2544 135464 30.2049 224.841 26.2513 
Wt 3 12831 5193.88 0.253682 35 17.02 218383 107.526 276.548 25.4352 
Wt 4 15877 6426.88 0.309315 35 22.7095 360559 164.767 262.98 17.4217 
Wt 5 13597 5503.95 0.26675 35 16.7141 227261 216.497 330.375 27.2523 
Wt 6 8550 3460.97 0.477427 35 14.6854 125560 318.703 228.068 34.3013 
Wt 7 12344 4996.75 0.260774 35 19.5429 241237 286.56 363.89 38.8339 
Wt 8 3497 1415.56 0.373463 35 19.5997 68540 47.3151 108.661 33.9317 
Wt 9 10450 4230.07 0.33311 35 17.1344 179054 135.489 143.198 38.2557 
Wt 
10 14308 5791.76 0.263629 35 16.6615 238393 216.4 330.081 27.5336 
 152 
          
Img 
No 3 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(ChS1-
T3) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 9713 3931.74 43.957 26 82.8864 805076 74.0667 362.499 9.42335 
Wt 1 14577 5900.65 0.684709 26 86.6768 1.26E+06 476.324 77.7023 11.8076 
Wt 2 15524 6283.99 0.505153 26 91.1451 1.41E+06 348.618 150.611 11.4173 
Wt 3 15461 6258.49 0.555591 26 94.9919 1.47E+06 213.919 235.506 10.5077 
Wt 4 17659 7148.22 0.511977 26 97.138 1.72E+06 96.4015 201.057 10.0208 
Wt 5 9231 3736.63 0.479363 26 69.6121 642589 155.105 447.927 30.5911 
Wt 6 13415 5430.28 0.549981 26 76.5278 1.03E+06 315.171 265.271 19.3022 
Wt 7 15663 6340.25 0.580859 26 92.0846 1.44E+06 15.0774 252.234 10.7504 
Wt 8 14949 6051.23 0.557161 26 96.4496 1.44E+06 214.071 235.305 9.98368 
Wt 9 15644 6332.56 0.448031 26 85.5269 1.34E+06 179.728 354.157 13.0488 
Wt 
10 11272 4562.81 0.387243 26 67.912 765504 120.142 474.708 28.3434 
          
Img 
No 4 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 727 294.284 10.7909 21 122.993 89416 67.0248 154.905 38.63 
Wt 1 11295 4572.12 3.04294 21 58.1656 656981 241.914 214.363 13.255 
Wt 2 11062 4477.81 2.93256 21 53.076 587127 373.285 432.568 11.4071 
Wt 3 4995 2021.93 1.99339 21 54.1461 270460 337.868 280.066 16.8771 
Wt 4 2795 1131.39 2.11521 21 33.9692 94944 487.1 401.273 19.917 
Wt 5 3148 1274.28 0.991741 21 26.1185 82221 416.013 485.062 28.2004 
Wt 6 6126 2479.75 2.13892 21 61.9993 379808 189.625 165.182 13.0215 
Wt 7 10947 4431.26 2.37992 21 46.8976 513388 293.593 412.935 19.3351 
Wt 8 3960 1602.98 2.70253 21 51.6929 204704 477.209 482.578 8.53359 
Wt 9 10808 4374.99 1.97326 21 40.413 436784 236.15 350.271 22.2197 
Wt 
10 4469 1809.01 2.23831 21 56.3439 251801 139.318 38.4133 17.2806 
          
Img 
No 5 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 2305 933.045 9.51584 34 150.09 345957 418.873 383.629 14.308 
Wt 1 7164 2899.93 3.07733 34 107.409 769478 119.171 144.13 15.5197 
Wt 2 4616 1868.52 2.21599 34 86.3419 398554 104.826 207.596 26.4892 
Wt 3 11121 4501.69 2.46902 34 102.178 1.14E+06 186.737 225.569 18.8666 
Wt 4 10000 4047.92 2.1642 34 96.5643 965643 248.932 188.418 17.5805 
Wt 5 8133 3292.17 1.5597 34 75.3111 612505 303.439 193.339 25.9203 
Wt 6 4515 1827.63 1.73378 34 130.238 588025 359.948 232.992 15.0151 
Wt 7 2391 967.857 4.32246 34 139.151 332710 430.93 293.207 10.5491 
Wt 8 3679 1489.23 0.915466 34 56.6379 208371 231.796 276.044 35.0106 
Wt 9 8345 3377.99 1.54344 34 74.3587 620523 303.499 193.23 25.7584 
Wt 
10 4590 1857.99 1.72636 34 129.429 594079 359.933 232.923 14.8725 
          
Img 
No 6 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 3891 1575.04 7.50938 27 108.935 423868 362.315 327.984 27.2005 
Wt 1 7615 3082.49 0.405384 27 109.478 833678 267.77 423.111 29.9326 
Wt 2 15103 6113.57 0.537046 27 104.657 1.58E+06 191.953 165.423 16.5025 
Wt 3 14416 5835.48 0.616121 27 137.093 1.98E+06 252.638 222.69 12.7725 
Wt 4 13189 5338.8 0.342407 27 107.917 1.42E+06 283.423 161.627 28.6243 
Wt 5 6312 2555.05 0.125158 27 74.1838 468248 218.26 139.211 52.9053 
Wt 6 6406 2593.1 0.823915 27 88.3445 565935 225.078 354.378 37.4243 
Wt 7 10209 4132.52 1.2012 27 128.725 1.31E+06 331.765 460.056 13.1615 
Wt 8 14221 5756.54 0.519795 27 120.86 1.72E+06 201.248 281.138 16.9596 
Wt 9 2955 1196.16 0.111675 27 68.3675 202026 189.482 227.658 50.9411 
Wt 
10 13769 5573.58 0.631346 27 140.253 1.93E+06 252.778 222.504 12.2768 
          
Img 
No 7 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 6978 2824.64 9.682 27 108.015 753732 126.706 71.2154 12.3951 
Wt 1 3127 1265.78 1.02047 27 70.2926 219805 441.243 464.01 16.3307 
Wt 2 10745 4349.49 1.2966 27 53.1686 571297 259.473 311.824 17.5252 
Wt 3 8662 3506.31 1.18737 27 49.6199 429808 358.503 423.675 19.1952 
Wt 4 10235 4143.04 1.32702 27 57.4064 587555 327.06 351.838 17.288 
Wt 5 12214 4944.13 1.14745 27 44.283 540872 284.17 418.687 19.4485 
 153 
Wt 6 9760 3950.77 1.1291 27 49.7862 485913 203.725 366.296 19.9442 
Wt 7 5656 2289.5 0.766443 27 40.4565 228822 310.768 488.902 26.0483 
Wt 8 11559 4678.99 3.07942 27 77.2421 892841 177.364 173.684 13.4064 
Wt 9 7461 3020.15 1.12009 27 37.9983 283505 250.085 185.736 27.3605 
Wt 
10 4237 1715.1 0.707576 27 39.5138 167420 312.635 264.51 34.4397 
          
Img 
No 8 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 6584 2665.15 21.4598 27 151.11 994909 298.28 409.585 11.1315 
Wt 1 12081 4890.29 3.6372 27 83.3689 1.01E+06 204.17 314.177 14.3757 
Wt 2 9646 3904.62 3.00021 27 75.9962 733059 287.268 178.736 22.5122 
Wt 3 2769 1120.87 2.64175 27 65.4485 181227 319.649 61.2929 19.333 
Wt 4 7302 2955.79 2.13106 27 61.6913 450470 223.472 119.868 32.9984 
Wt 5 8749 3541.52 2.99577 27 73.0786 639365 307.337 265.496 24.6226 
Wt 6 2641 1069.06 2.11208 27 44.248 116859 338.086 151.421 33.3453 
Wt 7 4833 1956.36 1.63915 27 42.66 206176 254.585 16.1235 30.6313 
Wt 8 5695 2305.29 2.84039 27 62.7845 357558 179.637 406.727 28.4291 
Wt 9 2759 1116.82 2.35774 27 56.9239 157053 326.845 336.399 33.8663 
Wt 
10 2964 1199.8 1.94872 27 43.8988 130116 183.949 302.899 37.9551 
          
Img 
No 9 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min 
(ChS1-
T3) 
Mean 
(ChS1-T3) 
Sum (ChS1-
T3) 
Centroi
d X 
Centroid 
Y 
Centroi
d Z 
Clon
e cell 6723 2721.41 13.6903 70 118.427 796185 399.693 306.836 32.221 
Wt 1 11361 4598.84 6.18484 70 135.942 1.54E+06 304.203 157.528 15.1175 
Wt 2 11241 4550.26 5.45877 70 136.744 1.54E+06 404.655 130.763 12.9722 
Wt 3 10068 4075.44 5.4122 70 133.857 1.35E+06 372.911 63.6268 16.8599 
Wt 4 10606 4293.22 6.67198 70 134.476 1.43E+06 245.338 378.501 6.56958 
Wt 5 10535 4264.48 6.05857 70 128.342 1.35E+06 491.866 97.5585 21.9106 
Wt 6 8438 3415.63 6.82259 70 130.373 1.10E+06 30.3668 434.829 7.31785 
Wt 7 9630 3898.14 4.95794 70 122.78 1.18E+06 255.281 437.855 20.0157 
Wt 8 9978 4039.01 5.3625 70 127.947 1.28E+06 442.811 20.4209 13.4531 
Wt 9 9465 3831.35 5.69593 70 130.392 1.23E+06 161.446 409.706 10.0875 
Wt 
10 9491 3841.88 5.82699 70 139.631 1.33E+06 188.005 481.672 15.6344 
          
Img 
No 
10 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y Centroid Z 
Mean 
(ChS2-T2) 
Sum 
(ChS2-
T2) 
Mean 
(Ch3-T3) 
Min 
(Ch2-
T4) 
Clon
e cell 12208 4941.7 227.164 65.372 18.3965 112.579 
1.37E+
06 27.9812 30 
Wt 1 7614 3082.08 242.085 350.458 18.2434 28.1027 213974 4.85671 30 
Wt 2 11171 4521.93 350.813 448.677 7.20526 30.6185 342039 7.14027 30 
Wt 3 7611 3080.87 437.641 417.774 11.0122 27.1084 206322 5.53804 30 
Wt 4 14011 5671.54 312.357 343.563 10.2438 33.4028 468007 6.14481 30 
Wt 5 13142 5319.77 380.114 270.696 16.9997 41.2019 541476 6.84485 30 
Wt 6 5034 2037.72 68.3619 11.1134 8.68733 27.9062 140480 8.47815 30 
Wt 7 11361 4598.84 302.521 74.1784 27.9856 69.6052 790785 8.87131 30 
Wt 8 12102 4898.79 291.566 176.595 23.9484 50.8028 614815 7.23732 30 
Wt 9 11151 4513.83 205.787 239.251 20.9495 30.9032 344602 6.26616 30 
Wt 
10 1840 744.817 145.205 179.559 26.0353 30.7864 56647 5.93804 30 
          
Average intensity of Mi-2 localization in 10 non adjacent wild type cells     
 Img No 1 
67.9
16         
 Img No 2 
18.3
41         
 Img No 3 
85.8
06         
 Img No 4 
99.7
62         
 Img No 5 
48.2
82         
 Img No 6 
107.
99         
 Img No 7 
51.9
77         
 Img No 8 
61.0
1         
 Img No 9 
132.
05         
 Img No 10 
37.0
44         
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Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non adjacent wild type cells 
 Img No 1 1.61         
 Img No 2 4.8         
 Img No 3 0.97         
 Img No 4 1.5         
 Img No 5 2.5         
 Img No 6 1         
 Img No 7 2         
 Img No 8 2.47         
 Img No 9 0.89         
 Img No 10 3         
          
Average value of the ratio of the clone cell V wild type cells 
acquired from Img No 1 to Img No 10  2.074      
Standard deviation of the average value 
1.199594
376      
 
 
B.3. Visualization of Dref protein in single cell clones expressing NOS2 
B.3. (i) Visualization of Dref protein in GFP marked control clone cells 
Img No 
1 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 10100 4088.4 24.5897 21 29.3016 295946 371.281 252.13 18.9531 
Wt 1 12595 5098.35 2.07868 21 46.786 589270 214.03 177.03 17.5405 
Wt 2 5066 2050.68 1.76905 21 85.5517 433405 222.544 338.52 15.5914 
Wt 3 7061 2858.23 2.61663 21 84.1685 594314 288.309 416.21 9.03711 
Wt 4 7295 2952.96 2.27567 21 74.4814 543342 343.797 476.33 8.87361 
Wt 5 14946 6050.02 2.35809 21 163.747 2.45E+06 269.889 70.472 13.943 
Wt 6 11170 4521.52 1.6701 21 91.5438 1.02E+06 192.808 93.23 22.4355 
Wt 7 9654 3907.86 1.93806 21 95.1569 918645 390.351 64.592 20.1717 
Wt 8 8349 3379.61 1.64032 21 22.0971 184489 386.266 420.17 21.3259 
Wt 9 12396 5017.8 1.99734 21 60.2462 746812 308.241 152.54 18.1158 
Wt 10 7093 2871.19 2.47328 21 80.8893 573748 340.135 369.27 10.0925 
          
Img No 
2 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 8583 3474.33 28.0068 21 102.769 882067 226.969 394.36 11.449 
Wt 1 13876 5616.89 3.88642 21 40.2023 557847 280.627 365.44 20.4447 
Wt 2 8287 3354.51 4.17184 21 72.0115 596759 287.077 54.621 14.8924 
Wt 3 12570 5088.23 4.04503 21 42.9156 539449 280.893 365.33 19.3656 
Wt 4 2389 967.048 2.23273 21 40.9029 97717 333.625 308.61 34.1168 
Wt 5 9228 3735.42 4.42393 21 32.4777 299704 251.97 473.89 13.8808 
Wt 6 4587 1856.78 4.34772 21 93.0961 427032 225.109 282.67 21.3056 
Wt 7 12401 5019.82 3.41626 21 70.9943 880400 223.214 34.749 28.2733 
Wt 8 6597 2670.41 4.05063 21 39.0361 257521 195.338 446.19 18.6382 
Wt 9 7394 2993.03 4.40371 21 74.8171 553198 264.299 138.57 13.9145 
Wt 10 4317 1747.49 2.91267 21 20.9134 90283 321.005 431.59 27.9657 
          
Img No 
3 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 14975 6061.76 9.62938 21 16.3048 244165 236.487 179.98 28.3275 
Wt 1 12144 4915.79 1.78664 21 1.49251 18125 310.228 373.67 34.1846 
Wt 2 9671 3914.74 1.82318 21 13.3727 129327 174.523 295 34.5521 
Wt 3 24228 9807.29 1.94473 21 45.8214 1.11E+06 116.571 311.43 13.7265 
Wt 4 21231 8594.13 2.88705 21 48.7589 1.04E+06 188.523 378.97 12.2754 
Wt 5 10525 4260.43 2.35211 21 14.6205 153881 108.672 125.97 38.9587 
Wt 6 8275 3349.65 1.29583 21 2.39384 19809 395.4 435.52 34.3932 
Wt 7 18812 7614.94 3.34287 21 16.4358 309190 327.715 247.09 11.7219 
Wt 8 24906 10081.7 8.53541 21 61.5791 1.53E+06 192.68 114.57 15.2904 
Wt 9 9982 4040.63 1.93588 21 11.0224 110026 125.625 219.58 35.1589 
Wt 10 8748 3541.12 1.6158 21 5.97062 52231 376.333 319.92 26.6973 
          
Img No 
4 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 10509 4253.96 24.0914 21 41.834 439633 283.312 358.62 10.6986 
Wt 1 5095 2062.41 4.75172 21 30.1095 153408 329.4 332.5 25.4471 
Wt 2 1558 630.666 2.84403 21 50.2529 78294 216.202 15.135 27.5026 
Wt 3 2751 1113.58 2.87096 21 17.5867 48381 249.663 300.16 26.8957 
Wt 4 15426 6244.32 4.60755 21 40.3641 622657 215.428 386.74 15.6644 
Wt 5 9604 3887.62 3.54425 21 44.4399 426801 72.5614 32.748 15.9109 
Wt 6 5536 2240.93 3.07912 21 30.5307 169018 158.256 420.22 25.7607 
Wt 7 4736 1917.09 4.78273 21 28.8562 136663 328.663 333.16 25.4419 
Wt 8 8686 3516.02 3.43587 21 64.784 562714 236.458 125.97 19.9026 
 155 
Wt 9 9440 3821.23 4.86578 21 40.3535 380937 329.424 437.93 8.18994 
Wt 10 16918 6848.27 5.29885 21 61.767 1.04E+06 188.863 66.022 8.65132 
          
Img No 
5 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 17461 7068.07 17.1294 21 33.0357 576836 333.379 391.89 15.9236 
Wt 1 15682 6347.94 4.48992 21 54.3709 852645 138.334 71.042 16.3758 
Wt 2 11022 4461.61 4.28171 21 66.2457 730160 226.068 65.968 11.2556 
Wt 3 15751 6375.87 5.44372 21 96.1859 1.52E+06 207.588 124.53 8.3709 
Wt 4 9513 3850.78 4.13844 21 72.7508 692078 285.647 143.27 11.324 
Wt 5 16394 6636.16 4.35434 21 56.6882 929346 240.875 204.4 12.4241 
Wt 6 15894 6433.76 3.93545 21 46.4575 738395 286.018 271.53 15.9278 
Wt 7 14339 5804.31 3.93821 21 33.1852 475842 423.636 352.68 14.3792 
Wt 8 15038 6087.26 4.40371 21 37.0817 557634 354.699 318.67 12.5285 
Wt 9 8802 3562.98 3.7354 21 44.6003 392572 379.971 250.66 12.8348 
Wt 10 8973 3632.2 2.60493 21 41.5951 373233 301.171 84.714 26.0578 
          
Img No 
6 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 16299 6597.7 20.4275 21 94.7001 1.54E+06 297.438 231.8 19.4014 
Wt 1 15456 6256.46 6.44979 21 73.0057 1.13E+06 200.76 421.06 8.60287 
Wt 2 7333 2968.34 5.90113 21 69.6506 510748 114.159 403.42 7.12628 
Wt 3 9003 3644.34 6.37343 21 62.9328 566584 172.578 336.5 10.1002 
Wt 4 16888 6836.12 5.37056 21 54.5131 920617 331.239 123.98 15.3115 
Wt 5 14781 5983.23 5.51512 21 88.3513 1.31E+06 240.84 351.68 11.4536 
Wt 6 16706 6762.45 6.32617 21 76.3911 1.28E+06 248.406 81.013 12.1808 
Wt 7 6682 2704.82 6.23451 21 76.0492 508161 105.635 482.73 5.81562 
Wt 8 8575 3471.09 5.43953 21 60.3621 517605 150.585 271.72 12.4609 
Wt 9 8242 3336.29 4.31376 21 52.859 435664 91.6744 349.71 24.5901 
Wt 10 1549 627.022 3.85539 21 51.5642 79873 190.343 166.88 27.9032 
          
Img No 
7 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 3793 1535.38 24.3201 26 95.4205 361930 228.221 146.73 39.8587 
Wt 1 14204 5749.66 8.38658 26 75.9005 1.08E+06 205.605 421.8 18.5348 
Wt 2 9065 3669.44 8.20375 26 43.6707 395875 203.432 301.96 29.8202 
Wt 3 6481 2623.46 6.18917 26 88.985 576712 348.304 345.37 34.2978 
Wt 4 8199 3318.89 6.27869 26 78.6364 644740 364.778 183.15 31.8572 
Wt 5 8048 3257.76 6.2459 26 56.5017 454726 343.611 456.09 31.1148 
Wt 6 15049 6091.71 10.0706 26 100.521 1.51E+06 261.238 459.13 8.75008 
Wt 7 14520 5877.58 9.28733 26 97.8848 1.42E+06 282.646 90.114 16.2149 
Wt 8 14549 5889.32 10.0059 26 99.152 1.44E+06 315.805 165.81 11.6897 
Wt 9 3462 1401.39 8.5959 26 117.754 407663 375.4 43.009 15.2386 
Wt 10 3117 1261.74 6.15656 26 91.6567 285694 347.735 264.66 26.872 
          
Img No 
8 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 8451 3420.9 37.8313 24 51.5898 435985 81.5251 116.1 10.2569 
Wt 1 12349 4998.77 3.52231 24 123.722 1.53E+06 258.838 209.53 10.4983 
Wt 2 10642 4307.79 3.77382 24 208.041 2.21E+06 148.509 266.48 19.8272 
Wt 3 12539 5075.68 3.43863 24 73.126 916927 196.495 23.456 12.1596 
Wt 4 8306 3362.2 4.24115 24 36.0211 299191 91.6183 16.678 8.27751 
Wt 5 11520 4663.2 3.17543 24 54.8467 631834 249.576 390.37 16.3724 
Wt 6 6166 2495.95 3.3495 24 96.8793 597358 102.012 207.21 19.0062 
Wt 7 11100 4493.19 2.70865 24 45.3246 503103 311.154 106.51 15.4815 
Wt 8 7015 2839.61 3.00613 24 25.9706 182184 419.088 391.36 10.0744 
Wt 9 3524 1426.49 2.51703 24 29.6348 104433 368.052 206.22 14.3383 
Wt 10 3026 1224.9 2.36682 24 11.0231 33356 444.518 292.61 18.0145 
          
Img No 
9 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean (ChS1-
T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 11034 4466.47 56.0247 24 65.4313 721969 397.064 189.49 11.5333 
Wt 1 6803 2753.8 2.19756 24 58.8455 400326 157.571 255.41 20.9337 
Wt 2 12136 4912.55 3.61149 24 102.993 1.25E+06 130.207 208.92 10.2523 
Wt 3 10534 4264.08 4.03332 24 56.8899 599278 301.353 271.16 14.301 
Wt 4 8787 3556.91 3.37316 24 61.3249 538862 228.947 254.14 14.8284 
Wt 5 7436 3010.03 3.34817 24 78.0258 580200 446.381 332.39 12.0344 
Wt 6 3121 1263.36 7.8917 24 47.0119 146724 241.539 87.713 23.71 
          
Average intensity of Mi-2 localization in 10 non adjacent wild type cells    
 Img No 1 82.942        
 Img No 2 53.955        
 Img No 3 25.559        
 156 
 Img No 4 38.366        
 Img No 5 57.87        
 Img No 6 70.156        
 Img No 7 80.156        
 Img No 8 82.991        
 Img No 9 67.515        
          
Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non adjacent wild type cells 
          
 Img No 1 0.35        
 Img No 2 1.9        
 Img No 3 0.64        
 Img No 4 1.08        
 Img No 5 0.57        
 Img No 6 1.35        
 Img No 7 1.19        
 Img No 8 0.62        
 Img No 9 0.97        
          
Average value of the ratio of the clone cell V wild type cells acquired from Img No 1 
to Img No 10  0.96333    
Std Dev of the avg ratio of clone cell / wild type cell 0.48026      
 
B.3. (ii) Visualization of Dref  protein in single cell clones expressing NOS2 
 
Img No 
1 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 3626 1467.77 52.7733 27 88.7921 321960 211.278 406.154 37.4702 
Wt 1 9799 3966.55 0.221349 27 100.989 989594 280.865 145.563 14.9135 
Wt 2 11017 4459.59 0.248797 27 83.9361 924724 224.906 131.776 15.083 
Wt 3 11920 4825.12 1.82508 27 88.6872 1.06E+06 290.347 52.5028 16.4854 
Wt 4 9315 3770.64 0.271605 27 97.0998 904485 341.577 110.028 16.748 
Wt 5 10358 4192.83 0.234987 27 99.7947 1.03E+06 266.654 239.678 16.2033 
Wt 6 11610 4699.63 0.215245 27 80.7769 937820 203.227 254.361 13.7073 
Wt 7 9348 3783.99 0.238126 27 80.2221 749916 115.219 295.267 18.0088 
Wt 8 10233 4142.23 0.311346 27 76.4842 782663 92.9304 435.065 15.1652 
Wt 9 3141 1271.45 0.370901 27 68.9908 216700 21.0729 492.247 13.8695 
Wt 10 10489 4245.86 0.260559 27 91.8657 963579 341.066 109.913 17.0923 
          
Img No 
2 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 7079 2865.52 38.2705 27 134.448 951759 162.137 217.752 14.5158 
Wt 1 8590 3477.16 0.701746 27 132.28 1.14E+06 364.034 124.077 16.2549 
Wt 2 11504 4656.72 1.22827 27 109.556 1.26E+06 294.905 186.818 12.2437 
Wt 3 11697 4734.85 0.637599 27 106.184 1.24E+06 282.354 90.1641 14.496 
Wt 4 9533 3858.88 1.08161 27 101.002 962855 284.921 246.106 28.8481 
Wt 5 11784 4770.07 0.657841 27 93.5411 1.10E+06 222.041 103.322 23.3759 
Wt 6 5520 2234.45 6.67355 27 68.8748 380189 79.4187 327.19 15.1049 
Wt 7 6372 2579.33 0.77511 27 101.116 644309 181.127 133.68 41.8183 
Wt 8 3684 1491.25 0.411509 27 99.813 367711 372.173 182.286 34.8149 
Wt 9 5383 2178.99 0.316366 27 73.8148 397345 227.502 21.3974 38.7044 
Wt 10 3393 1373.46 0.57707 27 71.7645 243497 248.473 234.055 48.0631 
          
Img No 
3 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 5951 2408.92 33.2437 24 49.5656 294965 407.968 243.998 22.7158 
Wt 1 10988 4447.85 1.53722 24 101.557 1.12E+06 106.594 36.709 20.9018 
Wt 2 15072 6101.02 1.93305 24 91.7006 1.38E+06 183.121 47.0123 15.4599 
Wt 3 13800 5586.13 2.2208 24 107.252 1.48E+06 70.0538 93.0271 6.18065 
Wt 4 14703 5951.65 2.44011 24 60.4169 888309 153.869 222.235 6.9949 
Wt 5 10909 4415.87 2.32414 24 59.172 645507 243.545 275.975 10.1966 
Wt 6 15746 6373.85 2.18068 24 63.2905 996572 250.651 106.739 14.3565 
Wt 7 9274 3754.04 1.68191 24 72.4582 671977 133.677 140.967 18.3428 
 157 
Wt 8 12176 4928.74 1.7909 24 64.9811 791210 203.258 189.859 19.656 
Wt 9 2662 1077.56 2.26108 24 12.7926 34054 281.814 121.879 1.32494 
Wt 10 16022 6485.57 2.19966 24 63.0753 1.01E+06 250.775 106.477 14.5888 
          
Img No 
4 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 12736 5155.43 20.3642 24 93.3568 1.19E+06 387.162 366.016 16.1611 
Wt 1 11992 4854.26 2.99867 24 86.4139 1.04E+06 84.0986 210.525 18.9256 
Wt 2 13833 5599.48 3.66464 24 93.05 1.29E+06 71.8269 269.347 14.7801 
Wt 3 13624 5514.88 2.86472 24 71.2801 971120 230.258 250.543 20.6847 
Wt 4 14197 5746.83 3.02895 24 72.8785 1.03E+06 215.315 310.294 20.2059 
Wt 5 9355 3786.83 4.1054 24 105.957 991227 289.179 287.547 10.3844 
Wt 6 10057 4070.99 2.36383 24 53.4162 537207 189.602 198.404 30.7734 
Wt 7 5860 2372.08 2.33925 24 77.9171 456594 92.7949 167.5 33.3911 
Wt 8 8815 3568.24 4.2186 24 70.5612 621997 459.062 307.781 27.6853 
Wt 9 6909 2796.71 3.07555 24 81.8987 565838 337.13 264.154 21.7645 
Wt 10 6129 2480.97 2.40888 24 78.2211 479417 152.181 244.605 18.5401 
          
Img No 
5 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 7777 3148.07 94.5059 24 88.2321 686181 349.104 56.5303 9.88016 
Wt 1 5956 2410.94 0.260745 24 80.8573 481586 143.693 347.979 7.7824 
Wt 2 9036 3657.7 0.336653 24 80.3962 726460 260.197 310.275 9.63103 
Wt 3 6693 2709.27 0.443747 24 78.0883 522645 174.675 490.083 7.84432 
Wt 4 7507 3038.77 0.299454 24 73.2836 550140 285.603 474.779 13.3077 
Wt 5 2532 1024.93 0.382306 24 83.7536 212064 442.077 258.901 9.85624 
Wt 6 8787 3556.91 0.337544 24 94.5047 830413 164.273 209.366 9.62217 
Wt 7 7197 2913.29 0.451855 24 76.1791 548261 174.426 490.026 8.26539 
Wt 8 5826 2358.32 0.263646 24 81.7317 476169 143.736 347.937 7.77326 
          
Img No 
6 
Voxel 
Count 
Volume 
(µm³) 
Mean (Ch3-
T1) 
Min (Ch2-
T2) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 11357 4597.22 32.6142 21 100.826 1.15E+06 345.561 157.249 11.3082 
Wt 1 8683 3514.81 1.22101 21 103.873 901929 165.205 377.412 12.0988 
Wt 2 3506 1419.2 1.14404 21 123.233 432055 67.6098 318.207 10.8274 
Wt 3 5201 2105.32 1.64757 21 99.7641 518873 173.053 43.5485 10.4586 
Wt 4 2303 932.235 1.52149 21 128.276 295420 61.2979 174.663 10.7082 
Wt 5 5245 2123.13 1.67207 21 99.0766 519657 173.068 43.4463 10.5701 
Wt 6 7868 3184.9 1.24428 21 115.677 910149 392.012 43.7262 12.6459 
Wt 7 7023 2842.85 1.35441 21 100.501 705819 269.834 21.6046 9.96768 
Wt 8 1526 617.712 0.694626 21 92.5714 141264 274.197 371.68 20.5917 
          
Img No 
7 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) Centroid X Centroid Y 
Centroid 
Z 
Min 
(Ch2-T1) 
Mean 
(Ch3-T2) 
Clone 
cell 3529 1428.51 57.9544 204521 240.852 415.278 20.3961 24 66.5384 
Wt 1 8899 3602.24 83.301 741296 301.43 201.784 20.6468 24 1.62187 
Wt 2 6672 2700.77 74.4571 496778 193.729 159.2 19.7235 24 0.84967 
Wt 3 4949 2003.31 94.5557 467956 128.728 304.521 20.6789 24 1.55789 
Wt 4 3838 1553.59 62.3609 239341 387.838 49.4192 21.7939 24 1.1334 
Wt 5 3790 1534.16 71.2443 270016 402.341 203.139 21.3541 24 1.22507 
Wt 6 3835 1552.38 62.442 239465 387.913 49.4149 21.7718 24 1.13325 
Wt 7 8527 3451.66 53.1391 453117 340.801 385.277 12.6475 24 0.40319 
Wt 8 8172 3307.96 67.635 552713 326.275 291.646 21.3922 24 1.01199 
Wt 9 3241 1311.93 62.8747 203777 255.277 487.528 5.22092 24 0.523604 
          
Img No Voxel Volume Mean Sum Centroid X Centroid Y Centroid Min Mean 
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8 Count (µm³) (ChS1-T3) (ChS1-T3) Z (Ch2-T1) (Ch3-T2) 
Clone 
cell 8035 3252.5 84.1187 675894 98.1469 200.325 11.7135 21 17.69 
Wt 1 12912 5226.67 90.096 1.16E+06 312.575 81.7982 15.0163 21 2.70074 
Wt 2 11038 4468.09 91.6124 1.01E+06 376.477 181.518 10.3351 21 3.67992 
Wt 3 6196 2508.09 103.359 640414 463.473 230.712 12.4921 21 3.01436 
Wt 4 9976 4038.2 109.533 1.09E+06 185.327 76.2812 19.7971 21 3.67622 
Wt 5 11955 4839.29 87.5757 1.05E+06 357.072 250.722 10.2494 21 3.35274 
Wt 6 1771 716.886 131.58 233029 458.623 101.809 14.5184 21 2.65556 
Wt 7 3285 1329.74 100.128 328922 444.549 353.646 19.0061 21 1.70837 
Wt 8 12159 4921.86 98.2656 1.19E+06 254.704 311.163 10.7201 21 4.09351 
Wt 9 7287 2949.72 111.578 813072 105.476 353.682 10.4304 21 4.39495 
Wt 10 10792 4368.51 103.222 1.11E+06 151.934 380.232 14.1374 21 3.2702 
          
Img No 
9 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS1-T3) 
Sum 
(ChS1-T3) Centroid X Centroid Y 
Centroid 
Z 
Min 
(Ch2-T1) 
Mean 
(Ch3-T2) 
Clone 
cell 2959 1197.78 63.8516 188937 119.635 395.084 19.2068 21 44.2143 
Wt 1 8979 3634.63 82.0533 736757 330.342 88.6629 18.2284 21 1.20314 
Wt 2 4541 1838.16 63.9176 290250 395.763 278.13 19.1956 21 1.39242 
Wt 3 9714 3932.15 113.691 1.10E+06 269.71 200.867 19.4888 21 1.31141 
Wt 4 7641 3093.01 77.3464 591004 340.994 344.606 23.8799 21 1.28452 
Wt 5 4596 1860.42 93.01 427474 356.205 253.341 30.3734 21 1.16819 
Wt 6 6544 2648.96 97.3046 636761 243.536 485.942 28.0254 21 1.24801 
Wt 7 7018 2840.83 113.345 795454 322.159 155.405 28.1386 21 1.2666 
Wt 8 1278 517.324 81.9116 104683 421.169 39.2199 9.53052 21 1.55634 
Wt 9 8085 3272.74 99.3396 803161 384.368 121.232 8.57069 21 2.02474 
Wt 10 11461 4639.32 90.9728 1.04E+06 264.649 266.729 9.1177 21 2.24317 
          
Average intensity of Mi-2 localization in 10 non adjacent wild type cells     
 Img 
No 1  88.4987        
 Img 
No 2  101.546        
 Img 
No 3  77.6035        
 Img 
No 4  78.9342        
 Img 
No 5  81.099        
 Img 
No 6  107.872        
 Img 
No 7  71.141        
 Img 
No 8  101.518        
 Img 
No 9  90.3224        
          
Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non adjacent wild type cells 
 Img 
No 1  1        
 Img 
No 2  1.32        
 Img 
No 3  0.639        
 Img 
No 4  1.18        
 Img 
No 5  1.08        
 Img 
No 6  0.93        
 Img 
No 7  0.82        
 Img 
No 8  0.83        
 Img 
No 9  0.7        
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Average value of the ratio of the clone cell V wild type cells acquired from Img No 1 to Img No 
10  0.944333   
Std Dev of the average ratio of clone cell / wild type cell  0.22356   
 
B.4. Study of the phenotype imparted by NOS in a Mi-2 down regulated background 
B.4.(i). Measurements of nuclei volume of third instar salivary glands from wild type larvae  
Img No 1 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 7392.91 184.623 62.4133 13.2324 21 
N 2 6476.06 163.611 266.174 14.2848 21 
N 3 5903.28 239.937 177.215 13.3151 21 
N 4 5236.18 324.832 376.693 10.6902 21 
N 5 5079.12 342.004 245.054 15.707 21 
N 6 3192.39 292.652 25.3614 19.7381 21 
N 7 3516.63 405.742 441.422 10.1335 21 
N 8 5390.81 112.81 201.254 21.928 21 
N 9 2401.83 307.634 119.887 21.0839 21 
N 10 3188.95 174.177 402.736 22.3257 21 
      
Img No 2 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 5315.32 173.843 97.7574 9.35172 21 
N 2 10406.4 141.609 187.206 18.0304 21 
N 3 5090.05 272.01 250.705 9.0499 21 
N 4 8198.45 195.354 292.501 20.8716 21 
N 5 8026.62 307.656 400.657 15.0082 21 
N 6 6941.37 361.455 300.488 19.2854 21 
N 7 7185.66 279.054 162.921 18.6745 21 
N 8 8201.89 420.55 388.435 13.3555 21 
N 9 7349.8 426.915 489.146 15.3673 21 
N 10 4896.16 278.384 70.0888 26.1336 21 
      
Img No 3 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 5680.65 348.15 315.296 24.0569 21 
N 2 6327.5 51.4387 279.789 21.3139 21 
N 3 5811.19 406.219 97.0093 30.7798 21 
N 4 6141.91 168.527 387.378 24.6353 21 
N 5 5950.44 101.468 476.957 39.4082 21 
N 6 5189.63 123.095 169.505 35.8173 21 
N 7 3561.97 491.827 311.984 48.9158 21 
N 8 6347.54 371.677 203.275 18.1129 21 
      
Img No 4 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 5466.92 192.708 57.3339 16.0009 21 
N 2 4704.09 111.849 157.832 22.7933 21 
N 3 5440.2 204.311 193.536 12.411 21 
N 4 6172.87 154.848 295.398 14.6124 21 
N 5 6384.17 242.095 407.061 11.6266 21 
N 6 5367.13 298.77 297.066 13.7222 21 
N 7 6701.93 294.665 36.7634 13.0157 21 
N 8 5646.64 338.983 135.82 21.5394 21 
N 9 4821.07 353.759 220.725 20.8775 21 
N 10 1935.11 137.172 400.752 24.9955 21 
      
Img No 5 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 6934.89 21 253.128 111.448 14.7375 
 160 
N 2 6394.09 21 362.816 99.4427 14.6919 
N 3 7140.12 21 198.271 215.018 16.9155 
N 4 3754.65 21 188.006 421.383 12.774 
N 5 4260.43 21 251.233 296.355 10.9383 
N 6 4223.39 21 133.607 346.366 14.0396 
N 7 4740.92 21 437.791 157.504 21.9969 
N 8 2815.12 21 48.8673 382.974 21.0347 
N 9 4601.27 21 219.32 75.9959 33.7449 
N 10 1784.32 21 141.027 178.63 31.9435 
      
Img No 6 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 4310.02 21 133.526 335.599 10.8968 
N 2 4395.63 21 156.845 145.17 7.59955 
N 3 3669.03 21 27.9704 99.8825 9.16119 
N 4 3828.52 21 381.691 242.988 7.59817 
N 5 4054.6 21 243.573 386.428 12.3903 
N 6 4311.44 21 133.202 335.269 10.9962 
N 7 3995.5 21 148.984 53.1881 14.3316 
N 8 2774.44 21 472.479 213.41 11.9706 
N 9 2205.31 21 271.298 161.912 10.8811 
N 10 2566.58 21 193.089 257.614 7.62077 
      
Img No 7 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 7384.62 21 143.994 395.659 12.1537 
N 2 7216.63 21 155.85 247.465 13.3592 
N 3 6974.76 21 331.468 313.02 10.6789 
N 4 7016.26 21 281.637 462.83 14.2638 
N 5 7164.81 21 234.994 107.399 13.4492 
N 6 7754.6 21 338.839 187.201 17.9582 
N 7 5792.37 21 477.918 289.286 15.0953 
N 8 5652.51 21 174.451 458.012 35.3182 
N 9 5324.63 21 211.633 206.052 35.0866 
N 10 5206.03 21 59.2358 68.0933 34.1458 
      
Img No 8 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 6789.17 21 227.709 429.976 27.9552 
N 2 4931.78 21 88.9654 345.386 16.1111 
N 3 6709.42 21 300.888 156.261 14.2303 
N 4 3670.65 21 131.348 169.486 31.2569 
N 5 5533.1 21 460.275 236.129 15.2697 
N 6 6973.75 21 348.75 351.129 15.5739 
N 7 4457.97 21 218.888 266.487 14.2436 
N 8 3713.76 21 131.442 169.522 31.3414 
N 9 5701.49 21 460.436 236.172 15.2821 
N 10 5126.69 21 89.1217 345.293 15.7753 
      
Img No 9 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 4568.07 21 382.479 343.711 9.46074 
N 2 4191.01 21 220.526 241.191 9.95398 
N 3 3746.75 21 292.332 100.682 18.6231 
N 4 4443.6 21 286.104 329.871 13.1107 
N 5 3856.86 21 412.016 480.994 13.0535 
N 6 3920.41 21 338.195 438.299 14.2308 
N 7 3085.73 21 132.521 218.755 15.9349 
 161 
N 8 4081.31 21 130.616 55.4287 7.79494 
N 9 4252.94 21 196.13 141.436 8.15095 
N 10 2705.02 21 475.44 378.325 18.3009 
      
Average value of the volume of the nuclei  5159.21225  
Standard deviation of the average value of the volume of nuclei 1697.29525  
 
B.4. (ii). Measurement of nuclei volume of third instars salivary glands from larvae where expression of NOS2 
was driven by c147-GAL4.  
 
Img No 1 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1522.55 41 244.779 213.433 43.6247 
N 2 1329.46 41 185.191 152.753 40.1936 
N 3 1711.61 41 137.567 173.921 43.6768 
N 4 1984.92 41 213.299 267.936 45.2282 
N 5 1834.97 41 137.659 174.177 44.1538 
N 6 2031.18 41 263.421 167.165 42.8309 
N 7 1560.76 41 143.657 239.146 45.0119 
N 8 1800.33 41 36.1984 324.419 48.094 
N 9 3553.72 41 46.8244 203.563 42.4571 
N 10 3336.5 41 63.3762 163.446 37.3709 
      
Img No 2 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1067.99 59 192.075 298.823 14.6717 
N 2 2325.94 59 23.3662 409.054 14.5086 
N 3 2222.92 59 52.8034 341.861 15.305 
N 4 2009.95 59 326.998 220.52 22.4067 
N 5 2378.24 59 111.542 294.466 14.5671 
N 6 1765.46 59 295.851 180.512 35.9847 
N 7 2014.86 59 144.031 247.78 23.286 
N 8 1468.46 59 275.005 319.513 15.7987 
N 9 1384.66 59 82.9254 389.643 17.7272 
N 10 2225.6 59 239.174 346.413 31.4921 
      
Img No 3 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 2326.17 54 168.53 317.908 21.0677 
N 2 2410.86 54 231.58 277.534 25.0113 
N 3 1749.37 54 366.311 62.1473 19.4075 
N 4 2615.57 54 241.401 187.072 25.3392 
N 5 1981.79 54 365.282 107.636 26.5575 
N 6 2400.36 54 192.328 252.292 30.8737 
N 7 2082.35 54 398.653 30.6933 32.0005 
N 8 1817.76 54 310.039 127.23 21.1892 
N 9 2365.28 54 291.94 95.8109 21.0841 
N 10 2779.82 54 316.614 170.353 25.435 
      
Img No 4 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 2141.55 221.835 231.965 10.3341 24 
N 2 1504.41 265.608 288.811 9.46522 24 
N 3 1510.48 310.009 398.346 10.8223 24 
N 4 848.444 281.599 355.814 10.1109 24 
N 5 1510.68 309.934 398.341 10.8624 24 
N 6 1223.48 333.68 336.51 11.736 24 
N 7 1778.86 341.873 426.232 24.8752 24 
N 8 1632.93 281.773 398.592 24.5212 24 
 162 
N 9 987.287 281.881 356.435 9.12567 24 
N 10 1068.65 211.889 305.849 8.23731 24 
      
Img No 5 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 2071.32 167.77 116.476 13.792 21 
N 2 1778.25 106.728 191.21 15.4284 21 
N 3 1846.26 148.98 199.722 20.0926 21 
N 4 1640.01 300.54 252.859 14.25 21 
N 5 1686.97 370.935 343.7 9.81188 21 
N 6 1596.9 377.391 241.794 10.949 21 
N 7 1352 132.154 145.402 6.45404 21 
N 8 1081.2 87.977 159.319 6.66323 21 
N 9 711.826 129.487 173.868 33.9949 21 
N 10 1702.35 370.822 343.89 9.66817 21 
      
Img No 6 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 1797.68 251.962 286.808 11.8194 27 
N 2 1331.56 297.985 296.409 14.3535 27 
N 3 1258.7 244.564 223.723 6.72053 27 
N 4 1337.63 289.835 251.012 7.45877 27 
N 5 1469.19 298.176 295.931 14.7169 27 
N 6 1540.64 379.404 353.367 9.16014 27 
N 7 1120.26 85.6596 87.1705 24.0573 27 
N 8 1407.26 209.729 244.35 8.97929 27 
N 9 1165.6 244.468 223.828 6.3768 27 
N 10 931.426 333.076 261.478 9.60083 27 
      
Img No 8 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 1586.58 180.663 263.931 29.8227 27 
N 2 1047.4 298.323 140.281 24.8696 27 
N 3 1309.3 251.569 127.378 27.5137 27 
N 4 1672.19 308.502 49.2699 21.6245 27 
N 5 1109.74 345.775 20.7137 9.09684 27 
N 6 1214.58 390.733 26.1601 22.3088 27 
N 7 1568.37 180.853 263.929 29.8022 27 
N 8 1009.55 133.978 456.476 17.8998 27 
N 9 1095.57 347.992 99.0028 13.9516 27 
N 10 749.472 253.244 241.904 18.2039 27 
      
Img No 10 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 864.23 247.53 99.9035 10.2581 27 
N 2 1303.43 277.212 181.476 10.5137 27 
N 3 1219.23 296.33 228.315 11.3315 27 
N 4 738.34 215.772 26.2484 8.99644 27 
N 5 752.913 207.24 55.7694 7.94462 27 
N 6 807.155 298.345 293.387 17.8771 27 
N 7 851.682 234.842 11.2548 19.3634 27 
N 8 1185.64 192.726 86.1758 10.7835 27 
N 9 755.139 260.511 425.365 25.5704 27 
N 10 653.941 289.169 332.272 27.2392 27 
      
Average valu of the vol of Nuclei  1582.3458  
SD of the Vol pf nuclei   584. 00291  
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B.4. (iii). Measurement of nuclei volume of third instars salivary glands from larvae where UAS-NOS2 and 
UAS-RNAi-Mi-2 were co expressed  
 
Img No 1 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 3986.82 61 239.637 265.088 14.0555 
N 2 3528.92 61 172.442 192.335 10.8894 
N 3 2382.93 61 103.148 155.158 23.7584 
N 4 2971.34 61 48.4228 186.801 22.6211 
N 5 2698.48 61 122.916 195.66 30.5372 
N 6 3557.08 61 335.168 356.703 21.4542 
N 7 2114.54 61 350.693 310.198 40.8691 
N 8 2118.56 61 37.3095 119.824 25.3175 
N 9 2168.62 61 282.156 295.969 23.2276 
N 10 1950.5 61 410.449 323.424 37.9448 
      
Img No 2 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 3033.47 59 277.004 232.537 38.0145 
N 2 1411.25 59 190.699 284.481 15.9017 
N 3 1791.16 59 208.676 318.957 24.4851 
N 4 1446.79 59 141.907 393.89 18.7702 
N 5 2671.44 59 252.089 238.4 23.3252 
N 6 1672.72 59 319.732 147.136 21.7733 
N 7 1598.53 59 277.918 176.804 24.2238 
N 8 1643.67 59 367.28 158.518 37.5753 
N 9 1256.61 59 183.925 355.491 18.4302 
N 10 1409.91 59 95.1 352.391 23.162 
      
Img No 3 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1917.21 66 308.656 383.369 34.5863 
N 2 1635.4 66 213.142 351.612 33.0872 
N 3 2375.78 66 213.603 332.035 16.8159 
N 4 2885.98 66 255.16 76.0026 19.1419 
N 5 1482.54 66 203.785 228.937 18.5222 
N 6 2083.02 66 145.879 234.486 20.6106 
N 7 1990.28 66 187.466 273.155 15.6353 
N 8 1139.51 66 140.847 110.113 24.109 
N 9 1031.79 66 183.594 201.111 34.9251 
N 10 1708.25 66 258.673 404.932 17.144 
      
Img No 4 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1710.27 58 264.115 286.457 13.7202 
N 2 2067.16 58 227.701 223.214 14.4211 
N 3 1619.76 58 222.132 296.817 20.9985 
N 4 995.141 58 297.569 392.06 32.8439 
N 5 1332.59 58 269.166 363.558 29.4496 
N 6 1587.8 58 320.02 331.003 14.4662 
N 7 1421.09 58 150.168 196.949 19.7691 
N 8 1758.54 58 100.157 91.7193 31.9328 
N 9 1942.68 58 34.4539 97.4881 14.7017 
N 10 1588.92 58 76.3816 27.1707 16.2954 
      
Img No 5 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1539.31 41 280.54 271.116 11.848 
N 2 2508.08 41 140.376 231.421 12.645 
 164 
N 3 1338.85 41 332.295 208.409 12.2752 
N 4 867.536 41 88.9222 185.98 13.8769 
N 5 2453.55 41 269.995 169.129 18.2892 
N 6 1097.27 41 339.855 258.532 33.4532 
N 7 1586.91 41 362.812 290.057 19.1901 
N 8 1049.89 41 151.399 262.969 27.1158 
N 9 503.493 41 475.577 207.299 14.5504 
N 10 1064.2 41 123.665 168.508 15.5672 
      
Img No 6 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1306.67 41 95.7809 154.518 38.7789 
N 2 1337.73 41 280.268 189.135 37.7917 
N 3 1004.97 41 50.062 157.284 40.1076 
N 4 2831.89 41 213.581 141.543 15.1555 
N 5 2656.24 41 460.72 227.784 16.0008 
N 6 2497.57 41 433.531 273.287 15.7185 
N 7 2031.18 41 213.76 212.449 15.8626 
N 8 1914.52 41 13.9623 139.78 39.6229 
N 9 1961.68 41 467.096 330.424 17.9294 
N 10 3231.92 41 302.628 302.848 23.1456 
      
Img No 8 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 1544.45 83 319.141 265.889 16.821 
N 2 1294.82 83 259.723 226.155 18.7829 
N 3 1045.2 83 327.666 297.269 29.5123 
N 4 1838.99 83 206.341 235.953 46.7877 
N 5 2060.23 83 279.614 251.311 15.4466 
N 6 975.252 83 155.384 214.06 18.0687 
N 7 1934.41 83 141.372 185.302 42.1862 
N 8 598.023 83 385.888 286.493 38.9638 
N 9 1354.71 83 34.0668 131.258 24.1579 
N 10 1295.49 83 259.641 226.169 18.7061 
      
Img No 10 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 3047.33 58 248.794 94.3459 27.2226 
N 2 2319.69 58 203.639 17.7687 28.9678 
N 3 2258.9 58 208.572 110.376 27.3783 
N 4 2616.02 58 272.332 213.598 24.8275 
N 5 2563.05 58 286.542 317.289 29.9609 
N 6 1551.6 58 258.568 343.251 21.1383 
N 7 2296.22 58 277.879 365.263 39.908 
N 8 2478.35 58 248.548 57.6103 42.5077 
N 9 1137.27 58 233.393 416.481 34.0586 
N 10 958.267 58 219.342 366.63 28.0128 
      
Average value of the volume of the nuclei   1870.484775 
Standard deviation of the average value of the volume of nuclei  712.7873072 
 
B.4. (iv). Measurement of nuclei volume of UAS-NOS2 over expressed third instar salivary glands from Mi-2 
transheterozygous mutants  
 
Img No 1 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 1264.57 151.398 163.05 11.6759 83 
N 2 525.217 98.0204 135.712 16.59 83 
N 3 964.416 315.98 213.998 12.1889 83 
 165 
N 4 501.335 363.956 178.846 14.3242 83 
N 5 816.87 269.761 181.878 16.2252 83 
N 6 1186.85 53.8404 153.808 24.9072 83 
N 7 559.625 123.267 136.279 29.0817 83 
N 8 384.957 293.258 165.13 21.0421 83 
N 9 947.415 269.236 227.45 16.1938 83 
N 10 1140.91 29.8923 123.82 36.9258 83 
      
Img No 2 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 1070.88 58 325.784 144.932 10.5381 
N 2 671.954 58 331.774 202.451 15.5455 
N 3 950.856 58 351.436 166.762 32.1237 
N 4 1543.07 58 369.591 184.294 11.8258 
N 5 1137.67 58 357.531 150.308 10.9338 
N 6 745.829 58 287.203 241.374 12.1251 
N 7 1032.42 58 346.684 230.457 11.8996 
N 8 1451.18 58 259.238 123.95 20.1165 
N 9 752.103 58 332.466 123.673 21.694 
N 10 890.137 58 362.439 230.081 25.0705 
      
      
Img No 5 Volume (µm³) Min (Ch2-T1) Centroid X Centroid Y Centroid Z 
N 1 2264.93 69 233.306 209.126 15.4465 
N 2 1348.68 69 384.339 257.447 16.8437 
N 3 1221.08 69 341.115 224.568 20.1746 
N 4 3511.49 69 108.96 169.536 40.7226 
N 5 3272.81 69 133.979 199.696 28.5379 
N 6 467.289 69 430.844 223.549 17.8761 
N 7 636.238 69 364.237 211.698 25.0414 
N 8 824.628 69 275.111 251.428 13.4702 
N 9 1517.63 69 202.523 183.707 32.6501 
N 10 1353.6 69 182.15 182.05 19.3107 
      
Img No 6 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 716.279 183.903 222.676 10.3815 100 
N 2 925.759 275.786 253.109 11.3778 100 
N 3 672.562 184.514 246.912 7.88173 100 
N 4 695.027 89.9822 211.354 8.79324 100 
N 5 1013.19 235.056 265.903 19.8881 100 
N 6 817.072 239.165 232.201 16.0037 100 
N 7 886.899 289.074 242.599 24.105 100 
N 8 651.31 262.325 248.629 25.8434 100 
N 9 854.515 335.27 279.541 13.8124 100 
N 10 804.119 165.724 259.404 15.9202 100 
      
Img No 7 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 583.103 245.501 144.981 21.5588 147 
N 2 445.878 181.003 103.956 18.7081 147 
N 3 946.606 241.951 247.724 18.5687 147 
N 4 891.351 196.074 319.252 19.3122 147 
N 5 993.764 159.474 341.37 21.9662 147 
N 6 764.854 103.873 347.881 28.4686 147 
N 7 775.986 210.309 222.745 13.2287 147 
N 8 745.626 231.434 95.9894 8.04425 147 
 166 
N 9 643.012 206.802 101.03 7.38621 147 
N 10 573.995 181.848 86.5628 7.58956 147 
      
Img No 8 Volume (µm³) Centroid X Centroid Y Centroid Z Min (Ch2-T2) 
N 1 1016.43 165.904 235.754 19.725 65 
N 2 1340.06 155.921 159.901 22.9227 65 
N 3 1381.35 308.522 303.116 20.5519 65 
N 4 1632.53 261.83 223.865 13.7104 65 
N 5 1190.09 125.666 179.863 8.41071 65 
N 6 2088.32 86.2031 112.925 11.4595 65 
N 7 2041.36 268.478 317.905 6.00991 65 
N 8 933.45 347.272 377.367 4.70512 65 
N 9 831.24 57.4069 129.298 20.3073 65 
N 10 1916.69 211.563 164.804 13.2357 65 
      
Img No 9 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 1303.23 61 263.096 320.657 24.0311 
N 2 1356.86 61 216.733 288.807 25.3082 
N 3 1345.12 61 270.31 295.422 12.8562 
N 4 868.886 61 244.66 271.792 9.52248 
N 5 1413.13 61 233.237 210.828 26.4258 
N 6 1385.8 61 195.178 179.957 28.0022 
N 7 1381.96 61 180.147 225.401 11.779 
N 8 1193.33 61 150.863 215.536 17.5293 
N 9 1314.56 61 195.23 179.934 27.9812 
N 10 852.087 61 286.283 359.121 19.6059 
      
Img No 10 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 1357.67 96 248.413 332.241 33.3904 
N 2 2986.55 96 183.341 252.096 26.8399 
N 3 2042.38 96 285.452 311.686 37.4758 
N 4 2562.33 96 269.043 268.498 17.7375 
N 5 1919.52 96 313.812 353.326 23.9146 
N 6 1136.66 96 278.72 371.32 40.9801 
N 7 2062.21 96 306.255 457.673 34.974 
N 8 960.976 96 331.223 435.557 23.007 
N 9 1231.58 96 327.372 463.297 25.6687 
N 10 2234.45 96 121.456 161.552 14.6901 
      
Average value of the volume of the nuclei   1195.479438 
Standard deviation of the average value of the volume of nuclei  621.2223307 
 
B.4. (v). Measurement of nuclei volume of third instar salivary glands from Mi-2 transheterozygous mutants  
 
Img No 1 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 5284.15 46 339.143 342.411 10.6727 
N 2 4749.42 46 382.36 107.7 14.7634 
N 3 5255.01 46 240.829 397.543 17.1951 
N 4 5590.58 46 338.864 342.288 10.994 
N 5 6033.83 46 92.3254 480.879 11.0765 
N 6 3420.49 46 494.129 32.0604 17.9116 
N 7 5166.76 46 138.03 223.444 16.3266 
N 8 5684.49 46 254.865 171.762 13.9235 
N 9 4882.8 46 408.516 272.056 14.8096 
N 10 2300.03 46 450.333 483.4 22.5701 
      
Img No 3 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
 167 
N 1 5831.03 27 347.11 157.802 10.9839 
N 2 5145.31 27 36.6176 217.464 11.1124 
N 3 5641.18 27 197.054 205.976 10.0017 
N 4 5791.76 27 192.117 298.453 10.8653 
N 5 4183.12 27 465.67 220.114 7.34198 
N 6 4440.16 27 143.412 358.859 17.3444 
N 7 4689.51 27 29.0318 311.699 9.1678 
N 8 3910.69 27 423.951 70.3383 18.8939 
N 9 3556.7 27 288.942 331.97 24.402 
N 10 3637.46 27 100.797 170.774 25.9245 
      
Img No 4 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 4588.11 24 78.683 207.195 13.6887 
N 2 4891.3 24 341.522 233.853 10.1584 
N 3 4730.6 24 411.83 163.321 13.8161 
N 4 5218.37 24 335.79 440.364 15.9222 
N 5 4598.64 24 137.842 109.387 15.0939 
N 6 5239.02 24 240.165 287.727 15.4292 
N 7 4096.29 24 454.907 377.652 20.3982 
N 8 3964.33 24 475.186 119.927 36.143 
N 9 2376.53 24 216.954 80.6753 38.5052 
N 10 4746.59 24 197.875 478.598 11.7008 
      
Img No 5 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 5960.56 24 168.774 397.1 11.3218 
N 2 5711.81 24 282.327 329.973 6.58566 
N 3 6257.68 24 358.172 174.415 9.58228 
N 4 5557.79 24 294.93 49.2474 7.48263 
N 5 6167.61 24 276.838 480.986 10.9611 
N 6 5113.53 24 411.27 95.9673 15.4703 
N 7 4073.82 24 229.791 78.1601 29.4461 
N 8 6079.57 24 213.898 146.529 13.9651 
N 9 8586.85 24 355.885 370.515 25.5645 
N 10 4317.71 24 186.662 349.131 24.7128 
      
Img No 6 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 5101.79 24 329.907 274.881 33.1215 
N 2 4849.61 24 335.743 108.233 34.2701 
N 3 5006.87 24 119.597 236.029 31.0753 
N 4 4490.76 24 182.845 330.091 31.8416 
N 5 4458.98 24 335.299 108.005 33.9479 
N 6 5436.15 24 29.3824 241.579 24.3285 
N 7 3336.9 24 171.181 414.014 25.0283 
N 8 5866.65 24 266.067 65.4116 23.9173 
N 9 6427.49 24 186.582 212.695 12.1873 
N 10 3115.48 24 446.786 101.838 11.6269 
      
Img No 7 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 5176.27 24 111.124 153.643 11.7426 
N 2 4303.54 24 352.363 119.694 20.3326 
N 3 4509.18 24 242.531 200.084 14.7969 
N 4 5083.37 24 166.161 273.131 11.8575 
N 5 4830.99 24 348.61 27.3797 12.1967 
N 6 5471.57 24 237.377 386.926 12.1557 
N 7 3423.12 24 88.007 359.712 27.994 
N 8 2912.27 24 454.945 51.5696 30.513 
N 9 4815.4 24 83.9389 472.5 10.4827 
N 10 3773.67 24 221.68 485.579 26.2701 
      
Img No 8 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 6750.31 24 177.08 65.1586 12.0069 
N 2 6299.77 24 189.472 322.661 12.0355 
 168 
N 3 6185.83 24 121.831 429.633 12.3676 
N 4 5779.41 24 312.157 39.4423 11.7621 
N 5 5653.73 24 100.419 142.733 21.2535 
N 6 3527.96 24 363.988 136.551 13.6011 
N 7 5060.3 24 22.6492 310.445 12.2637 
N 8 6734.72 24 120.521 229.398 11.9996 
N 9 4538.53 24 90.3875 268.31 27.7173 
N 10 6062.36 24 304.71 246.137 11.0996 
Img No 9 Volume (µm³) Min (Ch2-T2) Centroid X Centroid Y Centroid Z 
N 1 6777.63 24 210.762 228.464 8.14379 
N 2 4240.19 24 302.81 213.304 12.7124 
N 3 5709.39 24 330.52 312.057 6.84228 
N 4 5096.53 24 57.8488 252.934 22.0597 
N 5 4306.17 24 138.081 101.968 9.61722 
N 6 4859.12 24 162.511 157.64 28.1226 
N 7 3888.63 24 314.969 236.368 22.5831 
N 8 4137.98 24 210.887 128.841 15.0736 
N 9 4133.33 24 445.687 483.852 9.32005 
N 10 4155.59 24 276.422 403.987 8.73183 
Average value of the volume of the nuclei  4921.984125  
Standard deviation of the average value of the 
volume of nuclei   1067.258082  
 
 
B.5. Analysis of the effect of FOXO expression in the whole salivary glands of YFP tagged Mi-2CPTI-000232. 
Cont A      
Name Voxel Count Volume (ｵ m ｳ) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 15 31881 5202.38 24.425 36.0363 1.15E+06 
Object 13 32314 5273.04 22.5145 41.6159 1.34E+06 
Object 12 24634 4019.81 20.5255 38.193 940846 
Object 10 31780 5185.9 19.8668 40.1613 1.28E+06 
Object 8 31251 5099.58 19.5871 38.9346 1.22E+06 
Object 5 29409 4799 17.4124 39.0328 1.15E+06 
Object 3 32159 5247.75 16.8994 41.5338 1.34E+06 
Object 6 30833 5031.37 16.8562 45.1009 1.39E+06 
Object 2 32521 5306.82 15.4246 41.4935 1.35E+06 
      
Expt A      
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 61 1913 312.166 75.7156 98.0831 187633 
Object 59 2063 336.643 70.5177 66.0388 136238 
Object 54 3474 566.892 66.8601 106.03 368348 
Object 57 5210 850.175 66.3315 84.7261 441423 
      
ContB       
Name Voxel Count Volume (ｵ m ｳ) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 48 37761 6161.89 70.0909 104.61 3.95E+06 
Object 45 40668 6636.26 70.0565 93.6996 3.81E+06 
Object 43 46486 7585.65 69.8131 109.71 5.10E+06 
Object 44 44879 7323.42 68.6141 119.723 5.37E+06 
Object 41 42676 6963.93 67.9987 94.108 4.02E+06 
Object 42 43156 7042.25 66.5385 103.563 4.47E+06 
Object 40 46822 7640.48 66.4077 74.1274 3.47E+06 
Object 39 40866 6668.57 65.4502 99.4989 4.07E+06 
Object 38 59577 9721.86 63.4074 94.5012 5.63E+06 
Object 36 29626 4834.41 62.97 84.0115 2.49E+06 
Object 35 42979 7013.37 60.8811 75.4185 3.24E+06 
      
 169 
Expt B      
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 48 2174 354.756 76.8878 64.6375 140522 
Object 49 7699 1256.33 74.6084 73.5711 566424 
Object 44 5631 918.874 71.5212 58.4218 328973 
Object 47 5594 912.837 70.5694 70.1144 392220 
Object 46 2942 480.08 69.4585 71.9643 211719 
Object 45 4654 759.446 69.2293 69.2295 322194 
Object 41 1922 313.635 68.6514 64.5812 124125 
Object 43 3900 636.407 67.188 69.6141 271495 
      
Cont C      
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 26 38109 6218.68 70.9409 46.5116 1.77E+06 
Object 27 34794 5677.73 70.254 42.448 1.48E+06 
Object 25 35241 5750.67 67.1465 36.7517 1.30E+06 
Object 24 37213 6072.47 63.5125 28.484 1.06E+06 
Object 23 38724 6319.03 60.9162 42.7212 1.65E+06 
      
Expt C      
Name Voxel Count Volume (ｵ m ｳ) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 88 5105 833.041 78.8641 73.7324 376404 
Object 95 9783 1596.4 77.8684 91.096 891192 
Object 93 2298 374.991 76.2245 59.1131 135842 
Object 91 4298 701.353 75.617 91.1519 391771 
Object 92 1870 305.149 75.3305 27.9754 52314 
Object 86 2746 448.096 71.8245 33.2436 91287 
Object 90 4767 777.886 71.0755 87.935 419186 
Object 87 7059 1151.9 70.9168 95.5135 674230 
Object 83 2286 373.033 70.5717 64.4654 147368 
Object 82 1614 263.375 69.6729 35.1846 56788 
      
Cont D      
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 26 39348 6420.86 67.1587 54.3412 2.14E+06 
Object 25 35681 5822.47 66.6211 48.5976 1.73E+06 
Object 23 39793 6493.48 58.7591 53.2384 2.12E+06 
Object 22 33547 5474.25 57.272 44.3536 1.49E+06 
      
Exp D      
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 35 6505 1061.49 32.7244 97.5127 634320 
Object 29 2694 439.611 31.3486 72.3589 194935 
Object 34 2754 449.401 30.7197 66.4942 183125 
Object 23 1041 169.872 30.4947 35.2968 36744 
Object 14 1470 239.877 29.0156 36.732 53996 
      
Cont E      
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 33 42655 17266.4 130.502 115.714 4.94E+06 
Object 35 43472 17597.1 129.228 128.01 5.56E+06 
Object 34 50963 20629.4 128.573 77.4575 3.95E+06 
      
Expt E      
 170 
Name Voxel Count Volume (µm³) Centroid Z Mean (Ch3-T1) Sum (Ch3-T1) 
Object 58 4782 1935.71 57.2279 89.8137 429489 
Object 59 6375 2580.55 55.3074 87.9973 560983 
Object 54 3786 1532.54 53.3761 74.5343 282187 
Object 57 5453 2207.33 53.2536 80.0776 436663 
Object 55 4457 1804.16 52.188 77.3177 344605 
Object 53 6212 2514.57 49.3158 66.9316 415779 
Ratio of average intensity of YFP tagged Mi-2 in Experimental A/ Control A  2.2 
Ratio of average intensity of YFP tagged Mi-2 in Experimental B/ Control B  0.7 
Ratio of average intensity of YFP tagged Mi-2 in Experimental C / Control C  1.67 
Ratio of average intensity of YFP tagged Mi-2 in Experimental D / Control D  1.23 
Ratio of average intensity of YFP tagged Mi-2 in Experimental E / Control E  0.74 
Average value of the ratio of 5 experimental / 5 control salivary glands  1.308 
 
B.6. Visualization of endogenous Mi-2 protein in a single cell clones expressing FOXO  
For the data of Visualization of Mi-2 protein in GFP marked control clone cells refer Appendix No B.2 (i) 
B.6. (i) Visualization of Mi-2 protein in single cell clones expressing FOXO 
Img No 1 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS2-
T2) 
Sum 
(ChS2-T2) 
Mean (Ch3-
T3) 
Min (Ch2-
T4) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 5926 2398.8 49.6775 294389 75.1618 26 283.728 279.731 14.5257 
Wt 1 12524 5069.61 51.9359 650445 1.75591 26 204.025 453.549 16.7442 
Wt 2 11915 4823.09 51.2926 611151 1.8073 26 200.822 373.802 15.6193 
Wt 3 5783 2340.91 71.452 413207 4.53761 26 367.516 484.065 16.9395 
Wt 4 11616 4702.06 45.6989 530839 1.19249 26 146.313 140.711 19.3238 
Wt 5 11405 4616.65 51.7989 590766 1.81482 26 200.966 373.643 15.7554 
Wt 6 12158 4921.46 59.2497 720358 1.899 26 244.909 174.154 13.7122 
Wt 7 9716 3932.96 49.2633 478642 1.40675 26 320.911 243.523 19.2008 
Wt 8 6781 2744.89 86.3367 585449 1.36794 26 256.284 65.1146 16.5195 
Wt 9 8147 3297.84 36.0713 293873 1.04812 26 167.601 280.355 25.001 
Wt 10 4494 1819.13 44.3981 199525 1.45972 26 347.175 321.852 24.9395 
          
Img No 2 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS2-
T2) 
Sum 
(ChS2-T2) 
Mean (Ch3-
T3) 
Min (Ch2-
T4) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 4031 1631.72 56.3659 227211 54.2803 26 411.026 344.151 16.6075 
Wt 1 7965 3224.17 162.892 1.30E+06 0.283365 26 57.1547 185.962 9.78293 
Wt 2 12462 5044.51 50.2859 626663 0.179024 26 263.574 372.198 14.1944 
Wt 3 11982 4850.21 57.0273 683301 0.13345 26 319.826 254.969 12.526 
Wt 4 13807 5588.96 96.4381 1.33E+06 0.176505 26 234.058 246.358 9.52937 
Wt 5 10972 4441.38 72.4608 795040 0.155031 26 190.322 309.921 13.5886 
Wt 6 6730 2724.25 77.8829 524152 0.175632 26 133.884 323.739 18.3195 
Wt 7 6233 2523.07 43.3003 269891 0.0657789 26 261.776 223.175 27.1943 
Wt 8 2222 899.447 149.495 332178 0.30333 26 23.5603 122.674 10.7259 
Wt 9 3811 1542.66 94.7798 361206 0.160588 26 47.8061 309.798 21.6106 
Wt 10 5549 2246.19 132.363 734480 0.11876 26 145.192 174.409 19.0674 
          
Img No 3 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS2-
T2) 
Sum 
(ChS2-T2) 
Mean (Ch3-
T3) 
Min (Ch2-
T4) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 6309 2553.83 65.1783 411210 33.119 26 228.382 236.142 6.49152 
Wt 1 9874 3996.91 31.3227 309280 0.632874 26 228.931 458.284 4.37108 
Wt 2 12115 4904.05 32.2943 391246 0.758729 26 265.294 373.192 4.5319 
Wt 3 11272 4562.81 43.4707 490002 0.818045 26 222.045 135.728 5.56441 
Wt 4 11185 4527.6 93.7366 1.05E+06 0.77139 26 239.796 70.0352 10.0338 
Wt 5 11076 4483.47 45.278 501499 0.660437 26 304.409 140.721 5.87306 
Wt 6 6704 2713.72 133.328 893830 0.832339 26 373.837 16.761 9.53058 
 171 
Wt 7 6182 2502.42 55.3874 342405 0.686024 26 355.403 193.393 4.02491 
Wt 8 1539 622.975 25.575 39360 0.649123 26 360.851 396.452 1.19883 
Wt 9 8229 3331.03 18.2867 150481 0.421801 26 283.387 454.664 8.75987 
Wt 10 2639 1068.25 40.0955 105812 0.660856 26 321.793 261.483 9.21448 
          
Img No 4 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-
T2) 
Mean 
(ChS2-T2) 
Sum (ChS2-
T2) 
Mean 
(Ch3-T3) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 10468 4237.36 33 106.383 1.11E+06 83.4519 452.46 327.76 45.6859 
Wt 1 10131 4100.95 33 72.2375 731838 0.657191 246.275 213.674 42.5127 
Wt 2 13212 5348.11 33 78.3427 1.04E+06 0.859824 183.799 155.159 31.8678 
Wt 3 14576 5900.24 33 82.0093 1.20E+06 0.79871 331.533 233.046 36.0607 
Wt 4 19480 7885.34 33 98.6917 1.92E+06 1.4098 255.995 194.506 12.9562 
Wt 5 20915 8466.22 33 95.0971 1.99E+06 1.89716 177.245 213.141 7.78982 
Wt 6 12057 4880.57 33 84.9721 1.02E+06 1.63291 375.39 339.631 10.0046 
Wt 7 10045 4066.13 33 74.0866 744200 1.60627 471.267 414.628 11.513 
Wt 8 15079 6103.85 33 86.6016 1.31E+06 1.66072 119.862 266.294 8.96518 
Wt 9 12232 4951.41 33 84.4053 1.03E+06 1.63309 374.928 339.581 9.88645 
Wt 10 16867 6827.62 33 94.3196 1.59E+06 1.11282 402.08 278.675 26.2702 
          
Img No 5 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-
T2) 
Mean 
(ChS2-T2) 
Sum (ChS2-
T2) 
Mean 
(Ch3-T3) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 12821 5189.84 27 56.7188 727192 111.852 231.773 389.54 8.53288 
Wt 1 13638 5520.55 27 59.5908 812700 0.557633 201.071 218.046 13.4928 
Wt 2 16085 6511.08 27 80.3816 1.29E+06 0.870314 20.8121 80.8275 7.58781 
Wt 3 14627 5920.89 27 56.4721 826017 0.353388 312.262 180.041 16.2528 
Wt 4 15047 6090.9 27 66.1061 994698 0.585034 140.411 321.212 11.163 
Wt 5 12858 5204.81 27 59.7763 768604 0.449603 305.727 478.685 15.1924 
Wt 6 11386 4608.96 27 49.2402 560649 0.259441 354.742 359.779 17.6587 
Wt 7 12724 5150.57 27 56.8402 723235 0.541889 101.507 236.225 14.9732 
Wt 8 11370 4602.48 27 74.0076 841466 2.08971 201.332 431.815 11.537 
Wt 9 13420 5432.31 27 55.9759 751197 0.466841 220.797 102.485 15.3709 
Wt 10 1875 758.985 27 45.9237 86107 0.149333 368.123 255.357 30.992 
          
Img No 6 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS2-
T2) 
Sum 
(ChS2-T2) 
Mean (Ch3-
T3) 
Min (Ch2-
T4) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 6140 2485.42 68.6511 421518 55.8936 27 234.257 189.536 10.3487 
Wt 1 7019 2841.23 133.959 940260 1.24605 27 228.804 369.427 11.5736 
Wt 2 9267 3751.21 54.647 506414 0.727959 27 299.465 331.77 15.0627 
Wt 3 7951 3218.5 58.8676 468056 1.59401 27 337.06 60.5629 16.0509 
Wt 4 7673 3105.97 18.1108 138964 1.01251 27 371.73 211.195 13.9253 
Wt 5 5684 2300.84 91.8812 522253 0.937544 27 295.445 499.28 13.1816 
Wt 6 5337 2160.37 92.6457 494450 2.3961 27 236.2 14.2147 12.1447 
Wt 7 5317 2152.28 22.1896 117982 0.484484 27 293.854 419.962 30.2915 
Wt 8 5831 2360.34 26.6892 155625 0.526325 27 174.058 221.053 29.2072 
Wt 9 6359 2574.07 121.351 771668 0.980657 27 191.514 460.05 16.1038 
Wt 10 4472 1810.23 59.2339 264894 0.58229 27 168.235 330.141 27.0485 
          
Img No 8 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS2-
T2) 
Sum 
(ChS2-T2) 
Mean (Ch3-
T3) 
Min (Ch2-
T4) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 1421 525.06 57.3983 81563 134.306 21 355.334 251.882 37.0591 
Wt 1 12325 4554.09 63.5747 783558 1.10166 21 186.894 168.546 31.925 
Wt 2 13543 5004.14 65.0744 881303 0.594846 21 240.414 264.086 34.618 
Wt 3 12054 4453.96 43.7328 527155 0.388087 21 154.396 328.9 29.5766 
Wt 4 13875 5126.82 51.9299 720527 1.89477 21 145.61 132.192 20.7063 
 172 
Wt 5 17071 6307.74 69.2098 1.18E+06 1.63828 21 286.289 236.095 14.8433 
Wt 6 11560 4271.42 57.446 664076 1.96765 21 166.577 240.912 16.2061 
Wt 7 15473 5717.28 75.304 1.17E+06 0.760551 21 343.064 314.831 14.6899 
Wt 8 15948 5892.79 52.7918 841924 0.364623 21 305.497 387.945 22.9689 
Wt 9 15229 5627.12 68.4596 1.04E+06 1.12732 21 355.36 217.359 21.9091 
Wt 10 12201 4508.27 45.6923 557492 0.304319 21 406.471 262.782 28.7749 
          
Img No 9 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-
T2) 
Mean 
(ChS2-T2) 
Sum (ChS2-
T2) 
Mean 
(Ch3-T3) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 1956 791.773 30 56.7459 110995 161.799 370.33 218.358 7.32515 
Wt 1 9076 3673.89 30 73.0263 662787 1.43643 61.1887 172.685 12.9802 
Wt 2 14497 5868.27 30 63.2197 916496 1.60833 141.671 329.52 8.1143 
Wt 3 12837 5196.31 30 63.4625 814668 1.62102 243.821 338.514 11.4434 
Wt 4 10809 4375.39 30 71.3652 771386 1.6786 163.418 228.284 11.5409 
Wt 5 6680 2704.01 30 49.0921 327935 1.42051 153.951 408.168 14.6097 
Wt 6 14115 5713.64 30 98.0985 1.38E+06 1.53688 409.208 131.858 14.9501 
Wt 7 12282 4971.65 30 71.975 883997 2.01124 316.695 175.099 12.331 
Wt 8 7470 3023.79 30 74.2779 554856 1.06747 347.933 119.697 29.0462 
Wt 9 5310 2149.44 30 54.1989 287796 1.40904 35.2719 438.408 26.3774 
Wt 10 6647 2690.65 30 49.1405 326637 1.43719 153.926 408.087 14.6597 
          
Img No 10 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS2-
T2) 
Sum 
(ChS2-T2) 
Mean (Ch3-
T3) 
Min (Ch2-
T4) 
Centroid 
X Centroid Y 
Centroid 
Z 
Clone cell 12652 5121.43 20.3615 257614 24.4991 30 230.162 220.64 12.8897 
Wt 1 13263 5368.75 56.0877 743891 2.83314 30 259.755 389.231 11.2082 
Wt 2 12012 4862.36 27.1879 326581 1.14311 30 142.511 265.623 12.9088 
Wt 3 13311 5388.18 38.6086 513919 2.18894 30 315.96 294.045 13.314 
Wt 4 12435 5033.59 21.1697 263245 1.17982 30 268.577 52.6897 15.3642 
Wt 5 11803 4777.76 25.4222 300058 1.16242 30 294.699 131.011 18.4865 
Wt 6 8203 3320.51 16.8342 138091 1.69657 30 108.99 34.6136 12.7791 
Wt 7 12843 5198.74 90.3843 1.16E+06 2.02281 30 307.408 438.677 17.1863 
Wt 8 8344 3377.58 71.7765 598903 2.51953 30 431.846 343.675 13.3842 
Wt 9 10357 4192.43 38.7801 401645 1.08999 30 148.415 322.919 23.2528 
Wt 10 10806 4374.18 52.9699 572393 2.4777 30 217.675 375.933 24.7906 
          
Average intensity of Mi-2 localization in 10 non adjacent wild type cells      
Img No 1 
54.749
74         
Img No 2 
93.692
51         
Img No 3 
51.877
49         
Img No 4 
85.076
35         
Img No 5 
60.431
45         
Img No 6 
67.957
5         
Img No 8 
59.321
53         
Img No 9 
66.785
66         
Img No 10 
43.922
11         
          
Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non adjacent wild type cells  
Img No 1 0.9         
Img No 2 0.6         
Img No 3 1.26         
Img No 4 1.25         
 173 
Img No 5 0.94         
Img No 6 1.01         
Img No 8 0.97         
Img No 9 0.85         
Img No 10 0.46         
          
Average value of the ratio of the clone cell V wild type cells acquired from 
Img No 1 to Img No 10  0.91555556    
Std Dev of the average ratio of clone cell / wild type cell  0.26330169    
 
B.7.Visualization of Dref protein in a single cell clones expressing FOXO 
B.7 (i) Visualization of Dref protein in GFP marked control clone cells 
  
Img 
No 1 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 12537 5074.87 377.334 278.797 17.5966 77.1832 967646 27.3561 28  
Wt 1 9483 3838.64 359.095 81.8614 20.5164 54.1479 513485 2.68544 28  
Wt 2 11642 4712.59 263.146 193.081 13.9042 63.9853 744917 2.60651 28  
Wt 3 12018 4864.79 185.698 393.332 11.9659 35.7308 429413 3.42802 28  
Wt 4 12489 5055.44 182.309 274.892 13.9064 30.7777 384383 2.53503 28  
Wt 5 11620 4703.68 348.397 462.126 16.0906 52.1121 605543 3.6432 28  
Wt 6 10615 4296.86 327.269 152.408 18.7703 91.6864 973251 2.45455 28  
Wt 7 4020 1627.26 151.026 189.678 28.4408 5.951 23923 1.17438 28  
Wt 8 10639 4306.58 245.377 12.1003 18.4738 64.1035 681997 2.30228 28  
Wt 9 10148 4107.83 192.637 104.298 21.6854 46.2587 469433 2.01537 28  
Wt 10 10976 4442.99 253.629 500.166 12.9804 39.9289 438260 4.80603 28  
           
Img 
No 2 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 13725 5555.77 189.211 278.667 10.508 110.242 1.51E+06 18.7746 28  
Wt 1 8595 3479.19 48.7956 106.63 9.33426 102.433 880409 2.82664 28  
Wt 2 12677 5131.55 331.792 442.478 13.3376 43.1782 547370 2.07675 28  
Wt 3 10986 4447.04 92.478 210.866 9.60304 26.8934 295451 2.429 28  
Wt 4 10355 4191.62 164.653 464.446 13.6862 42.1197 436150 2.14505 28  
Wt 5 13742 5562.65 207.951 167.658 13.5564 112.788 1.55E+06 2.53631 28  
Wt 6 12488 5055.04 331.826 442.486 13.3804 43.5698 544100 2.09241 28  
Wt 7 2683 1086.06 248.127 42.8763 27.1979 38.9307 104451 2.83451 28  
Wt 8 7437 3010.44 302.292 228.063 22.551 21.6669 161137 1.53315 28  
Wt 9 1598 646.857 99.3811 299.512 27.1658 17.0663 27272 1.38173 28  
Wt 10 4257 1723.2 116.315 8.9495 15.1607 83.373 354919 2.74395 28  
           
Img 
No 3 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 13213 5348.51 125.298 81.419 15.3995 48.1247 635872 34.6765 28  
Wt 1 13557 5487.76 272.629 473.451 16.8263 59.3622 804773 3.89341 28  
Wt 2 12663 5125.88 332.65 285.733 19.6825 36.6146 463651 3.33112 28  
Wt 3 10549 4270.15 205.935 138.755 25.9397 28.2233 297728 2.73514 28  
Wt 4 9423 3814.35 22.5627 62.1387 11.9434 57.7552 544227 4.76992 28  
Wt 5 9954 4029.3 423.482 439.749 17.879 28.3051 281749 3.36528 28  
Wt 6 13952 5647.65 352.733 392.638 14.9992 39.9717 557685 3.80275 28  
Wt 7 14209 5751.69 255.721 359.249 14.0899 33.7422 479443 3.90647 28  
Wt 8 12965 5248.13 223.967 242.7 17.0882 39.3606 510310 3.77817 28  
Wt 9 10167 4115.52 52.3317 184.29 16.9343 33.5659 341264 3.49641 28  
Wt 10 13705 5547.67 163.323 346.92 15.7745 79.6242 1.09E+06 4.40803 28  
           
Img 
No 4 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 12393 5016.58 108.779 79.0319 15.1173 37.8518 469097 23.1597 28  
 174 
cell 
Wt 1 14981 6064.19 197.87 193.63 12.981 74.4835 1.12E+06 4.59182 28  
Wt 2 12747 5159.88 335.364 247.105 27.2068 24.0705 306827 3.12921 28  
Wt 3 11589 4691.13 413.58 369.367 22.9555 36.9629 428363 4.83001 28  
Wt 4 13575 5495.05 190.161 94.3954 11.811 62.1421 843579 4.15263 28  
Wt 5 11433 4627.98 129.733 165.207 17.2416 52.388 598952 4.05528 28  
Wt 6 14141 5724.16 267.585 184.327 15.5676 39.9018 564252 3.84697 28  
Wt 7 13774 5575.6 281.987 347.258 34.2766 47.3772 652574 3.67076 28  
Wt 8 9289 3760.11 180.812 238.778 35.0764 49.5626 460387 3.08752 28  
Wt 9 12298 4978.13 374.037 449.507 28.541 42.649 524498 4.85046 28  
Wt 10 6874 2782.54 237.471 116.882 34.1138 6.31001 43375 2.08525 28  
           
Img 
No 5 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 12826 5191.86 173.872 81.2192 21.6187 45.5204 583845 19.6176 28  
Wt 1 10794 4369.32 78.6402 14.7472 18.6827 45.2675 488617 5.03178 28  
Wt 2 11401 4615.03 182.806 363.443 26.6431 36.6784 418171 3.53294 28  
Wt 3 14528 5880.81 229.126 178.723 19.6211 36.1043 524523 3.9046 28  
Wt 4 12214 4944.13 275.857 287.76 23.5419 56.863 694525 4.09694 28  
Wt 5 7398 2994.65 81.1825 241.192 29.8727 28.7931 213011 2.92985 28  
Wt 6 3642 1474.25 36.8671 106.013 31.9822 46.1735 168164 3.37534 28  
Wt 7 13518 5471.97 125.319 161.095 17.9872 44.2779 598548 4.8866 28  
Wt 8 12292 4975.7 272.964 394.309 17.8211 82.228 1.01E+06 4.582 28  
Wt 9 3882 1571.4 225.233 463.533 32.5546 21.797 84616 2.21381 28  
Wt 10 10309 4173 78.5861 15.5431 18.9176 43.5723 449187 4.97934 28  
           
Img 
No 6 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 9718 3933.77 47.8345 464856 21.0777 28 407.54 314.64 
32.38
3  
Wt 1 17097 6920.72 87.5692 1.50E+06 6.47851 28 220.61 167.898 
16.31
6  
Wt 2 16241 6574.22 49.1439 798146 6.56659 28 215.256 253.571 
12.89
1  
Wt 3 16129 6528.89 61.9761 999613 6.64145 28 282.787 333.176 
13.36
8  
Wt 4 17725 7174.93 67.6987 1.20E+06 7.78307 28 374.625 404.233 
11.28
2  
Wt 5 6514 2636.81 42.6131 277582 4.42247 28 145.116 27.6939 
22.49
8  
Wt 6 4268 1727.65 46.8639 200015 3.84372 28 137.837 252.253 
24.18
2  
Wt 7 9174 3713.56 30.2893 277874 5.12666 28 301.379 397.25 32.33  
Wt 8 7365 2981.29 34.802 256317 4.82811 28 96.6781 173.173 
18.24
2  
Wt 9 10700 4331.27 36.9605 395477 3.95178 28 287.512 217.1 
32.57
8  
           
Img 
No 7 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 14826 6001.44 347.137 309.923 12.676 51.0206 756432 27.1224 28  
Wt 1 13007 5265.13 176.885 245.89 12.1716 55.505 721954 9.55155 28  
Wt 2 10132 4101.35 135.929 67.8035 14.0436 65.776 666442 11.5214 28  
Wt 3 14354 5810.38 210.721 138.556 11.5438 65.1238 934787 11.2294 28  
Wt 4 9144 3701.42 213.131 310.724 26.0844 38.6873 353757 6.4591 28  
Wt 5 11801 4776.95 279.501 135.065 23.8101 48.6785 574455 7.79951 28  
Wt 6 13859 5610.01 356.079 203.892 12.7502 58.2612 807442 9.22231 28  
Wt 7 10164 4114.3 424.537 267.964 12.4464 51.2433 520837 9.59111 28  
Wt 8 7314 2960.65 274.263 324.891 14.4835 52.458 383678 8.36164 28  
Wt 9 5671 2295.57 369.776 389.47 27.5486 28.6928 162717 5.389 28  
Wt 10 11475 4644.99 279.628 134.978 23.6501 49.8126 571600 7.81935 28  
 175 
           
Img 
No 8 
Voxel 
Count 
Volume 
(µm³) Centroid X 
Centroid 
Y 
Centroid 
Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 15618 6322.04 355.341 235.025 11.2604 44.6134 696772 29.8957 28  
Wt 1 15041 6088.47 292.529 172.075 14.4875 42.5186 639522 6.2543 28  
Wt 2 11501 4655.51 189.084 456.15 17.9236 45.3553 521631 6.87323 28  
Wt 3 12430 5031.56 198.322 330.373 18.4267 35.9471 446823 6.03492 28  
Wt 4 14967 6058.52 296.91 474.318 13.3031 34.7166 519604 6.36099 28  
Wt 5 12609 5104.02 381.612 409.883 14.8718 27.2877 344070 5.93735 28  
Wt 6 10090 4084.35 231.77 237.227 24.1376 27.8793 281302 5.57047 28  
Wt 7 6607 2674.46 406.453 167.022 24.6911 43.0506 284435 6.01256 28  
Wt 8 8938 3618.03 380.3 495.088 23.6531 31.1232 278179 17.2517 28  
Wt 9 17111 6926.39 269.011 292.252 9.96733 29.7325 508753 6.95769 28  
Wt 10 5138 2079.82 423.35 12.3854 21.6162 131.713 676739 5.91475 28  
           
Img 
No 11 
Voxel 
Count 
Volume 
(µm³) 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Centroid 
X 
Centroid 
Y 
Centroid 
Z 
Clone 
cell 6177 2500.4 82.6667 510632 117.508 28 400.127 412.595 
8.524
2  
Wt 1 14232 5761 66.314 943781 4.34444 28 157.131 370.754 
11.18
2  
Wt 2 13875 5616.49 74.1209 1.03E+06 4.30941 28 160.762 225.75 
14.38
6  
Wt 3 13205 5345.28 75.2273 993376 5.34373 28 158.826 291.771 
8.703
8  
Wt 4 13733 5559.01 53.2673 731520 3.87847 28 279.895 268.383 
15.40
8  
Wt 5 13664 5531.07 72.8897 995965 5.32897 28 158.707 291.782 
9.039
5  
Wt 6 12309 4982.58 74.2259 913646 4.52458 28 157.332 370.887 10.29  
Wt 7 12352 4999.99 71.6338 884821 5.22579 28 224.97 301.92 
9.888
1  
Wt 8 8663 3506.71 81.2463 703837 4.8332 28 29.0914 304.518 
13.88
9  
Wt 9 10430 4221.98 77.3235 806484 3.73873 28 97.7404 201.518 
23.07
8  
           
Average intensity of Dref localization in 10 non adjacent wild type cells      
Img 
No 1 48.4682          
Img 
No 2 53.2019          
Img 
No 3 43.6525          
Img 
No 4 43.5848          
Img 
No 5 44.1755          
Img 
No 6 50.8796          
Img 
No 7 51.4239          
Img 
No 8 44.9324          
Img 
No 11 71.8054          
           
Intensity of Dref localization in clone cell V average intensity of Dref localization in 10 non adjacent wild type cells 
Img 
No 1 1.59          
Img 
No 2 2.07          
Img 
No 3 1.1          
Img 
No 4 0.87          
Img 
No 5 1.03          
Img 
No 6 0.94          
Img 
No 7 1          
 176 
Img 
No 8 1          
Img 
No 11 1.15          
           
Average value of the ratio of the clone cell V wild type cells acquired from 
Img No 1 to Img No 10  0.388365521     
Std Dev of the average ratio of clone cell / wild type cell 1.19444444     
 
B.7. (ii) Visualization of Dref protein in single cell clones expressing FOXO 
 
 
Img No 
1 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 4897 1982.27 375.6 310.878 14.2473 21.8517 107008 16.0856 28  
WT 1 15575 6304.63 224.415 206.745 10.6781 136.941 2.13E+06 5.42324 28  
WT 2 11078 4484.28 89.2942 311.583 19.7867 88.1677 976722 2.73948 28  
WT 3 13479 5456.19 108.379 226.299 11.448 16.1433 217596 3.19341 28  
WT 4 14319 5796.21 195.504 337.59 14.0323 200.847 2.88E+06 3.43292 28  
WT 5 11212 4538.53 361.481 166.222 20.1654 49.3318 553108 2.18016 28  
WT 6 9469 3832.97 193.071 274.472 6.26296 62.4085 590946 3.37744 28  
WT 7 10808 4374.99 424.286 242.217 9.79247 76.0552 822005 2.98788 28  
WT 8 13510 5468.74 108.421 226.299 11.4486 16.166 218403 3.18838 28  
           
Img No 
2 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 6049 2448.59 342.108 225.587 20.3715 38.0374 230088 20.8823 28  
WT 1 15331 6205.86 199.32 279.764 9.01644 55.5711 851961 6.06444 28  
WT 2 15335 6207.48 199.324 279.765 9.01682 55.5605 852021 6.06528 28  
WT 3 13747 5564.67 128.1 200.438 9.4721 40.3461 554638 6.69266 28  
WT 4 14356 5811.19 349.122 324.05 12.6733 18.8101 270038 5.81081 28  
WT 5 5396 2184.26 24.126 222.529 12.7166 90.1638 486524 5.4381 28  
WT 6 8868 3589.69 261.217 318.455 29.1053 19.6314 174091 3.39502 28  
WT 7 11157 4516.26 88.4358 113.169 12.9671 31.0388 346300 5.38003 28  
WT 8 15199 6152.43 241.383 354.481 11.1677 31.1371 473253 5.04744 28  
           
Img No 
3 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 1216 492.227 41.1513 241.415 11.0033 57.6488 70101 27.8865 21  
WT 1 11256 4556.34 232.274 186.324 18.3171 16.8251 189383 4.133 21  
WT 2 8793 3559.33 369.008 129.241 17.1591 26.4664 232719 3.57125 21  
WT 3 10942 4429.23 300.819 200.67 16.772 15.468 169251 4.37224 21  
WT 4 8095 3276.79 151.714 132.005 22.157 9.37356 75879 2.8656 21  
WT 5 8826 3572.69 330.107 229.223 23.8482 18.4099 162486 3.03988 21  
WT 6 8170 3307.15 188.566 251.02 25.0628 4.62876 37817 2.70184 21  
WT 7 6949 2812.9 204.129 115.043 31.1917 3.99597 27768 2.09656 21  
WT 8 8527 3451.66 303.025 102.961 28.4169 19.1637 163409 2.07928 21  
           
Img No 
4 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 7303 2956.19 363.386 443.577 7.60016 59.8228 436886 22.9521 21  
WT 1 14132 5720.52 291.554 249.164 13.6359 46.2291 653309 6.4821 21  
WT 2 14354 5810.38 281.576 310.506 18.2718 34.1589 490317 5.37829 21  
WT 3 12635 5114.54 240.532 263.373 21.9619 26.9453 340454 4.13613 21  
WT 4 12267 4965.58 168.99 124.452 23.8687 59.9623 735558 4.85701 21  
WT 5 7981 3230.64 299.287 119.725 23.5886 67.9777 542530 4.04999 21  
WT 6 6103 2470.44 399.066 355.092 20.1811 30.9023 188597 3.54039 21  
WT 7 12734 5154.62 161.215 47.8902 24.6492 63.2189 805030 3.6836 21  
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WT 8 8861 3586.86 206.572 148.584 13.0894 79.194 701738 6.11263 21  
           
Img No 
6 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 7098 2873.21 109.303 157.299 9.82065 29.8819 212102 21.2744 21  
WT 1 8172 3307.96 177.537 197.043 17.7122 11.0064 89944 4.9836 21  
WT 2 11857 4799.62 84.9397 73.8671 14.4626 24.8619 294787 5.42692 21  
WT 3 6720 2720.2 187.917 167.141 26.496 9.00863 60538 3.28914 21  
WT 4 6263 2535.21 86.7524 287.172 30.0158 8.88424 55642 2.32716 21  
WT 5 11596 4693.97 326.727 493.305 15.3965 23.0484 267269 7.31252 21  
WT 6 7473 3025.01 269.298 355.555 26.4081 12.2714 91704 6.21584 21  
WT 7 11716 4742.54 134.466 391.129 23.2597 9.80889 114921 4.20109 21  
WT 8 9167 3710.73 52.4041 207.399 26.4742 13.4633 123418 2.91153 21  
           
Img No 
7 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 1990 805.536 414.375 251.045 9.15327 55.8985 111238 29.5492 21  
WT 1 7877 3188.54 152.58 272.38 10.8956 31.1363 245261 8.23715 21  
WT 2 8771 3550.43 291.994 345.835 12.9498 21.3459 187225 6.32311 21  
WT 3 9096 3681.99 237.207 297.978 12.4757 21.2917 193669 7.35818 21  
WT 4 9921 4015.94 224.809 236.512 9.5953 52.1609 517488 7.90586 21  
WT 5 7586 3070.75 262.125 213.617 16.6277 7.28091 55233 10.7139 21  
WT 6 6072 2457.9 158.028 198.915 21.3613 40.5343 246124 4.55188 21  
WT 7 7967 3224.98 356.328 215.213 16.9667 30.1816 240457 4.37128 21  
WT 8 5026 2034.48 98.0251 206.822 12.0326 95.0493 477718 6.54318 21  
           
Img No 
8 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 11542 4672.11 286.499 408.29 15.9587 37.7211 435377 72.9244 21  
WT 1 12138 4913.36 201.222 373.605 15.6616 48.8208 592587 1.78687 21  
WT 2 13174 5332.73 203.953 453.387 16.8026 62.7194 826265 1.72666 21  
WT 3 10666 4317.51 320.98 243.583 19.2421 45.7475 487943 1.37943 21  
WT 4 7233 2927.86 368.211 484.199 16.6676 105.742 764835 4.51804 21  
WT 5 12259 4962.34 244.181 174.201 13.8058 65.4639 802522 1.85578 21  
WT 6 8244 3337.1 167.971 280.458 24.5304 17.759 146405 1.06174 21  
WT 7 5769 2335.24 347.098 321.55 24.832 44.0579 254170 1.45068 21  
WT 8 6319 2557.88 357.765 398.372 20.0392 42.9964 271694 2.04162 21  
           
Img No 
9 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 11905 4819.05 231.138 389.265 9.15691 46.5367 554020 115.238 21  
WT 1 10638 4306.17 296.272 279.017 13.4906 26.2712 279473 0.476593 21  
WT 2 11720 4744.16 201.702 217.089 13.9402 55.9625 655881 0.544881 21  
WT 3 10201 4129.28 222.283 101.375 14.6395 56.4311 575654 0.457504 21  
WT 4 10968 4439.76 303.885 479.659 16.1523 20.9043 229278 0.466083 21  
WT 5 6199 2509.3 356.197 359.769 16.8495 19.2707 119459 0.27327 21  
WT 6 4530 1833.71 91.689 151.512 16.2143 40.9161 185350 0.630243 21  
WT 7 7819 3165.07 103.409 234.773 15.7753 36.7053 286999 0.518736 21  
WT 8 4115 1665.72 164.33 350.827 27.7618 0.838639 3451 0.277278 21  
           
           
Img No 
10 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 6568 2658.67 312.575 157.738 8.83085 61.9353 406791 100.419 21  
WT 1 11559 4678.99 218.034 271.423 13.515 36.7489 424781 0.967731 21  
WT 2 6973 2822.61 228.82 369.204 11.4754 133.994 934340 1.24208 21  
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WT 3 6915 2799.13 191.89 459.823 16.4315 106.884 739105 0.941287 21  
WT 4 11006 4455.14 234.619 88.9119 15.9659 20.0054 220179 33.8953 21  
WT 5 9183 3717.2 337.44 60.5975 15.9796 30.5114 280186 1.6304 21  
WT 6 6719 2719.8 174.035 221.005 29.2913 4.43146 29775 0.507218 21  
WT 7 10410 4213.88 309.405 246.52 17.9939 21.483 223638 1.17839 21  
WT 8 4937 1998.46 168.635 3166.86 1713.94 29.4235 145264 0.575248 21  
           
Img No 
11 
Voxel 
Count 
Volume 
(µm³) 
Centroi
d X 
Centroi
d Y 
Centroi
d Z 
Mean 
(ChS1-T1) 
Sum 
(ChS1-T1) 
Mean 
(Ch3-T3) 
Min (Ch2-
T4) 
Clone 
cell 9637 3900.98 238.783 109.481 22.5438 12.1881 117457 53.0554 21  
WT 1 9380 3796.95 369.856 296.816 8.20992 82.7686 776369 1.17559 21  
WT 2 12345 4997.15 313.687 420.875 16.8358 38.7673 478582 0.701418 21  
WT 3 10599 4290.39 370.005 296.718 8.85876 75.5053 800281 1.09124 21  
WT 4 11512 4659.96 124.578 223.788 12.3464 83.7859 964543 0.946056 21  
WT 5 10073 4077.47 122.759 98.9131 12.4406 49.9169 502813 13.6841 21  
WT 6 2232 903.495 443.285 190.723 14.3132 57.1335 127522 0.737455 21  
WT 7 1579 639.166 396.669 127.174 27.4471 62.8778 99284 0.535149 21  
WT 8 15089 6107.9 267.783 199.961 6.95367 95.2693 1.44E+06 1.11114 21  
           
Average intensity of Dref localization in 10 non adjacent wild type 
cells       
 Img No 
1 80.758          
 Img No 
2 42.782          
 Img No 
3 14.291          
 Img No 
4 51.074          
 Img No 
6 14.044          
 Img No 
7 37.373          
 Img No 
8 54.163          
 Img No 
9 32.162          
 Img No 
10 47.935          
 Img No 
11 68.253          
           
Intensity of Dref localization in clone cell V average intensity of Dref localization in 10 non adjacent wild type cells  
 Img No 
1 0.27          
 Img No 
2 0.89          
 Img No 
3 4.03          
 Img No 
4 1.17          
 Img No 
6 2.12          
 Img No 
7 1.5          
 Img No 
8 0.7          
 Img No 
9 1.44          
 Img No 
10 1.29          
 Img No 
11 0.18          
           
Average value of the ratio of the clone cell V wild type cells acquired from Img No 1 to 
Img No 11  1.359    
Std Dev of the average ratio of clone cell / wild type cell   1.10606861    
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B.8. Analysis of the phenotypic effect of Simj expression on salivary gland size          
B.8. (i) Measurement of DAPI stained nuclei size from yw third instar salivary glands 
 
SG 1 1 Length Distance µm 27.61 
 2 Length Distance µm 27.33 
 3 Length Distance µm 24.29 
 4 Length Distance µm 28.5 
 5 Length Distance µm 25.98 
SG 2 1 Length Distance µm 25.84 
 2 Length Distance µm 24.39 
 3 Length Distance µm 25.83 
 4 Length Distance µm 27.79 
 5 Length Distance µm 22.52 
SG 3 1 Length Distance µm 27.1 
 2 Length Distance µm 29.81 
 3 Length Distance µm 25.32 
 4 Length Distance µm 27.34 
SG 4 1 Length Distance µm 27.1 
 2 Length Distance µm 24.17 
 3 Length Distance µm 25.12 
 4 Length Distance µm 24.55 
 5 Length Distance µm 26.31 
SG 5 1 Length Distance µm 26.18 
 2 Length Distance µm 27.86 
SG 6 1 Length Distance µm 24.61 
 2 Length Distance µm 24.52 
 3 Length Distance µm 26.99 
SG 7 1 Length Distance µm 28.54 
 2 Length Distance µm 27.33 
 3 Length Distance µm 28.94 
 4 Length Distance µm 22.4 
SG 8 1 Length Distance µm 27.76 
 2 Length Distance µm 26.7 
 3 Length Distance µm 26.62 
SG 9 1 Length Distance µm 30.77 
 2 Length Distance µm 33.9 
 3 Length Distance µm 29.07 
 4 Length Distance µm 26.96 
 5 Length Distance µm 26.03 
 6 Length Distance µm 29.79 
SG 10  1 Length Distance µm 30.08 
 2 Length Distance µm 26.18 
 3 Length Distance µm 30.41 
 4 Length Distance µm 26.1 
 5 Length Distance µm 29.51 
 6 Length Distance µm 33.22 
SG 11 1 Length Distance µm 29.63 
 2 Length Distance µm 30.63 
 3 Length Distance µm 30.35 
 4 Length Distance µm 25.68 
 5 Length Distance µm 25.62 
SG 12 1 Length Distance µm 34.49 
 2 Length Distance µm 30.28 
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 3 Length Distance µm 30.38 
 4 Length Distance µm 30.84 
 5 Length Distance µm 28.4 
SG 13 1 Length Distance µm 26.54 
 2 Length Distance µm 28.14 
 3 Length Distance µm 29.36 
 4 Length Distance µm 29.68 
 5 Length Distance µm 30.99 
 6 Length Distance µm 24.82 
 7 Length Distance µm 32.45 
SG 14 1 Length Distance µm 29.22 
 2 Length Distance µm 25.61 
 3 Length Distance µm 27.78 
 4 Length Distance µm 24.29 
 5 Length Distance µm 29.97 
SG 15 1 Length Distance µm 32.91 
 2 Length Distance µm 28.79 
 3 Length Distance µm 35.38 
 4 Length Distance µm 31.87 
SG 16 1 Length Distance µm 28.36 
 2 Length Distance µm 28.86 
 3 Length Distance µm 36.72 
SG 17 1 Length Distance µm 22.41 
 2 Length Distance µm 20.22 
SG 18 1 Length Distance µm 23.88 
 2 Length Distance µm 19.33 
 3 Length Distance µm 21.07 
 4 Length Distance µm 23.85 
SG 19 1 Length Distance µm 34.37 
 2 Length Distance µm 31.11 
 3 Length Distance µm 31.42 
 4 Length Distance µm 30.3 
SG 20 1 Length Distance µm 27.6 
 2 Length Distance µm 23.77 
 3 Length Distance µm 24.25 
SG 21 1 Length Distance µm 25.47 
 2 Length Distance µm 25.73 
 3 Length Distance µm 22.63 
 4 Length Distance µm 24.57 
 5 Length Distance µm 21.02 
Average value of nuclei size from 21 salivary glands 27.53789 
Standard deviation of the average value of nuclei size 3.424241 
 
   
B.8. (ii) Measurement of DAPI stained nuclei size from salivary glands of UAS-simj containing third instar 
larvae where expression of UAS-simj was not driven by c147-GAL4 driver. 
 
SG 1 1 Length Distance µm 26.05 
 2 Length Distance µm 25.98 
 3 Length Distance µm 25.53 
 4 Length Distance µm 24.42 
SG 2 1 Length Distance µm 24.47 
 2 Length Distance µm 23.13 
 3 Length Distance µm 24.87 
SG 3 1 Length Distance µm 27.51 
 2 Length Distance µm 29.39 
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 3 Length Distance µm 25.72 
 4 Length Distance µm 25.69 
SG 4 1 Length Distance µm 25.51 
 2 Length Distance µm 19.6 
 3 Length Distance µm 26.66 
 4 Length Distance µm 24.13 
 5 Length Distance µm 20.96 
SG 5 1 Length Distance µm 28.63 
 2 Length Distance µm 27.6 
 3 Length Distance µm 27.7 
 4 Length Distance µm 26.49 
 5 Length Distance µm 24.66 
SG 6 1 Length Distance µm 29.23 
 2 Length Distance µm 27.7 
 3 Length Distance µm 30.85 
 4 Length Distance µm 29.88 
SG 7 1 Length Distance µm 28.95 
 2 Length Distance µm 26.33 
 3 Length Distance µm 26.34 
 4 Length Distance µm 24.41 
 5 Length Distance µm 27.67 
 6 Length Distance µm 29.75 
 7 Length Distance µm 29.86 
SG 8 1 Length Distance µm 25.34 
 2 Length Distance µm 26.99 
 3 Length Distance µm 23.48 
SG 9 1 Length Distance µm 27.51 
 2 Length Distance µm 28.01 
 3 Length Distance µm 29.43 
 4 Length Distance µm 26.66 
 5 Length Distance µm 23.68 
 6 Length Distance µm 23.93 
 7 Length Distance µm 29.07 
SG 10 1 Length Distance µm 23.88 
 2 Length Distance µm 23.05 
 3 Length Distance µm 23.53 
 4 Length Distance µm 27.09 
 5 Length Distance µm 23.14 
SG 11 1 Length Distance µm 19.51 
 2 Length Distance µm 17.61 
 3 Length Distance µm 16.68 
 4 Length Distance µm 18.15 
 5 Length Distance µm 17.86 
 6 Length Distance µm 19.74 
 7 Length Distance µm 15.58 
SG 12 1 Length Distance µm 19.77 
 2 Length Distance µm 20.41 
 3 Length Distance µm 21.25 
 4 Length Distance µm 18.23 
 5 Length Distance µm 21.27 
SG 13 1 Length Distance µm 18.83 
 2 Length Distance µm 21.3 
 3 Length Distance µm 20.75 
 4 Length Distance µm 19.95 
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SG 14 1 Length Distance µm 20.71 
 2 Length Distance µm 19.66 
 3 Length Distance µm 20.53 
 4 Length Distance µm 21.98 
SG 15 1 Length Distance µm 24.02 
 2 Length Distance µm 23.32 
 3 Length Distance µm 23.47 
 4 Length Distance µm 27.84 
 5 Length Distance µm 23.1 
SG 16 1 Length Distance µm 25.9 
 2 Length Distance µm 25.23 
 3 Length Distance µm 20.77 
 4 Length Distance µm 24.19 
 5 Length Distance µm 23.89 
 1 Length Distance µm 25.18 
 2 Length Distance µm 23.74 
 3 Length Distance µm 25.91 
 4 Length Distance µm 24.98 
SG 17 1 Length Distance µm 27.77 
 2 Length Distance µm 27.19 
 3 Length Distance µm 24.58 
 4 Length Distance µm 27.03 
SG 18 1 Length Distance µm 25.04 
 2 Length Distance µm 20.89 
 3 Length Distance µm 21.77 
 4 Length Distance µm 26.81 
SG 19 1 Length Distance µm 21.51 
 2 Length Distance µm 21.01 
 3 Length Distance µm 20.5 
 4 Length Distance µm 21.41 
 5 Length Distance µm 19.96 
SG 20 1 Length Distance µm 25.24 
 2 Length Distance µm 22.07 
 3 Length Distance µm 21 
 4 Length Distance µm 20.75 
SG 21 1 Length Distance µm 21.1 
 2 Length Distance µm 26.78 
 3 Length Distance µm 23.05 
 4 Length Distance µm 21.88 
SG 22 1 Length Distance µm 27.16 
 2 Length Distance µm 24.4 
 3 Length Distance µm 25.5 
 4 Length Distance µm 20.86 
 5 Length Distance µm 26.01 
SG 23 1 Length Distance µm 19.98 
 2 Length Distance µm 20.88 
 3 Length Distance µm 20.54 
 4 Length Distance µm 18.66 
SG 24 1 Length Distance µm 22.43 
 2 Length Distance µm 19.68 
 3 Length Distance µm 25.41 
 4 Length Distance µm 21.1 
SG 25 1 Length Distance µm 30.54 
 2 Length Distance µm 24.64 
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 3 Length Distance µm 24.4 
SG 26 1 Length Distance µm 21.99 
 2 Length Distance µm 20.48 
 3 Length Distance µm 23.8 
SG 27 1 Length Distance µm 25.61 
 2 Length Distance µm 21.96 
 3 Length Distance µm 22.05 
 4 Length Distance µm 19.81 
SG 28 1 Length Distance µm 22.2 
 2 Length Distance µm 19.93 
 3 Length Distance µm 21.02 
 4 Length Distance µm 19.13 
 5 Length Distance µm 19.47 
SG 29 1 Length Distance µm 24.09 
 2 Length Distance µm 21.42 
 3 Length Distance µm 20.19 
 4 Length Distance µm 24.32 
 5 Length Distance µm 20.74 
SG 30 1 Length Distance µm 25.76 
 2 Length Distance µm 24.05 
 3 Length Distance µm 20.73 
SG 31 1 Length Distance µm 22.83 
 2 Length Distance µm 22.82 
 3 Length Distance µm 25.59 
SG 32 1 Length Distance µm 21.53 
 2 Length Distance µm 23.82 
 3 Length Distance µm 24.85 
B.8. (iii) Measurement of DAPI stained nuclei size from salivary glands of third instar larvae where expression 
of UAS-simj was driven by c147-GAL4 driver. 
 
SG 1 1 Length Distance µm 21.94 
 2 Length Distance µm 27.75 
 3 Length Distance µm 23.26 
 4 Length Distance µm 23.6 
 5 Length Distance µm 21.77 
SG 2 1 Length Distance µm 24.52 
 2 Length Distance µm 26.2 
 3 Length Distance µm 22.69 
SG 3 1 Length Distance µm 19.54 
 2 Length Distance µm 19.17 
 3 Length Distance µm 19.77 
 4 Length Distance µm 20.55 
 5 Length Distance µm 18.84 
SG 4 1 Length Distance µm 19.48 
 2 Length Distance µm 19.32 
 3 Length Distance µm 21.28 
 4 Length Distance µm 20.83 
 5 Length Distance µm 17.33 
 6 Length Distance µm 18.95 
 7 Length Distance µm 22.33 
SG 5 1 Length Distance µm 19.26 
 2 Length Distance µm 20.36 
 3 Length Distance µm 20.32 
 4 Length Distance µm 18.48 
SG 6 1 Length Distance µm 22.11 
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 2 Length Distance µm 26.07 
 3 Length Distance µm 17.49 
 4 Length Distance µm 21.03 
 5 Length Distance µm 18.33 
SG 7 1 Length Distance µm 19.53 
 2 Length Distance µm 20.55 
 3 Length Distance µm 19.66 
 4 Length Distance µm 19.4 
 5 Length Distance µm 18.4 
SG 8 1 Length Distance µm 17.59 
 2 Length Distance µm 14.45 
 3 Length Distance µm 17.26 
 4 Length Distance µm 15.72 
 5 Length Distance µm 18.81 
SG 9 1 Length Distance µm 16 
 2 Length Distance µm 17.95 
 3 Length Distance µm 17.33 
 4 Length Distance µm 17.71 
 5 Length Distance µm 16.65 
 6 Length Distance µm 17.11 
 7 Length Distance µm 17.55 
SG 10 1 Length Distance µm 16.68 
 2 Length Distance µm 18.89 
 3 Length Distance µm 19.03 
 4 Length Distance µm 19.7 
 5 Length Distance µm 21.56 
 6 Length Distance µm 19.4 
SG 11 1 Length Distance µm 21.66 
 2 Length Distance µm 21.3 
 3 Length Distance µm 21.58 
 4 Length Distance µm 20.87 
 5 Length Distance µm 18.94 
 6 Length Distance µm 19.67 
SG 12 1 Length Distance µm 26.04 
 2 Length Distance µm 23.58 
 3 Length Distance µm 20.96 
 4 Length Distance µm 20.7 
 5 Length Distance µm 19.88 
 6 Length Distance µm 23.03 
 7 Length Distance µm 22.83 
SG 13 1 Length Distance µm 21.42 
 2 Length Distance µm 23.52 
 3 Length Distance µm 22.35 
 4 Length Distance µm 23.39 
SG 14 1 Length Distance µm 27.11 
 2 Length Distance µm 25.36 
 3 Length Distance µm 24.08 
 4 Length Distance µm 26.26 
 5 Length Distance µm 23.65 
SG 15 1 Length Distance µm 20.75 
 2 Length Distance µm 26.84 
 3 Length Distance µm 21.81 
 4 Length Distance µm 24.9 
SG 16 1 Length Distance µm 22.66 
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 2 Length Distance µm 22.38 
 3 Length Distance µm 25.11 
 4 Length Distance µm 22.63 
 5 Length Distance µm 21.66 
SG 17 1 Length Distance µm 21.72 
 2 Length Distance µm 26.29 
 3 Length Distance µm 22.7 
 4 Length Distance µm 23.25 
 5 Length Distance µm 23.41 
 6 Length Distance µm 23.5 
 7 Length Distance µm 22.82 
 8 Length Distance µm 25.87 
SG 18 1 Length Distance µm 27.6 
 2 Length Distance µm 25.59 
 3 Length Distance µm 25.11 
 4 Length Distance µm 27.19 
SG 19 1 Length Distance µm 22.1 
 2 Length Distance µm 21.63 
 3 Length Distance µm 22.96 
 4 Length Distance µm 21.53 
 5 Length Distance µm 23.4 
SG 20 1 Length Distance µm 19.99 
 2 Length Distance µm 21.51 
 3 Length Distance µm 22.5 
 4 Length Distance µm 20.94 
SG 21 1 Length Distance µm 19.37 
 2 Length Distance µm 25.12 
 3 Length Distance µm 22.29 
 4 Length Distance µm 21.81 
SG 22 1 Length Distance µm 17.89 
 2 Length Distance µm 17.81 
 3 Length Distance µm 17.71 
 4 Length Distance µm 18.77 
SG 23 1 Length Distance µm 17.81 
 2 Length Distance µm 17.7 
 3 Length Distance µm 18.87 
 4 Length Distance µm 17.87 
SG 24 1 Length Distance µm 18.15 
 2 Length Distance µm 17.51 
 3 Length Distance µm 19.8 
 4 Length Distance µm 20.09 
 5 Length Distance µm 21.68 
 6 Length Distance µm 20.08 
 7 Length Distance µm 19.7 
 8 Length Distance µm 18.3 
 9 Length Distance µm 20.54 
SG 25 1 Length Distance µm 21.05 
 2 Length Distance µm 19.77 
 3 Length Distance µm 19.99 
 4 Length Distance µm 21.07 
 5 Length Distance µm 19.19 
Average value of nuclei size from 25 salivary glands 21.061308 
Standard deviation of the average value of nuclei size 2.8174103 
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B.8. (iv) One way ANOVA analysis of the data shown in appendix B.8 (i), B.8 (ii) and B.8 (iii)  
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One-way ANOVA: DATA versus GENES  
 
Source   DF       SS       MS       F      P 
GENES     2  2231.47  1115.73  113.53  0.000 
Error   361  3547.93     9.83 
Total   363  5779.39 
 
S = 3.135   R-Sq = 38.61%   R-Sq(adj) = 38.27% 
 
                          Individual 95% CIs For Mean Based on 
                           Pooled StDev 
Level    N    Mean  StDev  -------+---------+---------+---------+-- 
1       90  27.538  3.424                                 (---*--) 
2      144  23.621  3.218               (-*--) 
3      130  21.061  2.817  (-*--) 
                           -------+---------+---------+---------+-- 
                               22.0      24.0      26.0      28.0 
Pooled StDev = 3.135 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons among Levels of GENES 
 
Individual confidence level = 98.02% 
 
GENES = 1 subtracted from: 
 
GENES   Lower  Center   Upper  -----+---------+---------+---------+---- 
2      -4.902  -3.916  -2.930           (--*--) 
3      -7.483  -6.477  -5.470  (--*---) 
                               -----+---------+---------+---------+---- 
                                 -6.0      -3.0       0.0       3.0 
GENES = 2 subtracted from: 
 
GENES   Lower  Center   Upper  -----+---------+---------+---------+---- 
3      -3.448  -2.560  -1.672                (-*--) 
                               -----+---------+---------+---------+---- 
                                 -6.0      -3.0       0.0       3.0 
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B.9. Effect of Simj expression on Mi-2 localization in single cell clones 
For the data of  Visualization of Mi-2 protein in GFP marked control clone cells. refer Appendix B.2. (i)  
For the data of  Visualization of Mi-2 protein in single cell clones expressing NOS2 refer Appendix B.2. (ii) 
B.9. (i) Visualization of Mi-2 protein in single cell clones expressing simj 
  
          
Img No 
1 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 16360 6622.39 57 141.12 2.31E+06 34.0834 450.376 121.158 6.58191 
Wt 1 7803 3158.59 57 134.5 1.05E+06 0.066641 58.9468 231.115 6.39536 
Wt 2 6450 2610.91 57 137.121 884431 0.0724031 135.03 228.92 7.17395 
Wt 3 6553 2652.6 57 127.699 836809 0.0602777 146.638 318.454 7.77537 
Wt 4 6067 2455.87 57 124.882 757657 0.0525795 253.202 287.083 8.43036 
Wt 5 7037 2848.52 57 128.13 901654 0.0667898 321.164 297.007 8.19582 
Wt 6 11357 4597.22 57 130.938 1.49E+06 0.07185 85.6533 381.751 8.85163 
Wt 7 4918 1990.77 57 124.378 611690 0.0518503 37.2056 191.542 16.0702 
Wt 8 4313 1745.87 57 120.296 518836 0.0428936 483.09 306.288 14.2054 
Wt 9 4564 1847.47 57 128.315 585628 0.0580631 145.961 366.089 17.4189 
Wt 10 7057 2856.62 57 127.882 902460 0.0671674 321.05 296.46 8.18591 
          
Img No 
2 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 14667 5937.08 57 147.235 2.16E+06 106.857 111.108 355.654 8.96755 
Wt 1 6379 2582.17 57 107.023 682698 0.773632 422.654 171.442 8.37827 
Wt 2 2836 1147.99 57 96.3551 273263 0.538082 465.529 91.0815 6.44288 
Wt 3 6290 2546.14 57 105.174 661545 0.793323 286.41 127.942 7.10127 
Wt 4 4997 2022.74 57 98.9956 494681 0.923154 243.587 206.562 6.3336 
Wt 5 3766 1524.45 57 95.427 359378 0.644981 170.429 44.2262 6.25544 
Wt 6 4603 1863.26 57 98.6007 453859 1.09841 59.3167 160.709 6.10146 
Wt 7 5385 2179.8 57 107.846 580751 0.803528 460.835 324.756 8.42581 
          
Img No 
3 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 1 10897 4411.02 43 105.125 1.15E+06 100.482 69.3808 410.013 9.28421 
Wt 1 9418 3812.33 43 100.859 949889 5.40285 167.029 97.5033 14.8709 
Wt 2 10938 4427.61 43 116.031 1.27E+06 0.360304 393.396 64.4188 16.2063 
Wt 3 10338 4184.74 43 109.234 1.13E+06 0.397079 265.724 60.3963 17.8363 
Wt 4 10249 4148.71 43 119.768 1.23E+06 0.465997 369.051 186.718 14.6418 
Wt 5 9484 3839.05 43 103.639 982913 0.499578 374.002 395.276 13.7109 
Wt 6 7438 3010.84 43 100.523 747693 0.661871 186.82 355.517 13.5144 
Wt 7 9304 3766.18 43 100.792 937768 5.42197 166.839 97.4275 14.9012 
Wt 8 4113 1664.91 43 83.2815 342537 0.222952 465.848 362.801 13.3744 
          
Img No 
4 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 1 12135 4912.15 46 136.017 1.65E+06 131.048 73.6278 66.9926 6.75731 
Wt 1 9413 3810.3 46 104.73 985828 0.232976 299.246 192.522 11.1588 
Wt 2 7596 3074.8 46 98.5566 748636 0.180358 366.104 159.209 15.7353 
Wt 3 8831 3574.72 46 104.357 921574 0.226362 395.488 228.113 10.5665 
Wt 4 6251 2530.35 46 108.921 680867 0.158695 430.473 188.593 18.9736 
Wt 5 4965 2009.79 46 83.3398 413782 0.181269 388.245 438.983 12.4427 
          
Img No 
5 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 1 11912 4821.88 46 116.041 1.38E+06 86.7053 262.517 377.754 4.94233 
Wt 1 7862 3182.47 46 104.207 819274 1.43933 389.811 237.671 6.54299 
Wt 2 8910 3606.69 46 103.984 926498 0.885297 446.283 32.5094 4.98328 
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Wt 3 8910 3606.69 46 103.984 926498 0.885297 446.283 32.5094 4.98328 
Wt 4 14570 5897.82 46 106.463 1.55E+06 1.53974 83.7579 392.986 10.0226 
Wt 5 3761 1522.42 46 91.8282 345366 0.711513 483.096 275.215 9.95799 
Wt 6 10828 4383.09 46 99.1778 1.07E+06 1.71888 173.078 301.655 7.16236 
Wt 7 6918 2800.35 46 92.9818 643248 1.46343 283.103 284.763 6.13544 
Wt 8 6202 2510.52 46 92.4595 573434 1.31699 233.008 462.724 12.1098  
Wt 9 7090 2869.97 46 100.922 715540 1.1165 468.742 147.919 6.06135 
Wt 10 8786 3556.5 46 105.365 925740 1.3402 381.439 334.936 7.32825 
          
Img No 
6 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 1 10737 4346.25 82 144.792 1.55E+06 99.106 382.245 205.242 8.45925 
Wt 1 8151 3299.46 82 138.355 1.13E+06 1.2439 190.642 266.164 9.98736 
Wt 2 5951 2408.92 82 138.537 824432 1.13325 63.2121 315.229 9.09746 
Wt 3 3516 1423.25 82 131.48 462284 0.877986 186.644 376.67 10.1183 
Wt 4 5396 2184.26 82 135.979 733744 0.6894 449.377 331.161 10.4459 
Wt 5 4025 1629.29 82 141.379 569051 0.693913 225.77 175.476 14.2631 
Wt 6 4172 1688.79 82 132.339 552119 0.697987 336.289 373.71 10.8015 
Wt 7 5133 2077.8 82 138.425 710534 1.15995 131.847 310.744 10.1773 
Wt 8 6482 2623.86 82 144.29 935288 0.695927 362.157 136.408 17.8952 
Wt 9 4665 1888.35 82 136.768 638023 0.627653 193.52 295.749 28.0585 
Wt 10 4404 1782.7 82 137.188 604178 0.864668 283.085 180.765 22.2007 
          
Img No 
7 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 2 12052 4878.55 48 115.294 1.39E+06 50.3392 446.966 131.514 9.66653 
Wt 1 10324 4179.07 48 114.416 1.18E+06 6.90672 206.639 62.141 13.3637 
Wt 2 8672 3510.35 48 97.4154 844786 1.07922 241.722 151.791 13.0232 
Wt 3 10713 4336.53 48 111.816 1.20E+06 0.782881 310.893 55.49 12.1105 
Wt 4 8377 3390.94 48 99.0227 829513 1.06589 49.0674 42.1019 13.7572 
Wt 5 6804 2754.2 48 93.1974 634115 1.14947 235.311 272.532 12.8602 
Wt 6 8038 3253.72 48 99.6891 801301 0.840134 383.176 82.4943 11.1687 
Wt 7 8274 3349.25 48 99.9821 827252 1.09137 117.506 90.594 15.2236 
Wt 8 6397 2589.45 48 95.6301 611746 0.849304 136.869 164.634 23.1369 
Wt 9 4070 1647.5 48 91.0776 370686 0.746437 441.777 415.365 14.5973 
Wt 10 3715 1503.8 48 90.6323 336699 0.474832 492.25 293.276 29.5489 
          
Img No 
8 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroi
d X 
Centroi
d Y Centroid Z 
Clone 
cell 1 6063 2454.25 48 92.7236 562183 71.2057 371.73 188.228 16.8872 
Wt 1 10285 4163.28 48 105.176 1.08E+06 0.685853 171.67 152.74 9.84414 
Wt 2 8555 3462.99 48 110.321 943799 0.881707 403.47 361.087 28.3517 
Wt 3 7818 3164.66 48 112.952 883058 0.46879 161.899 170.223 26.5562 
Wt 4 7314 2960.65 48 104.331 763075 0.331146 272.52 168.699 26.5334 
Wt 5 7368 2982.51 48 111.402 820808 0.452904 157.032 249.292 27.8422 
Wt 6 7900 3197.85 48 102.947 813279 9.6243 75.4914 275.457 20.8491 
Wt 7 8657 3504.28 48 111.391 964308 0.354511 289.877 334.798 26.7977 
Wt 8 7226 2925.03 48 100.072 723117 0.314282 215.965 89.5086 22.8316 
Wt 9 6204 2511.33 48 111.563 692136 0.436331 262.281 381.69 17.829 
Wt 10 9198 3723.27 48 113.835 1.05E+06 0.262122 415.942 473.261 27.6655 
          
Average intensity of Mi-2 localization in 10 non adjacent wild type cells      
Img No 1 128.4141 
Img No 2 101.34591 
Img No 3 104.26594 
Img No 4 99.98088 
Img No 5 100.13723 
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Img No 6 137.474 
Img No 7 99.28787 
Img No 8 108.399 
Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non adjacent wild type cells 
Img No 1 1.09 
Img No 2 1.45 
Img No 3 1 
Img No 4 1.36 
Img No 5 1.15 
Img No 6 1.05 
Img No 7 1.16 
Img No 8 0.85 
Average value of the ratio of the clone cell V wild type cells acquired from Img No 1 
to Img No 10  1.13875     
Std Dev of the average ratio of clone cell / wild type cell 0.192460571     
 
B.9. (ii) Visualization of Mi-2 protein in single cell clones co expressing simj and NOS2 
 
Img No 
1 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 16172 6546.29 74 123.38 2.00E+06 21.7323 209.454 400.617 17.4676 
Wt 1 10776 4362.04 74 107.156 1.15E+06 7.54092 252.024 225.261 8.25965 
Wt 2 11466 4641.34 74 108.849 1.25E+06 7.54457 259.279 136.932 10.5404 
Wt 3 8045 3256.55 74 107.111 861711 7.5376 433.186 53.2793 10.0894 
Wt 4 11732 4749.02 74 109.527 1.28E+06 7.51432 354.609 143.346 9.58302 
Wt 5 8333 3373.13 74 106.685 889005 7.52274 433.489 53.6209 10.2934 
Wt 6 10327 4180.28 74 110.942 1.15E+06 7.08086 96.8129 224.166 21.5723 
Wt 7 10455 4232.1 74 107.647 1.13E+06 7.45806 159.288 197.558 14.5456 
Wt 8 8031 3250.88 74 106.099 852080 7.37106 263.567 86.5598 17.6076 
Wt 9 11045 4470.92 74 109.702 1.21E+06 7.51299 335.895 229.224 9.92214 
Wt 10 14609 5913.6 74 104.654 1.53E+06 7.22411 394.799 249.991 20.6995 
Wt 11 12654 5122.23 74 112.387 1.42E+06 7.38897 457.86 211.473 10.6776 
Wt 12 10458 4233.31 74 109.68 1.15E+06 7.28772 56.4343 282.082 13.8287 
          
Img No 
2 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 7598 3075.61 20 140.452 1.07E+06 36.667 295.14 160.866 8.2656 
Wt 1 2229 902.281 20 120.628 268880 0.0592194 298.851 351.624 10.1534 
Wt 2 1839 744.412 20 122.661 225573 0.0598151 358.953 194.269 14.6324 
Wt 3 2933 1187.25 20 123.267 361543 0.603478 208.024 283.56 11.4398 
Wt 4 6200 2509.71 20 129.018 799912 0.0496774 210.263 109.745 8.24532 
          
Img No 
3 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 2 10518 4257.6 36 113.101 1.19E+06 25.9756 113.54 76.7985 7.80643 
Wt 1 5906 2390.7 36 97.1392 573704 0.028615 324.328 187.99 13.5229 
Wt 2 5764 2333.22 36 94.2611 543321 0.0294934 398.222 374.03 13.4434 
Wt 3 2894 1171.47 36 91.1334 263740 0.0342087 409.428 268.281 15.5746 
Wt 4 6295 2548.16 36 96.346 606498 0.029865 323.859 188.042 13.2818 
Wt 5 2464 997.407 36 90.9947 224211 0.0434253 287.119 57.7228 15.9123 
Wt 6 3128 1266.19 36 92.7986 290274 0.0457161 470.256 465.329 11.4655 
Wt 7 4965 2009.79 36 104.999 521320 5.7565 386.103 454.155 10.7984 
Wt 8 2797 1132.2 36 92.5359 258823 0.0207365 296.506 432.159 18.6232 
Wt 9 4845 1961.22 36 91.9154 445330 0.0276574 306.421 116.699 14.7889 
Wt 10 6512 2636 36 96.5951 629027 0.0325553 275.406 337.272 14.601 
          
Img No 
4 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 2 6762 2737.2 21 102.576 693617 40.5945 49.1375 241.077 22.5568 
Wt 1 2375 961.38 21 66.3562 157596 0.119158 250.877 195.117 21.968 
Wt 2 2585 1046.39 21 66.3749 171579 0.109865 298.417 126.352 18.7911 
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Wt 3 1409 570.352 21 66.0823 93110 0.106458 499.216 99.1249 18.4592 
Wt 4 5402 2186.69 21 68.4304 369661 0.15124 172.493 195.208 16.5041 
Wt 5 2597 1051.24 21 67.0316 174081 0.174817 327.301 200.939 19.8552 
Wt 6 11364 4600.05 21 92.0505 1.05E+06 0.25308 27.6017 290.467 19.4423 
Wt 7 11059 4476.59 21 93.0073 1.03E+06 0.156434 62.9432 335.013 20.1609 
Wt 8 2710 1096.99 21 69.5251 188413 0.101107 163.166 355.57 11.7786 
Wt 9 6774 2742.06 21 90.1255 610510 0.130794 115.738 341.5 18.6181 
          
Img No 
5 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 3 6347 2569.21 51 110.665 702390 52.8793 325.764 211.777 27.1484 
Wt 1 5563 2251.86 51 111.536 620473 0.724609 105.396 266.527 26.1719 
Wt 2 6571 2659.89 51 111.541 732938 1.54984 87.9379 289.157 7.86653 
Wt 3 6474 2620.62 51 115.156 745523 1.3565 55.7098 389.281 6.10148 
Wt 4 6519 2638.84 51 115.015 749780 0.799049 69.1131 436.459 11.7928 
Wt 5 6033 2442.11 51 110.87 668876 1.39715 195.29 319.728 7.98989 
Wt 6 6903 2794.28 51 102.42 707002 0.97914 146.301 193.111 15.4485 
Wt 7 3306 1338.24 51 93.6034 309453 0.805808 415.896 89.7958 11.0266 
Wt 8 6236 2524.28 51 99.8161 622453 0.68313 486.299 27.2901 7.37171 
Wt 9 3741 1514.33 51 100.294 375201 0.871157 417.927 33.6172 10.3617 
          
Img No 
6 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 1 12381 5011.73 33 118.317 1.46E+06 91.5425 68.9879 186.166 14.4475 
Wt 1 7812 3162.23 33 100.612 785979 5.30364 201.783 77.6409 12.6624 
Wt 2 5703 2308.53 33 92.2779 526261 0.96686 424.319 119.253 6.47466 
Wt 3 4305 1742.63 33 83.4839 359398 0.840186 253.371 411.972 11.1022 
Wt 4 3921 1587.19 33 85.8202 336501 0.624586 407.377 308.667 10.9064 
Wt 5 4673 1891.59 33 84.6719 395672 1.00492 111.663 439.067 8.6101 
Wt 6 3706 1500.16 33 89.8079 332828 0.66082 471.025 240.413 10.629 
Wt 7 8022 3247.24 33 99.8736 801186 5.27774 202.405 77.7253 12.4814 
Wt 8 7214 2920.17 33 96.9885 699675 0.754921 454.835 191.906 19.2657 
Wt 9 4095 1657.62 33 82.8821 339402 1.14701 25.3888 371.083 7.84249 
Wt 10 3689 1493.28 33 83.621 308478 0.952833 367.144 31.8336 7.0309 
          
Img No 
7 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 9126 59106.1 46 116.208 1.06E+06 55.5371 86.5536 67.8617 7.99025 
Wt 1 1431 9268.11 46 85.8134 122799 0.489867 339.789 367.468 13.6171 
Wt 2 2748 17797.9 46 92.321 253698 0.394469 375.177 453.989 15.2682 
Wt 3 2103 13620.4 46 84.1555 176979 0.470281 337.789 365.628 14.292 
Wt 4 698 4520.71 46 83.894 58558 0.848138 113.301 342.94 15.9943 
Wt 5 2014 13044 46 84.1837 169546 0.459782 254.818 400.292 15.2175 
Wt 6 1605 10395.1 46 82.5445 132484 0.322118 333.394 248.903 14.4997 
Wt 7 511 3309.58 46 95.7358 48921 0.215264 448.374 423.155 8.48532 
Wt 8 458 2966.31 46 103.332 47326 0.255459 52.3472 343.98 5.23144 
          
Img No 
8 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 1 5159 2088.32 33 89.4315 461377 12.1022 62.516 184.495 6.93584 
Wt 1 2965 1200.21 33 76.6513 227271 4.8543 313.632 191.968 6.60236 
Wt 2 3195 1293.31 33 80.713 257878 2.73646 465.044 158.479 8.9011 
Wt 3 3847 1557.23 33 83.1339 319816 6.03483 278.747 147.807 11.2132 
Wt 4 2165 876.374 33 73.3266 158752 4.67945 222.654 183.005 7.65589 
Wt 5 1864 754.532 33 74.9453 139698 3.603 13.4871 105.137 8.57135 
Wt 6 4364 1766.51 33 82.2523 358949 3.46746 454.75 212.85 8.04629 
Wt 7 1330 538.373 33 73.8128 98171 5.33308 260.156 253.741 6.69624 
Wt 8 3140 1271.05 33 77.3914 243009 6.39108 151.116 207.164 6.61911 
Wt 9 2481 1004.29 33 80.5917 199948 5.41838 241.277 154.473 18.894 
Wt 10 4847 1962.03 33 88.0881 426963 0.736125 468.567 210.101 28.1314 
Wt 11 5367 2172.52 33 83.9765 450702 5.50419 318.822 153.324 20.64 
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Img No 
9 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 1 4906 1985.91 51 126.627 621232 9.57073 190.359 349.251 20.1981 
Wt 1 3141 1271.45 51 108.847 341887 1.65266 366.957 200.716 16.7896 
Wt 2 5238 2120.3 51 117.063 613176 2.73654 290.002 182.944 12.4519 
Wt 3 5754 2329.17 51 123.906 712956 2.40945 35.8479 325.8 17.8203 
Wt 4 6808 2755.82 51 124.862 850061 2.17847 59.1281 420.543 17.8685 
Wt 5 6808 2755.82 51 124.862 850061 2.17847 59.1281 420.543 17.8685 
Wt 6 5504 2227.97 51 119.234 656265 5.80142 333.212 306.852 16.6154 
Wt 7 5927 2399.2 51 119.63 709046 3.69226 121.964 429.526 6.25696 
Wt 8 4345 1758.82 51 113.008 491020 2.46053 193.529 426.195 8.98067 
Wt 9 5179 2096.42 51 117.283 607408 2.50048 265.778 260.33 15.3862 
Wt 10 2788 1128.56 51 130.387 363519 3.10976 62.3633 217.58 21.1646 
          
Img No 
10 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 1 8386 3394.58 51 132.969 1.12E+06 24.102 127.356 112.763 8.90651 
Wt 1 5141 2081.03 51 115.911 595901 6.94242 212.348 170.187 10.3202 
Wt 2 3073 1243.93 51 111.569 342853 3.85421 323.234 273.354 13.7491 
Wt 3 4833 1956.36 51 113.276 547463 6.53404 201.155 373.923 8.15622 
Wt 4 5064 2049.87 51 113.955 577068 5.85999 166.625 446.863 11.0737 
Wt 5 5700 2307.31 51 114.321 651631 7.90053 247.03 234.362 7.06649 
Wt 6 5969 2416.2 51 120.682 720348 5.44848 235.86 27.0756 8.97638 
Wt 7 4039 1634.95 51 113.083 456744 6.35083 281.482 444.351 9.41025 
Wt 8 3700 1497.73 51 112.04 414547 4.34676 108.976 221.151 14.0205 
Wt 9 3258 1318.81 51 113.675 370352 4.34254 251.206 80.2769 16.1357 
Wt 10 4040 1635.36 51 116.712 471515 3.37673 306.012 43.2859 18.0121 
Wt 11 3040 1230.57 51 110.27 335220 3.8727 122.975 374.218 14.6049 
          
Img No 
11 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 1 6420 2598.76 51 132.426 850177 44.7316 204.724 422.07 11.4545 
Wt 1 4572 1850.71 51 113.974 521087 3.70516 318.287 307.999 11.2657 
Wt 2 7732 3129.85 51 122.111 944165 3.48047 317.877 172.161 8.02742 
Wt 3 4525 1831.68 51 111.473 504417 4.02762 268.03 212.661 10.3386 
Wt 4 5617 2273.72 51 113.031 634895 3.43493 222.777 270.272 9.98309 
Wt 5 4553 1843.02 51 113.834 518285 3.73951 317.936 307.867 11.4707 
Wt 6 6451 2611.31 51 119.129 768499 2.86529 424.715 117.475 10.1959 
Wt 7 4119 1667.34 51 115.759 476810 1.23258 147.434 257.38 19.4817 
Wt 8 7151 2894.67 51 124.812 892530 3.64494 296.389 473.039 9.57013 
Wt 9 9874 3996.91 51 134.116 1.32E+06 2.83755 378.877 288.534 12.1791 
Wt 10 5249 2124.75 51 117.71 617861 1.83768 369.971 393.477 11.9042 
          
Img No 
12 
Voxel 
Count 
Volume 
(µm³) 
Min 
(ChS2-T2) 
Mean 
(ChS2-T2) 
Sum 
(ChS2-T2) 
Mean 
(Ch3-T3) 
Centroid 
X 
Centroi
d Y 
Centroi
d Z 
Clone 
cell 1 1310 530.277 51 91.4618 119815 16.8015 246.427 331.27 11.2359 
Wt 1 10693 4328.44 51 128.509 1.37E+06 0.192088 348.976 190.269 9.67446 
Wt 2 8180 3311.2 51 121.693 995445 0.162103 459.046 217.906 9.19951 
Wt 3 8212 3324.15 51 112.869 926878 0.183999 79.0043 256.897 11.6111 
Wt 4 9819 3974.65 51 131.015 1.29E+06 0.217741 67.6166 87.7511 11.1855 
Wt 5 8974 3632.6 51 113.611 1.02E+06 0.167818 191.84 138.977 9.7183 
Wt 6 8322 3368.68 51 113.014 940506 0.173276 432.103 298.146 9.01754 
Wt 7 7475 3025.82 51 111.091 830408 0.146355 445.508 395.162 8.96829 
Wt 8 5311 2149.85 51 104.164 553217 0.144229 335.86 409.082 9.62531 
Wt 9 7779 3148.88 51 111.224 865209 0.137935 490.169 464.469 9.82311 
Wt 10 4368 1768.13 51 102.095 445951 0.466346 283.117 57.8633 8.54006 
Average intensity of Mi-2 localization in 10 non adjacent wild type cells    
Img No 1 108.3699 
Img No 2 123.8935 
Img No 3 94.87184 
Img No 4 75.44264 
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Img No 5 106.6946 
Img No 6 90.0039 
Img No 7 88.99749 
Img No 8 79.53481 
Img No 9 119.9082 
Img No 10 114.1358 
Img No 11 118.5949 
Img No 12 114.9285 
Intensity of Mi-2 localization in clone cell V average intensity of Mi-2 localization in 10 non adjacent wild type cells 
Img No 1 1.3 
Img No 2 1.13 
Img No 3 1.13 
Img No 4 1.19 
Img No 5 1.36 
Img No 6 1.03 
Img No 7 1.31 
Img No 8 1.12 
Img No 9 1.05 
Img No 10 1.16 
Img No 11 1.11 
Img No 12 0.79 
Average value of the ratio of the clone cell V wild type cells acquired from Img No 1 to Img No 10        1.14   
Std Dev of the average ratio of clone cell / wild type cell 0.15076 
 
C. List of CPTI lines Annotated and Screened  
 
C.1. List of CPTI lines Annotated 
 
CPTI-000106, CPTI-000110, CPTI 000205, CPTI-000232, CPTI-000239, CPTI-000256, CPTI 000340 , CPTI-000546, CPTI-000703, CPTI-
000762, CPTI-000765, CPTI 000774, CPTI-000787, CPTI-000836, CPTI-000847, CPTI-000877, CPTI-000943, CPTI-000944, CPTI 
001017, CPTI-001031, CPTI-001137, CPTI-001166, CPTI-001218, CPTI-001223, CPTI-001224, CPTI-001259, CPTI-001261, CPTI-
001262, CPTI-001272, CPTI-001279, CPTI-001282, CPTI-001308, CPTI-001309, CPTI-001323, CPTI-001324, CPTI-001328, CPTI-
001332, CPTI-001334, CPTI-001341, CPTI-001403, CPTI-001412, CPTI-001414, CPTI-001423, CPTI-001427, CPTI-001455, CPTI-
001478, CPTI-001481, CPTI-001488, CPTI-001495, CPTI-001515, CPTI-001516, CPTI-001527, CPTI-001569, CPTI-001586, CPTI-
001589, CPTI-001595, CPTI- 001636, CPTI-001654, CPTI-001660, CPTI-001678, CPTI 001685, CPTI-001692, CPTI-001693, CPTI-
001695, CPTI-001709, CPTI-001714 , CPTI-001718, CPTI-001735, CPTI-001740, CPTI-001765, CPTI-001769, CPTI-001771, CPTI-
001775, CPTI-001796, CPTI-001879, CPTI-001881, CPTI-001883, CPTI-001919, CPTI-001977, CPTI-001987, CPTI-001990, CPTI-
002016, CPTI-002032, CPTI-002035, CPTI-002085, CPTI-002102, CPTI-002118, CPTI-002129, CPTI-002256, CPTI-002264, CPTI-
002285, CPTI-002292, CPTI-002315, CPTI-002343, CPTI-002401, CPTI-002487, CPTI 002773 , CPTI 002786, CPTI-002805, CPTI-
100038. 
 
C.2. List of CPTI lines Screened 
 
CPTI-000847, CPTI-000256, CPTI-001409, CPTI- 000106, CPTI -000199, CPTI -001332, CPTI 000205, CPTI 000232, CPTI 000239, CPTI 
000340 CPTI 000472, CPTI 000546, CPTI 000703, CPTI 000762, CPTI 001017, CPTI 000765, CPTI 000774, CPTI 000787, CPTI 000836, 
CPTI 001224, CPTI 001223 , CPTI 000943, CPTI 001031, CPTI 001166, CPTI 001279, CPTI 001308, CPTI 001198, CPTI 001218, CPTI 
001259, CPTI 001262, CPTI 001272, CPTI 001282, CPTI 001309, CPTI 001323, CPTI 001324, CPTI 001328, CPTI 001334, CPTI 001883, 
CPTI 001455, CPTI 001478., CPTI 001775, CPTI 001802, CPTI 001881, CPTI 001987, CPTI 002118, CPTI 002292, CPTI 002016, CPTI 
001998, CPTI 002035, CPTI 002315, CPTI 002292, CPTI 002773, CPTI 002264, CPTI 001919, CPTI 002406, CPTI 002032, CPTI 000877, 
CPTI 002786, CPTI 002264, CPTI 002129, CPTI 002256, CPTI 002085, CPTI 001569, CPTI 001527,CPTI 001586, CPTI 001660, CPTI 
001636, CPTI 001685, CPTI 001714, CPTI 001718,  CPTI 001802, CPTI 001692 CPTI 000774, CPTI 001879, CPTI 002805, CPTI 100038. 
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 COMPONENTS OF NURD COMPLEX  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NuRD component Organism Developmental Roles 
HDAC1/2   
i) Rpd3 
 
ii) Hda-1 
 
iii) Hdac1/2 
D.  melanogaster 
 
C.  elegans 
 
M. musculus 
Groucho-mediated transcriptional repression. 
(Mannervik M, 1999). 
Embryonic viability.(Solari and Ahringer, 2000). 
 
Control of proliferation.(Montgomery et al., 2007) 
RbAp46/48   
i) Rba-1 
 
   ii)  RbAp46/48 
C. elegans 
 
D.  melanogaster 
 
Embryonic viability. (Solari and Ahringer, 2000) 
 
Histone binding. (Ahringer, 2000) 
Mi-2   
     i)   dMi-2 
 
 
    ii)   let-418 
   
 
    iii)  Chd4 
D.  melanogaster 
 
 
C. elegans. 
 
 
M. musculus 
 
Hox repression, larval and germ cell viability. 
(Kehle et al., 1998). 
 
Larval viability, vulval development, maintenance. 
(Solari and Ahringer, 2000). 
 
Haematopoiesis, epidermal development, 
peri-implantation development. 
(Kashiwagi M, 2007 ). 
MTA1/2  . 
    i)   mta1/2 
 
   ii)   Egr-1 
 
   iii)   Mta2 
D.  melanogaster 
 
C. elegans. 
 
M. musculus 
Interaction with hunchback, polycomb repression 
(Kehle et al., 1998). 
Embryonic patterning, Hox regulation. (Solari and 
Ahringer, 2000). 
Metastasis. (Toh et al., 1995). 
Mbd3   
    i) dMbd2/3 
 
  ii)  Mbd2/3 
 
  iii) Mbd3 
D.  melanogaster 
 
C. elegans. 
 
M. musculus 
 
Methylation mediated gene silencing (Feng and 
Zhang, 2001). 
Morphological defects. (Gutierrez and Sommer, 
2004) 
Silencing of pre-implanation genes. (Keisuke Kaji, 
2007) 
P66   
  i)  Simj 
 
 ii) p66 
D.  melanogaster 
 
M. musculus 
 
Wnt signalling, activation of ecdysone responsive 
genes. (Kon et al., 2005) 
Pleiotrophic effects post-gastrulation, silencing of a 
few TE genes. (Marino and Nusse, 2007). 
 
P66 
MTA1/2 Mi-2 
HDAC1 HDAC2 
RbAp46 RbAp48 
MBD3 
Schematic diagram of 2MDa NuRD complex consisting of eight polypeptides: MTA1/2, 
HDAC1, HDAC2, RbAp46, RbAp48, MBD3, p66 and Mi-2. Figure adopted from 
(Ahringer, 2000). 
  
